<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<!-- Created by: EDGAR Online, Inc. EDGAR Filing HTML Converter, Version: 4.63, http://www.edgar-online.com -->
<TITLE> MyoKardia Inc (Form: 10-K, Received: 03/18/2016 14:16:35) </TITLE>
<META NAME="TABLES" CONTENT="FIS_FORM **FIS_PART_I **FIS_BUSINESS **FIS_LEGAL_PROCEEDINGS **FIS_RISK_FACTORS **FIS_UNRESOLVED_STAFF_COMMENTS **FIS_PROPERTIES **FIS_MINE_SAFETY_DISCLOSURE **FIS_PART_II **FIS_MARKET **FIS_FINANCIAL_DATA **FIS_MANAGEMENTS_DISCUSSION **FIS_RESULTS_OF_OPERATIONS **FIS_LIQUIDITY_CAPITAL **FIS_MARKET_RISK **FIS_FINANCIAL_STATEMENTS **FIS_ACCOUNTING_CHANGES **FIS_CONTROL_AND_PROCEDURES **FIS_OTHER_INFORMATION **FIS_PART_III **FIS_DIRECTORS_AND_OFFICERS **FIS_COMPENSATION **FIS_SECURITY_OWNERS **FIS_OFFICER_TRANSACTIONS **FIS_ACCOUNTANT_FEES **FIS_PART_IV **FIS_EXHIBITS **FIS_NOTES_TO_FINANCIAL_STATEMENT **FIS_AUDITORS_OPINION **FIS_BALANCE_SHEET **FIS_INCOME_STATEMENT **FIS_STOCKHOLDERS_EQUITY **FIS_CASH_FLOW **FIS_INCOME_STATEMENT_2 **FIS_SIGNATURES **FIS_EXHIBIT_INDEX FIS_EXHIBIT_23 **FIS_EXPERTS_CONSENT FIS_EXHIBIT_31 **FIS_CERTIFICATION FIS_EXHIBIT_31_2 **FIS_CERTIFICATION_2 FIS_EXHIBIT_32 **FIS_CERTIFICATION_3 FIS_EXHIBIT_32_2 **FIS_CERTIFICATION_4 ">
<META NAME="DETECTED PAGES" CONTENT="112">
<STYLE TYPE="text/css">
<!--
	body          { background-color: white; color: black }
	.eolNewPage   { page-break-after: always; line-height: 0; height: 0; margin: 0; padding: 0 }
	.eolLeftAlign { text-align: left; margin-left: auto; margin-right: auto }
	.eolCenter    { text-align: center }
	a:link        { color: blue }
	a:active      { color: red }
	a:visited     { color: purple }
	
	@media print
	{
		@page           { margin: 0.25in }
		body            { font-size: 10pt }
		a               { text-decoration: none }
		thead           { display: table-header-group }
		tfoot           { display: table-footer-group }
		hr.eolPageBreak { display: none }
		.eolPrint50pt   { font-size: 5pt }
		.eolPrint55pt   { font-size: 5.5pt }
		.eolPrint60pt   { font-size: 6pt }
		.eolPrint65pt   { font-size: 6.5pt }
		.eolPrint70pt   { font-size: 7pt }
		.eolPrint75pt   { font-size: 7.5pt }
		.eolPrint80pt   { font-size: 8pt }
		.eolPrint85pt   { font-size: 8.5pt }
		.eolPrint90pt   { font-size: 9pt }
		.eolPrint95pt   { font-size: 9.5pt }
	}
-->
</STYLE>
</HEAD>
<BODY>
<A NAME="eolPage1"></A>
<A NAME="FIS_TOP_OF_DOCUMENT"></A>

<A NAME="MYOK-10K_20151231_HTM"></A>
<EFX_FORM>
<A NAME="FIS_FORM"></A>
<P STYLE="MARGIN-TOP:4PT;BORDER-TOP:DOUBLE 2.25PT;PADDING-TOP:1PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-SIZE:4PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:16PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	UNITED STATES
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:16PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	SECURITIES AND EXCHANGE COMMISSION
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:11PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	WASHINGTON, D.C. 20549
</P>
<P STYLE="TEXT-ALIGN:CENTER;BORDER-BOTTOM:SOLID 0.75PT;PADDING-BOTTOM:1PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:40%;MARGIN-RIGHT:40%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:3PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:16PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	FORM 10-K
</P>
<P STYLE="TEXT-ALIGN:CENTER;BORDER-BOTTOM:SOLID 0.75PT;PADDING-BOTTOM:1PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:40%;MARGIN-RIGHT:40%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:2PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Mark One)
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-SIZE:11PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:11PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:'WINGDINGS';">
</FONT>
<FONT STYLE="FONT-SIZE:11PT;FONT-FAMILY:'WINGDINGS'">
	&#120;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:11PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	For the Fiscal Year Ended December&#160;31, 2015
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:3PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Or
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:3PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-SIZE:11PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:11PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:'WINGDINGS';">
</FONT>
<FONT STYLE="FONT-SIZE:11PT;FONT-FAMILY:'WINGDINGS'">
	&#111;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:3PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:11PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:3PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__CP_TEXT_1_1">
</A>
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;">
	For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Commission File Number: 001-37609
</P>
<P STYLE="TEXT-ALIGN:CENTER;BORDER-BOTTOM:SOLID 0.75PT;PADDING-BOTTOM:1PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:40%;MARGIN-RIGHT:40%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:3PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:22PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA,&#160;INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Exact name of registrant as specified in its charter)
</P>
<P STYLE="TEXT-ALIGN:CENTER;BORDER-BOTTOM:SOLID 0.75PT;PADDING-BOTTOM:1PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:40%;MARGIN-RIGHT:40%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:2PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:3PT;">
	&nbsp;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:540PT;;">
<TR>
<TD STYLE="WIDTH:180.05PT;">
</TD>
<TD STYLE="WIDTH:180.05PT;">
</TD>
<TD STYLE="WIDTH:179.9PT;">
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Delaware
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2834
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	44-5500552
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:7PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(State or other jurisdiction of
<BR>
	incorporation or organization)
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:7PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Primary Standard Industrial
<BR>
	Classification Code Number)
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:7PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(I.R.S. Employer
<BR>
	Identification No.)
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333 Allerton Avenue
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	South San Francisco, CA 94080
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:7PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Address of Principal Executive Offices) (Zip Code)
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(650)&#160;741-0900
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:7PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Registrant&#8217;s Telephone Number, Including Area Code)
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Securities registered pursuant to Section&#160;12(b) of the Act:
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:3PT;">
	&nbsp;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:49%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:7PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Title of Each Class:
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:7PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:49%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:7PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Name of Each Exchange on which Registered
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:49%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:7PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Common Stock, par value $0.0001 per share
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:7PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:49%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:7PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The NASDAQ Global Select Market
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Securities registered pursuant to Section&#160;12(g) of the Act:
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	None
</P>
<P STYLE="TEXT-ALIGN:CENTER;BORDER-BOTTOM:SOLID 0.75PT;PADDING-BOTTOM:1PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:40%;MARGIN-RIGHT:40%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:2PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act. Yes&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#111;
</FONT>
</FONT>
	&#160;No&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#120;
</FONT>
</FONT>
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act. Yes&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#111;
</FONT>
</FONT>
	&#160;No&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#120;
</FONT>
</FONT>
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;Yes&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#120;
</FONT>
</FONT>
	&#160;No&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#111;
</FONT>
</FONT>
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&#160;405 of Regulation&#160;S-T
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;COLOR:#000000;">
	(&#167;232.405 of this chapter)
</FONT>
	during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit and post such files).&#160;Yes&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#120;
</FONT>
</FONT>
	&#160;No&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#111;
</FONT>
</FONT>
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__CP_TEXT_1_3">
</A>
	Indicate by check mark if disclosure of delinquent filers pursuant to Item&#160;405 of Regulation&#160;S-K
<A NAME="MYOK-10K_20151231_HTM__CP_TEXT_1_3">
</A>
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;COLOR:#000000;">
	(&#167;229.405)
</FONT>
	is not contained herein, and will not be contained, to the best of registrant&#8217;s knowledge, in definitive proxy or information statements incorporated by reference in Part&#160;III of this Form&#160;10-K or any amendment to this Form&#160;10-K.
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#120;
</FONT>
</FONT>
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;smaller reporting company&#8221; in Rule&#160;12b-2 of the Exchange Act.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:3PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:21%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Large accelerated filer
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:2%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:9PT;FONT-FAMILY:'WINGDINGS'">
	&#111;
</FONT>
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:55%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:20%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accelerated filer
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:2%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:9PT;FONT-FAMILY:'WINGDINGS'">
	&#111;
</FONT>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:21%;">
<P STYLE="MARGIN-TOP:3PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Non-accelerated filer
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:2%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:3PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:8.5PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#120;
</FONT>
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:55%;">
<P STYLE="MARGIN-TOP:3PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Do not check if a smaller reporting company)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:20%;">
<P STYLE="MARGIN-TOP:3PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Smaller reporting company
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:2%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:3PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:9PT;FONT-FAMILY:'WINGDINGS'">
	&#111;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;Yes&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#111;
</FONT>
</FONT>
	&#160;No&#160;
<FONT STYLE="FONT-FAMILY:'WINGDINGS';">
<FONT STYLE="FONT-SIZE:8PT;FONT-FAMILY:'WINGDINGS'">
	&#120;
</FONT>
</FONT>
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The registrant did not have a public float on June 30, 2015 (the last business day of its most recently completed second fiscal quarter) because there was no public market for the registrant&#8217;s common equity as of such date.
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The number of outstanding shares of the registrant&#8217;s common stock on March 15, 2016 was 27,016,081 shares.
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	DOCUMENTS INCORPORATED BY REFERENCE
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-SIZE:8.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Part&#160;III of this Annual Report on Form 10-K incorporates information by reference to portions of the definitive proxy statement for the Company&#8217;s Annual Meeting of Stockholders to be held in 2016, to be filed within 120&#160;days of the registrant&#8217;s fiscal year ended December&#160;31, 2015.
</P>
<P STYLE="BORDER-BOTTOM:DOUBLE 2.25PT;PADDING-BOTTOM:1PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:4PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:4PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:4PT;">
	&nbsp;
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage2"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU2">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	TABLE OF CONTENTS
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MyoKardia,&#160;Inc.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:11.67%;MARGIN-RIGHT:11.67%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Annual Report on Form&#160;10
<FONT STYLE="FONT-WEIGHT:NORMAL;">
	-
</FONT>
	K for the Fiscal Year Ended December 31, 2015
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_TOC">
</A>
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:8.5%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:83.16%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Page
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_PART_I">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Part&#160;I
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%; BORDER-TOP:SOLID 1PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;1. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_1_BUSINESS">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Business
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;1A. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_1A_RISK_FACTORS">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Risk Factors
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	34
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;1B. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_1B_UNRESOLSTAFFCOMMENTS">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Unresolved Staff Comments
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	60
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;2. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_2_PROPERTIES">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Properties
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	60
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;3. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_3_LEAGALPROCEEDINGS">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Legal Proceedings
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	61
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;4. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_4_MINESAFETYDIS">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Mine Safety Disclosures
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	61
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_PART_II">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Part&#160;II
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;5. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	62
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;6. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_6_SELECTED_CONSOLIDATED_FINANCIAL_D">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Selected Financial Data
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	64
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;7. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_7_MANAGEMENTS_DISCUSSION__ANALYSIS_">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	65
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;7A. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_7A_QQDISCMARKETRISK">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Quantitative and Qualitative Disclosures About Market Risk
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	74
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;8. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Financial Statements and Supplementary Data
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	75
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;9. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	75
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;9A. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_9_A_CONTROLS_PROCEDURE_S">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Controls and Procedures
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	75
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;9B. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_9_B_OR_INFORMATION">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Other Information
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	75
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_PART_III">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Part&#160;III
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;10. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_10_DIROFFANDCORPGOV">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Directors, Executive Officers and Corporate Governance
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	76
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;11. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_11_EXECUTIVE_COMPENSATION">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Executive Compensation
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	76
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;12. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	76
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;13. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Certain Relationships and Related Transactions, and Director Independence
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	76
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;14. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_14_PRINCIPAL_ACCOUNTANT_FEES_SERVIC">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Principal Accountant Fees and Services
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	76
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_PART_IV">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Part&#160;IV
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:8.5%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:10PT;;TEXT-INDENT:-10PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Item&#160;15. &#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:83.16%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Exhibits and Financial Statement Schedules
</FONT>
</A>
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	77
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage3"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU3">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management&#8217;s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Forward-looking statements include all statements that are not historical facts. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;objective,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;design,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;plan&#8221; or the negative of these terms, and similar expressions intended to identify forward
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	looking statements, and similar expressions and comparable terminology intended to identify forward
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties, including those set forth below in Item&#160;1A, &#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 10-K.&nbsp;&nbsp;Forward
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	looking statements include, but are not limited to, statements about:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the timing and success of our ongoing Phase 1 clinical trials of MYK-461;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the timing of, and our ability to initiate, Phase 2 clinical trials of MYK-461 in obstructive and symptomatic nonobstructive HCM patients;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to enroll patients in our clinical trials at the pace that we project;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to obtain regulatory approval for any of our product candidates without the need for large, outcome-based studies;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to identify and advance through clinical development any additional product candidates from our precision medicine platform, including from our HCM-2, DCM-1 and LUS-1 programs;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to successfully maintain our strategic collaboration with Sanofi;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to obtain and maintain intellectual property protection for our precision medicine platform and our product candidates;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to successfully build a specialty sales force and commercial infrastructure to market MYK-461 and any product candidates from our program, if approved, in the United States and any product candidates for our other programs worldwide;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to compete with companies currently producing or engaged in the clinical development of treatments for the disease indications that we pursue;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our reliance on third parties to conduct our clinical trials and to manufacture drug substance for use in our clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to retain and recruit key personnel;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our expectations regarding government and third-party payor coverage and reimbursement;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our estimates of our expenses, ongoing losses, future revenue, capital requirements and our needs for or ability to obtain additional financing;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our expectations regarding the time during which we will be an emerging growth company under the JOBS Act;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our financial performance; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	developments and projections relating to our competitors or our industry.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements represent our estimates and assumptions only as of the date of this Annual Report on Form&#160;10-K and, except as required by law, we undertake no obligation to update or revise publicly any forward
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	looking statements, whether as a result of new information, future events or otherwise after the date of this Annual Report on Form&#160;10 -K. We qualify all of our forward-looking statements by these cautionary statements.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-STYLE:ITALIC;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;">
	All
</FONT>
<FONT STYLE="COLOR:#000000;">
	brand
</FONT>
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;">
	names or trademarks appearing in this report are the property of their respective holders. Unless the context requires otherwise, references in this report to &#8220;MyoKardia&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to MyoKardia, Inc.
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage4"></A>
<EFX_PART_I>
<A NAME="FIS_PART_I"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU4">
</A>
<A NAME="MYOK-10K_20151231_HTM_PART_I">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_PART_I">
</A>
	PART
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	I
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:6PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:6PT;">
	&nbsp;
</P>
<EFX_BUSINESS>
<A NAME="FIS_BUSINESS"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_1_BUSINESS">
</A>
	ITEM 1.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_1_BUSINESS">
</A>
	BUSINESS
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Overview
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MyoKardia, Inc., incorporated under the laws of the State of Delaware in June 2012, is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Our initial focus is on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. We have used our precision medicine platform to generate an initial pipeline of four therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy&#8212;hypertrophic cardiomyopathy, or HCM, and dilated cardiomyopathy, or DCM. We have discovered and advanced our lead product candidate, MYK-461, into Phase 1 clinical development. In our first Phase 1 clinical trial, we have demonstrated proof of mechanism, or the ability of MYK-461 to reduce cardiac muscle contraction, an important biomarker of disease. We intend to expand our approach to deliver treatments with disease-modifying potential for patients with other forms of genetically-driven heart failure.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	HCM is caused by genetic mutations that result in a biomechanical defect leading to excessive cardiac muscle contraction. We estimate that as many as 630,000 people in the United States suffer from a form of HCM. DCM results from a biomechanical defect leading to inadequate cardiac muscle contraction. In a subset of DCM patients, genetic mutations have been identified as a cause of the biomechanical defect that leads to the abnormal cardiac muscle contraction. We refer to this subset of DCM as heritable DCM. We estimate that DCM afflicts about one million people in the United States, of which approximately 400,000 have a form of heritable DCM. There are currently no approved therapies indicated for the treatment of HCM or DCM, including heritable DCM, all of which are chronic and debilitating diseases. Patients are typically treated with drugs that are indicated for broader cardiovascular disorders and do not address the underlying cause of the disease. As the disease progresses, patients have limited treatment options, such as surgical or other invasive interventions and heart transplant.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our goal is to be the world&#8217;s leading precision cardiovascular medicine company. Precision medicine involves discovering and developing therapies that integrate clinical and molecular information based on the biological basis of disease. This approach has led to the efficient discovery and development of transformative therapies in areas such as oncology, cystic fibrosis and hypercholesterolemia, but has yet to be broadly applied to cardiovascular diseases.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our precision medicine platform incorporates disease research, drug discovery and clinical science in a self-reinforcing cycle that enables the iterative generation of new disease targets and clinical development candidates designed to establish early clinical proof of concept. We intend to use our platform to subdivide HCM and heritable DCM patients into subgroups based on genetic mutations and the resulting biomechanical defect leading to abnormal cardiac muscle contraction. We are developing targeted therapies designed to correct the underlying biomechanical defect of each subgroup. As a cornerstone of this platform, we have built the Sarcomeric Human Cardiomyopathy Registry, or SHaRe, which we believe is the world&#8217;s largest registry of patients with heritable cardiomyopathies. We use our platform to refine our understanding of which patients are most likely to benefit from our product candidates. Our clinical research strategy involves using biomarkers to directly measure the effects of our product candidates early in clinical development, establishing proof of mechanism and providing important early predictive value to inform the design of subsequent trials. We believe that this virtuous cycle is a competitive advantage that enables us to efficiently develop therapies with disease-modifying potential for heritable cardiomyopathies that could also be applied to other cardiovascular diseases.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Since our inception, our precision medicine platform has generated multiple programs to address a variety of disruptions in heart muscle contraction across different patient populations. We are advancing four research and development programs, each of which targets a distinct biomechanical defect that leads to either HCM or heritable DCM:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Our lead product candidate, MYK-461, is an orally-administered small molecule designed to reduce excessive cardiac muscle contractility leading to HCM. In preclinical models of HCM, MYK-461 has been shown to prevent and reverse disease progression and to reduce left ventricular outflow tract obstruction, a key physiological complication of the disease. We are currently evaluating MYK-461 in three Phase 1 clinical trials. In our first Phase 1 clinical trial of single ascending doses of MYK-461 in 48 healthy adult volunteers, MYK-461 was shown to be well tolerated across multiple dose levels up to 48 mg and has demonstrated clinical proof of mechanism in reducing cardiac contractility, an important biomarker of disease. We are currently enrolling two additional Phase&#160;1 clinical trials of MYK-461, the first of which is an open-label single ascending dose, or SAD, trial in adult HCM patients, and the second is a double blind, placebo-controlled, multiple ascending dose, or MAD, trial in healthy adult volunteers. We expect to report top-line data from the SAD trial in the second quarter of 2016 and to report top-line data from the MAD trial in the middle of 2016. We believe that if approved, MYK-461 would be the first targeted therapy to treat an underlying biomechanical defect leading to HCM.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage5"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU5">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our second program is DCM-
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1, where we have selected a development candidate and are performing IND enabling studies. This candidate is a novel drug compound designed to treat heritable DCM by restoring normal contractility in the diseased DCM heart. In preclinical animal models, ou
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	r DCM-1 candidate has been shown in separate experiments to improve cardiac muscle contractility and to improve stroke volume accompanied by a balanced decrease in heart rate. In both experiments, animals were dosed above the expected therapeutic range wit
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	hout adverse events or impact on cardiac rhythms. We intend to initiate a Phase 1 clinical trial of our DCM-1 product candidate in the first half of 2017. We believe that if approved, a product candidate from our DCM-1 program would be the first targeted t
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	herapy to treat an underlying biomechanical defect leading to DCM.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Additionally, we have two discovery programs, HCM-2 and LUS-1. HCM-2 is intended to reduce cardiac muscle contractility to normal levels in HCM patients through a different mechanism than that of MYK-461. LUS-1 is intended to counteract a muscle disruption that results in impaired relaxation of the heart, a biomechanical defect found in specific HCM and heritable DCM patient subgroups, as well as in other less common heritable cardiomyopathies.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have formed a strategic collaboration with Sanofi S.A. to help fund a portion of our research and development expenses while leveraging their cardiovascular and rare disease expertise in exchange for certain program and product rights, pursuant to a license and collaboration agreement we entered into in August 2014 with Aventis Inc., a wholly-owned subsidiary of Sanofi S.A., which we refer to as the Collaboration Agreement. Under the Collaboration Agreement, Sanofi also agreed to provide up to $200.0 million in upfront and milestone payments, equity investments and research and development support. To date, of such amount, we have received from Sanofi an initial non-refundable upfront cash payment of $35.0 million and equity investments of $10.0 million in exchange for Series&#160;A-1 redeemable convertible preferred stock, $5.0 million in exchange for Series&#160;B redeemable convertible preferred stock and $9.0 million in exchange for shares of our common stock in our initial public offering. The total payments we were originally eligible to receive also include a $45.0 million continuation payment, a $25.0 million milestone-based payment, and an obligation from Sanofi to purchase an additional $40.0 million of our capital stock if Sanofi provided notice of its intent to continue the collaboration prior to December&#160;31, 2016. Under the Collaboration Agreement, Sanofi&#8217;s obligation to purchase the additional $40.0 million of our capital stock (which was reduced by $5.0 million for its purchase of the Series&#160;B redeemable convertible preferred stock) terminated in connection with our initial public offering in October 2015. Additionally, we are eligible to receive up to $45.0 million of approved in-kind research and clinical activities.&nbsp;&nbsp;We retain the right to commercialize MYK-461 and HCM-2, and co-promotion rights for DCM-1, in the United States, and we are entitled to receive tiered royalties in the mid-single digits to the mid-teens on net sales of certain HCM and DCM products outside the United States and on net sales of certain DCM products in the United States. We retain all rights to our LUS-1 program and our future programs.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our Strategy
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our goal is to be the world&#8217;s leading precision cardiovascular medicine company and one of the next great, independent, research-driven biopharmaceutical companies. The critical elements of our strategy include:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Leverage and grow our precision medicine platform to fuel the development of novel targeted therapies for heritable cardiomyopathies.
</FONT>
	Our domain expertise and disease focus position us as a leader in precision cardiovascular medicine. Through our continued investment in our platform, we expect to generate additional development candidates, each designed to correct a specific biomechanical defect leading to abnormal cardiac muscle contraction. Our development strategy includes early biomarker-based indicators of safety, drug response and efficacy in well-defined patient subgroups. We believe that the data from these programs provide initial validation of our precision medicine platform, supporting the further development of additional cardiovascular medicines.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Advance the clinical development of MYK-461, the first product candidate generated by our precision medicine platform.
</FONT>
	MYK-461 is an orally-administered small molecule designed to reduce excessive cardiac muscle contractility leading to HCM and has the potential to prevent or reverse disease progression. We are currently evaluating MYK-461 in three Phase 1 clinical trials. In our first Phase 1 clinical trial of single doses of MYK-461 in 48 healthy volunteers, MYK-461 was shown to be well tolerated across multiple dose levels up to 48 mg and has demonstrated proof of mechanism in reducing cardiac muscle contractility, an important biomarker of disease. We believe that if approved, MYK-461 would be the first targeted therapy to treat an underlying biomechanical defect leading to HCM. We expect to advance MYK-461 into Phase 2 clinical development in the second half of 2016, initially focusing on two well-defined HCM patient subgroups, obstructive HCM and non-obstructive HCM.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Initiate clinical development of our DCM-1 program and pursue the development of additional product candidates generated by our precision medicine platform.
</FONT>
	We have selected a development candidate in our DCM-1 program, which has been designed to treat heritable DCM by restoring normal cardiac muscle contractility in the diseased DCM heart. We intend to initiate a Phase 1 clinical trial of our&nbsp;&nbsp;DCM-1 product candidate in the first half of 2017. Additionally, we have two discovery programs, HCM-2 and LUS-1. HCM-2 is intended to reduce cardiac muscle contractility to normal levels in HCM patients through a different mechanism than that of MYK-461, and LUS-1 is intended to counteract a muscle disruption that results in impaired relaxation of the heart.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage6"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU6">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Build a focused sales force to commercialize our initial product candidates in the United States
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	. We intend to build a focused sales force to market our product candidates to cardiomyopathy specialists and
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	targeted cardiologists in the United States. Under our collaboration with Sanofi, we retain rights to lead the commercialization of MYK-461 and the HCM-2 program, and have an option to co-promote our DCM-1 program, in the United States. We have retained w
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	orldwide commercial rights to our LUS-1 program and our future programs.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Strengthen our precision medicine platform by expanding our understanding of the molecular and genetic drivers of rare diseases of the heart.
</FONT>
	Our research efforts focus on deepening our already strong understanding of the underlying causes of rare heart diseases and identifying specific points of intervention that can be targeted to prevent or reverse disease progression. We believe that the insights gained through our preclinical and clinical research, together with our growing SHaRe registry, will inform the development of new precision cardiovascular therapies. We expect our continued engagement of the community of clinicians, scientists and patient groups will generate new disease insights and enhance our platform.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Persistent Obstacles to Innovative Cardiovascular Development
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	One out of every four deaths in the United States is attributable to cardiovascular disease, representing more deaths than all types of cancers combined. An important component of cardiovascular disease is heart failure, a serious, life-threatening medical condition in which the output of blood from the heart is insufficient to meet the body&#8217;s demands. Heritable cardiomyopathies are a group of rare, genetically-driven forms of heart failure that result from biomechanical defects caused by mutations in the proteins responsible for contraction of the heart muscle. These genetic disorders can result in a state of progressive and chronic heart failure and may lead to sudden cardiac death and other complications, including stroke, and may require invasive procedures such as heart transplantation.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Available treatments for patients with these forms of heart disease only treat the symptoms of their disease, do not influence disease progression and are not specifically indicated for cardiomyopathies. Current medical therapies, such as beta blockers, calcium channel blockers and disopyramide, are used off-label to treat HCM patients. The clinical&#160;benefits to HCM patients of these therapies are modest, and side effects further&#160;limit their utility.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Despite the increasing global burden of cardiovascular disease, investment in cardiovascular drug development has stagnated over the past two decades, resulting in a shortage of innovative therapies addressing the underlying causes of cardiovascular disease. We believe that traditional approaches to cardiovascular drug development have not adequately served patients with heritable cardiomyopathies due to the following limitations:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Existing therapies are designed to treat the symptoms and not the underlying cause of the disease.
</FONT>
	Despite important advances in understanding the clinical progression of cardiovascular diseases, a specific understanding of the fundamental molecular and genetic drivers of disease has been lacking. As a result, researchers have been limited in their ability to discover or develop therapies that target causal disease mechanisms and to properly select patients. This lack of understanding limits the predictive value of early clinical results. Heart failure therapies available to patients and physicians today only attempt to treat symptoms or manage the compensatory responses of the heart and cardiovascular system to disease. These drugs tend to have only modest efficacy, are not disease-modifying, and often have poor side effect profiles.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Large, outcome-based studies are needed to demonstrate statistical significance, requiring lengthy and expensive trials.
</FONT>
	Due to the size and heterogeneity of the cardiovascular patient population, large numbers of patients typically must be studied for extended periods to accumulate enough data regarding clinical events such as cardiovascular death, heart attack, stroke or hospitalization for heart failure. We believe the non-targeted nature of these lengthy studies has discouraged investment and innovation in novel cardiovascular drug development due to the costs and risk of late-stage failures.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	The drug development model neglects rare disease populations.
</FONT>
	Due to the high costs and risks of executing large trials in cardiovascular disease, approved therapies typically must target large patient segments, without differentiating among unique potential subgroups, in order to be commercially viable. For example, physicians have historically approached the treatment of patients with heritable cardiomyopathies in the same manner as the broader, undifferentiated heart failure population, resulting in therapies not specifically designed for their disease.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	These challenges have resulted in a relatively low number of cardiovascular new molecular entities approved by the U.S. Food and Drug Administration, or the FDA, including no approved therapies indicated for heritable cardiomyopathies. As a result, there is a significant opportunity to improve clinical benefits through the use of precision medicine for the discovery and development of new treatments for HCM and heritable DCM, including those with disease-modifying potential.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage7"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU7">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our Solution: MyoKardia Approach to Precision Cardiovasc
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ular Therapies
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are pioneering the application of precision medicine to cardiovascular disease, with an initial focus on delivering the first approved therapies specifically targeting the underlying causes of heritable cardiomyopathies. Our precision medicine platform enables the efficient discovery and development of novel precision therapies with disease modifying potential. By leveraging our platform to generate therapies similar to MYK-461, we believe we can overcome many of the challenges associated with traditional cardiovascular drug development.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our Precision Medicine Platform
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our precision medicine platform incorporates disease research, drug discovery and clinical science in a self-reinforcing cycle that enables the iterative generation of new disease targets and clinical development candidates designed to establish early clinical proof of concept.&#160;By efficiently developing product candidates that target distinct biomechanical defects associated with heritable cardiomyopathies, we use clinical feedback on patient genetics, response to therapy and disease presentation to refine our understanding of which patients are most likely to benefit from our product candidates. We believe this virtuous cycle is a competitive advantage that enables us to efficiently develop therapies with disease-modifying potential for heritable cardiomyopathies that could also be applied to other cardiovascular diseases.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our target hypotheses are based on patient data from SHaRe, coupled with a mechanistic understanding of how disease-causing mutations affect the biomechanical function of the heart.&#160;These hypotheses are translated into screens that help us identify small molecule agents that are optimized to correct the underlying defect using preclinical models of increasing complexity.&#160;These models are also used to develop biomarkers of drug action and, when possible, disease modification, that integrate into our early clinical development strategies.&#160;By applying this cycle to multiple programs, we have generated a growing library of proprietary drug molecules that target a wide range of potential cardiac disease related mechanisms and that can be used to test new hypotheses arising from our clinical research.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Advantages of Our Approach
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We believe that our approach can overcome many of the obstacles facing cardiovascular drug discovery and development that have resulted in a lack of disease modifying therapies for heritable cardiomyopathies for the following reasons:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Our precision medicine platform enables the discovery and development of therapies with disease modifying potential.
</FONT>
	We believe our deep understanding of heritable cardiomyopathies and the biomechanical&#160;defects causing them allows us to target disease mechanisms that are critical or causal to the disease in humans. We intend to develop each of our product candidates to prevent or reverse disease progression by correcting underlying biomechanical defects in the heart&#8217;s contractile machinery. SHaRe, which currently consists of data from more than 10,000 patients, enables us to identify the relationships between genetics and clinical manifestations of disease in a large, centralized collection of patient data, resulting in novel genetic insights for new drug discovery and stratification and enrollment of patients most likely to benefit from our targeted therapies.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Our clinical development approach is designed to establish efficacy and safety in smaller, less time-consuming clinical trials.
</FONT>
	Our approach has the potential to significantly reduce the time and cost of drug development. Through the use of appropriate predictive biomarkers and patient selection strategies we believe that we can reduce the risk of late-stage clinical failures. This approach is consistent with recent FDA communications and publications on how the pharmaceutical and biotechnology industry can improve efficiency and the likelihood of success in cardiovascular drug development.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;">
	Our approach facilitates the efficient discovery of novel therapies for neglected, rare heart diseases.
</FONT>
	We are focused on the treatment of rare patient populations with heritable cardiomyopathies. By integrating all of the elements of our platform, we believe that we can efficiently develop disease modifying therapies.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Overview of Cardiac Muscle Contraction and the Biomechanical Defects Causing Cardiomyopathies
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	A sarcomere is an assembly of proteins that forms the smallest contractile unit of muscle. Each cardiac muscle cell contains many sarcomeres, and these cells are arranged in an organized manner as cardiac muscle fibers. Thousands of sarcomeres acting in concert provide the ensemble force for muscle contraction. Sarcomeres are composed of a thin filament and a thick filament, each of which contains multiple proteins braided together. To initiate contraction, myosin, the motor protein anchored to the thick filament, binds to actin, the main protein of the thin filament, forming a cross-bridge. The contraction of the sarcomere is driven by the swinging of the cross-bridge causing the thin filament to slide over the thick filament, shortening the length of a sarcomere. Myosin attaches to the thin filament, pulls it forward and detaches in a tightly-regulated cycle. In the heart, contraction corresponds to systole and relaxation corresponds to diastole.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	7
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage8"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU8">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In the graphic below, the dark myosin heads are engaged with the thin filament, each forming a cross-bridge between actin and myosin. One mechanistic disruption that is understood to lead to
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	HCM is shown in the lower left graphic, illustrating a situation in which too many cross-bridges are engaged. Conversely, the opposite situation is shown in the lower right graphic, illustrating a situation in which too few cross-bridges are engaged, lead
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ing to DCM.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371566216236.JPG" TITLE="" ALT="" STYLE="WIDTH:602PX;HEIGHT:375PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Heritable cardiomyopathies are caused by mutations in cardiac sarcomere proteins that disrupt normal cardiac muscle contraction. The mutations affect the power of contraction, the efficiency of relaxation, or both, reducing the overall ability and efficiency of the heart to pump blood at an output that matches the needs of the rest of the body. The disruptions in cardiac muscle contraction result in abnormal intracardiac blood pressures and chamber volumes, and thickening or thinning of the walls of the heart. These pathological changes often result in a cascade of events with devastating consequences to patients, including reduced exercise capacity limited by shortness of breath or chest pain, reduced blood flow to the heart muscle, dangerous abnormal heart rhythms, stroke, progressive heart failure and sudden cardiac death. In some cases, these events lead to the need for heart transplantation.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage9"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU9">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	There are hundreds of individual mutations that have been identified in the genes encoding the
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	proteins of the sarcomere that are implicated as causal (pathogenic or likely pathogenic) in HCM and heritable DCM. These mutations, while many, give rise to only a few common biomechanical defects in the sarcomere at the protein level. Through our resear
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ch, we have linked these biomechanical defects to three distinct cardiac muscle disruptions that act to cause HCM and heritable DCM, as illustrated in the figure below.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371567716237.JPG" TITLE="" ALT="" STYLE="WIDTH:600PX;HEIGHT:411PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Today&#8217;s genetic diagnostic tools for heritable cardiomyopathies are limited to panels consisting only of identifiable known pathogenic mutations. As a result, current genetic analyses only reveal the underlying cause of disease in a subset of patients with heritable cardiomyopathies. This subset of patients carries identified sarcomeric mutations, which we designate as positive for an Identified Sarcomeric Mutation, or ISM+. A substantial number of patients with heritable cardiomyopathies have either not been genetically diagnosed or carry sarcomeric mutations that have yet to be fully characterized; we designate these patients as ISM-. Broader applications of next-generation sequencing technologies have the potential to enable more cardiomyopathy patients to be classified as ISM+.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our Pipeline
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have generated several proprietary, orally administered small molecules to address a variety of biomechanical defects that cause disruptions in heart muscle contraction. By correcting the underlying biomechanical defects, we believe targeted therapies can correct or offset the downstream disruption in cardiac muscle function that drives disease progression. Our lead drug candidate, MYK-461, is designed for patients with HCM caused by excessive cardiac muscle contraction, and has been shown to reduce the number of cross-bridges to lower contractile power output to restore normal cardiac muscle contraction. Our DCM-1 program is intended to restore normal cardiac muscle contractility in patients with DCM caused by mutations that result in inadequate cardiac muscle contraction because of either too few cross-bridges or insufficient intrinsic force of individual cross-bridges. In addition, LUS-1, one of our several discovery programs, is intended to counteract a mechanistic defect in which detachment of cross-bridges does not appropriately occur, resulting in impaired cardiac muscle relaxation.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage10"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU10">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table summarizes our product development pipeline:
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371569316238.JPG" TITLE="" ALT="" STYLE="WIDTH:675PX;HEIGHT:424PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYK-461 for Hypertrophic Cardiomyopathy
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYK-461 is an orally administered small molecule that reduces left ventricular contractility to potentially alleviate the functional consequences and symptoms of HCM and prevent or reverse HCM progression. We are currently evaluating MYK-461 in three Phase 1 clinical trials. In our first Phase 1 clinical trial of single ascending doses of MYK-461 in 48 healthy adult volunteers, MYK-461 was shown to be well tolerated across multiple dose levels up to 48&#160;mg and has demonstrated clinical proof of mechanism in reducing cardiac contractility, an important disease biomarker. We believe that if approved, MYK-461 would be the first targeted therapy to treat an underlying biomechanical defect leading to HCM.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Overview of Hypertrophic Cardiomyopathy
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	HCM is the most common form of heritable cardiomyopathy. It is estimated that as many as 630,000 people in the United States have a form of HCM. HCM is caused by mutations in the sarcomere that result in excessive cardiac muscle contraction. HCM is defined as an otherwise unexplained thickening of the walls of the heart, known as hypertrophy. The consequences include reduced blood volumes and cardiac output, reduced ability of the left ventricle to expand, and high filling pressures. These can all contribute to reduced effort tolerance and symptoms that include shortness of breath and chest pain. In patients with HCM, the muscles forming the left ventricle contract excessively, are abnormally stiff and are prone to both fibrosis and muscle cell death. As result, the left ventricular chamber is smaller than normal and is not able to relax and expand properly, thus reducing the heart&#8217;s pumping capacity.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage11"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU11">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371570816239.JPG" TITLE="" ALT="" STYLE="WIDTH:512PX;HEIGHT:266PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	HCM is a chronic disease and for the majority of patients, the disease progresses slowly and can be extremely disabling. Mild exertion can quickly result in fatigue or shortness of breath, and a patient&#8217;s ability to participate in normal work, family or recreational activities can be substantially curtailed. In approximately 15% to 20% of patients, disease progression results in disabling heart failure that can prevent the patients from holding a job or even performing everyday household tasks or other activities of daily living. HCM can also cause stroke or sudden cardiac death. HCM is the most common cause of sudden cardiac death in young people, with an incidence of 4% to 6% in children and adolescents.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Obstructive HCM Patients.
<FONT STYLE="FONT-STYLE:NORMAL;">
	In approximately two-thirds of HCM patients, the path followed by blood exiting the heart, known as the left ventricular outflow tract, or LVOT, becomes obstructed by the enlarged and diseased muscle, restricting the flow of blood from the heart to the rest of the body. These patients, referred to as obstructive HCM patients, are at an increased risk of severe heart failure and death. We estimate that there are approximately 410,000 obstructive HCM patients in the United States, of which we plan to target an initial population of patients that are ISM+ and symptomatic, representing approximately 70,000 patients. We additionally plan to target another population of obstructive HCM patients that are ISM- and symptomatic, also representing approximately 70,000 patients.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Non-Obstructive HCM Patients.
<FONT STYLE="FONT-STYLE:NORMAL;">
	Symptomatic, yet non-obstructive, HCM patients represent a distinct subgroup that is difficult to manage medically. This segment may contain a more severely affected population because non-obstructive HCM patients may progress to a more advanced state of disease than obstructive HCM patients before becoming symptomatic. Furthermore, for obstructive HCM patients, relief of the obstruction is often associated with an improvement in symptoms, while no such treatment option is available to non-obstructive HCM patients. We estimate that there are approximately 220,000 non-obstructive HCM patients in the United States, of which we plan to target an initial population of patients that are ISM+ and symptomatic, representing approximately 30,000 patients.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Current Standard of Care for Patients with Hypertrophic Cardiomyopathy
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	There are currently no approved therapeutic products indicated for the treatment of HCM. Patients are typically prescribed one or more drugs indicated for the treatment of hypertension, heart failure or other cardiovascular disorders more generally. These drugs, including beta blockers, non-dihydropyridine calcium channel blockers (such as verapamil and diltiazem) and disopyramide, do not address the underlying cause of HCM, do not appear to affect disease progression, and are generally used only in symptomatic patients. While clinical experience and expert opinion suggest that these drugs may provide symptom relief in some patients, no strong, controlled clinical research evidence exists to directly support their efficacy. For a subset of HCM patients with more advanced disease progression or more pronounced symptoms, surgical or other invasive interventions may be appropriate, including heart transplantation, use of an implantable cardioverter-defibrillator, or ICD, open surgical myectomy or percutaneous alcohol septal ablation.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Clinical Trials of MYK-461
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are currently evaluating MYK-461 in three Phase 1 clinical trials, including two SAD trials and one MAD trial. These three trials are primarily designed to evaluate safety and tolerability of oral doses of MYK-461 and are expected to provide data on its pharmacokinetic, or PK, and pharmacodynamic, or PD, profile.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	11
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage12"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU12">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The first-in-human SAD trial includes 48 healthy adult volunteers (36 active, 12 placebo). The primary objective is to establish safety and tolerability of single oral doses of MYK-46
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1. Secondary objectives include documenting the PK profile and generating evidence of PD activity, defined as a decrease in cardiac contractility, as measured by chest wall echocardiography, an established biomarker of activity. This trial design supports
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	our long-term development strategy and is consistent with our precision medicine approach.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have completed dosing in six cohorts in this SAD trial at doses of 1, 2, 6, 12, 24 and 48 mg of MYK-461 or matching placebo. MYK-461 has been well tolerated at all of these doses. A total of nine clinical adverse events, all mild in severity, were reported during this trial of 48 healthy subjects. There have been no serious adverse events or clinically important findings in vital signs, electrocardiogram recordings or safety laboratory tests. MYK-461 has neither been found to affect skeletal muscle function, as assessed by handgrip strength testing, nor has it been found to negatively impact alternate forms of myosin elsewhere in the body.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our trials have demonstrated rapid absorption of MYK-461 following an oral dose. As shown in the graph below, plasma concentrations of MYK-461 demonstrate a dose-linear and dose-proportional PK profile, with low inter-subject variability.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYK-461 Demonstrates a Dose-Linear and Dose-Proportional PK Profile
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371574016240.JPG" TITLE="" ALT="" STYLE="WIDTH:505PX;HEIGHT:332PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Proof of mechanism was demonstrated by PD activity at doses of 12 mg and above, with each dose cohort clearly differentiated from placebo. PD activity was assessed by three different biomarkers: (i)&#160;left ventricular ejection fraction, or LVEF, representing the amount of blood pumped with each heartbeat, as a percentage of the total left ventricle volume; (ii)&#160;left ventricular outflow tract velocity-time integral, or LVOT-VTI, representing a calculation of stroke volume; and (iii)&#160;left ventricular fractional shortening, LVFS, representing a proxy for cardiac output by measuring the change in the size of the left ventricle during a heartbeat. Echocardiographic data were blinded and independently double read by experts at a core laboratory.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	12
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage13"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU13">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We observed that each of these biomarkers (LVEF, LVOT-VTI and LVFS), which are independent measures of cardiac contractility, were concor
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	dant with respect to dose-response and time course of onset and return to baseline following a single dose. These results are illustrated in the graphs below.
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Dose-Dependent PD Response as Measured by LVEF
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371575516241.JPG" TITLE="" ALT="" STYLE="WIDTH:349PX;HEIGHT:231PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Dose-Dependent PD Response as Measured by LVOT-VTI
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371575516242.JPG" TITLE="" ALT="" STYLE="WIDTH:349PX;HEIGHT:231PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Dose-Dependent PD Response as Measured by LVFS
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371575516243.JPG" TITLE="" ALT="" STYLE="WIDTH:349PX;HEIGHT:232PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	13
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage14"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU14">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our second Phase 1 SAD clinical trial of MYK-461 is currently enrolling
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	adult HCM patients. As a complement to our Phase 1 SAD trial in healthy volunteers, the primary objective of this trial is to gain initial safety and tolerability data in HCM patients. Secondary objectives include comparing the PK and PD profiles in patie
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	nts with those in healthy adult volunteers. To assess PD activity, we are using the same three independent biomarkers of contractility: (i) LVEF, (ii) LVOT-VTI and (iii) LVFS.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have completed dosing in two patients in this SAD trial at doses of 48 mg of MYK-461, which matches the amount of drug administered to the highest-dosed cohort in our healthy volunteer SAD trial. For these two patients, MYK-461 has been well tolerated and there have been no serious adverse events or clinically important safety findings. We intend to continue enrolling HCM patients in this trial and, once enrollment is complete, expect to report top-line data in the second quarter of 2016.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Preliminary results from dosing these two patients at 48 mg of MYK-461 demonstrate proof of mechanism in patients. We observed similar PD activity in these two HCM patients as we observed in healthy volunteers in our other trials (HV). The results are illustrated in the graphs below, which show the effect on these biomarkers of MYK-461, or placebo, for: (i) the healthy volunteer placebo cohorts shown above, (ii) Cohort 6 of the healthy volunteer trial, representing a 48 mg dose of MYK-461 and (iii) the two individual HCM patients dosed to date in this trial.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	PD Activity in HCM Patients Similar to HV, as Measured by LVEF
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371577116244.JPG" TITLE="" ALT="" STYLE="WIDTH:349PX;HEIGHT:242PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage15"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU15">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	PD Activity in HCM Patients Similar to HV, as Measured by LVOT-VTI
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371578716245.JPG" TITLE="" ALT="" STYLE="WIDTH:349PX;HEIGHT:243PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	PD Activity in HCM Patients Similar to HV, as Measured by LVFS
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371578716246.JPG" TITLE="" ALT="" STYLE="WIDTH:350PX;HEIGHT:244PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our third Phase 1 clinical trial is a double blind, placebo-controlled, MAD trial of MYK-461 in healthy adult volunteers. We initiated dosing of this trial in August 2015, and subject to enrollment in accordance with our current plans, we expect to announce top-line data from this trial in mid-2016.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Several cohorts of healthy volunteers will be administered low (1 to 10 mg) doses daily until they reach steady-state concentrations of MYK-461. The goals of the trial are to:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Establish the tolerability of repeat doses, at or near steady state, of MYK-461 in healthy volunteers across a range of potentially therapeutic doses;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Document a repeat dose PK profile of MYK-461;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Determine the degree and stability of pharmacological activity of MYK-461 when administered as repeat doses at or near steady state; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Generate data sufficient to guide dosage and administration of MYK-461 in subsequent chronic dosing outpatient studies in HCM patients designed to evaluate clinical benefits.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Preclinical Data for MYK-461
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition to the preclinical studies necessary to support clinical development of MYK-461, we have also studied the effects of MYK-461 in multiple animal models of HCM.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	15
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage16"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU16">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In the first set of experiments, MYK-461 demonstrated disease prevention and reversal in multiple established mouse models that hav
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	e been genetically modified, each carrying a myosin mutation identified to cause HCM. These mice develop the characteristic thickening and fibrosis of the left ventricle of the heart over time, mirroring the progressive nature of human disease. Results fro
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	m these preclinical experiments were published in February 2016 in
</FONT>
<FONT STYLE="FONT-STYLE:ITALIC;">
	Science
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	under the title &#8220;A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.&#8221;
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The first part of the study evaluated MYK-461&#8217;s ability to prevent the development of HCM in mutant mice that had yet to develop symptoms of hypertrophy. The treated mutant mice developed significantly less left ventricular fibrosis (p &lt; 0.02), as compared to the untreated mutant mice. In addition, untreated mutant mice developed HCM as reflected by an increased thickness of the left ventricular wall, while mutant mice treated with daily oral doses of MYK-461 did not develop HCM. Furthermore, the thickness of the left ventricle posterior wall, or LVWT, of the treated mice was similar to that of wild-type mice without the genetic mutation, as shown in the graph below:
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYK-461 Observed to Prevent Development of Hypertrophy in Mouse Models of HCM
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371603716247.JPG" TITLE="" ALT="" STYLE="WIDTH:228PX;HEIGHT:308PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The second part of the study evaluated MYK-461&#8217;s effect on mutant mice that developed HCM symptoms prior to treatment with MYK-461. Untreated mutant mice continued to develop progressive left ventricular wall thickening while the LVWT in mutant mice treated with MYK-461 showed a measurable decline two to four weeks after initiating treatment that persisted for the duration of the study, as shown in the chart below. Throughout both experiments, MYK-461 was well tolerated in both wild-type and mutant mice.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYK-461 Observed to Reverse Hypertrophy in Mouse Models of HCM
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371603716248.JPG" TITLE="" ALT="" STYLE="WIDTH:341PX;HEIGHT:211PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	16
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage17"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU17">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In a second set of experiments, MYK-461 demonstrated that it can alleviate LVOT gradient in feline models of obstructive HCM. Maine coon cats naturally demonstrate key features of human obstructive HCM, including LVOT gradient and systolic anterior moti
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	on (SAM) of the mitral valve leaflets. The study evaluated MYK-461&#8217;s ability to alleviate LVOT gradient in these animals. Two groups of cats were dosed with either MYK-461, or vehicle, at gradually increasing doses while various measurements were taken to
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	document the degree of LVOT obstruction and the severity of SAM in these animals. Cats treated with MYK-461 showed a significant decrease in LVOT obstruction, as measured by the pressure drop (in mmHg) across the LVOT, as shown below. Additionally, cats tr
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	eated with MYK-461 were relieved of SAM, as observed via non-invasive imaging.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYK-461 Observed to Alleviate LVOT Gradient in Feline Models of HCM
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371605216249.JPG" TITLE="" ALT="" STYLE="WIDTH:305PX;HEIGHT:288PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Other preclinical studies have been conducted to support the clinical development of MYK-461. Toxicology studies in rat and dog suggest that MYK-461 has the potential to be safe and well tolerated. At dose levels equivalent to anticipated therapeutic dose levels, no significant adverse effects were observed. At higher dose levels, adverse effects consistent with an exaggerated on-target pharmacology of MYK-461 were observed. There was no evidence of tolerability issues with MYK-461 at lower exposures producing the intended degree of target modulation to be studied in the clinic. The pattern of appearance of MYK-461 in the bloodstream following oral dosing, the high proportion of an oral dose that is absorbed, a long persistence of the drug in the bloodstream, and the eventual elimination of the drug through multiple clearance mechanisms all suggest that MYK-461 may be well suited for a chronic, orally administered therapy.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Anticipated Development Pathway
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Given the absence of any approved therapies for HCM, there is no established FDA registration pathway for such a therapy. We do not anticipate the need for outcomes-based studies in order to obtain regulatory approval. In our clinical program, we will seek to clearly understand the impact of dosing, genotype, phenotype and other factors on the safety and efficacy of MYK-461, in several different patient cohorts. Following the successful completion of our three currently ongoing Phase 1 clinical trials, we expect to initiate two separate Phase 2 clinical trials of MYK-461 in obstructive and non-obstructive HCM patients to evaluate the drug&#8217;s safety and efficacy. We anticipate that we would enroll approximately 100 patients in each of these two trials. In addition to imaging-based biomarkers of PD activity, we intend to assess all patients using cardiopulmonary exercise testing, or CPET, an established basis for registration. Specific to the obstructive HCM patient group, we will evaluate patients for reduction of their LVOT gradients, a short term measure of disease modification.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	DCM-1 Program for Dilated Cardiomyopathy
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU18">
</A>
	In our DCM-1 program, we have selected a development candidate and are performing IND enabling studies. The candidate is a novel drug compound designed to treat heritable DCM caused by mutations in sarcomeric proteins by restoring normal cardiac muscle contractility in the diseased DCM heart. This initial targeted therapy attempts to counteract one known mechanistic disruption by increasing the number of cross-bridges formed during cardiac muscle contraction, thereby increasing the ensemble force of contraction and improving cardiac output. In preclinical animal models, our DCM-1 candidate has been shown in separate experiments to improve cardiac muscle contractility and to improve cardiac stroke volume with a balanced decrease in heart rate. In
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	17
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage18"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	both experiments, animals were dosed above the expecte
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	d therapeutic range without adverse events or impact on cardiac rhythms. We anticipate initiating Phase 1 clinical trials in our DCM-1 program in the first half of 2017. We believe that if approved, a product candidate from our DCM-1 program would be the f
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	irst targeted therapy to treat an underlying biomechanical defect leading to DCM.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Overview of Dilated Cardiomyopathy
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	DCM is defined broadly as heart failure with reduced ejection fraction in the absence of prior heart attack or other recognized causes. In DCM, the walls of the left ventricle are thin and over-expanded, leading to improper contraction and insufficient blood being pumped by the heart. In contrast to HCM, the sarcomere afflicted by DCM is characterized by reduced overall power output. Also known as hypocontractility, this results in a dilated, thin-walled left ventricle that does not supply sufficient blood to the body.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371606816250.JPG" TITLE="" ALT="" STYLE="WIDTH:528PX;HEIGHT:263PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:2PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	DCM is a life-threatening progressive disease. Once symptoms appear, a patient&#8217;s condition typically declines steadily over the next few years. Typical symptoms of DCM include shortness of breath, fatigue, swelling in the extremities or an irregular heartbeat. As the disease progresses, patients become increasingly debilitated and experience persistent shortness of breath, even at rest. Diastolic function, or the heart&#8217;s ability to relax and fill with blood, is also impaired because the heart is already expanded. The dilated left ventricle is itself deprived of an adequate supply of oxygen that may contribute to fibrosis and the risk of dangerous heart rhythm disturbances. In addition, whether or not symptoms have appeared, DCM patients are at risk of sudden cardiac death.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The fundamental cause of all DCM is that the heart muscles are not able to contract with sufficient force. In heritable DCM, this lack of power is caused in certain cases by genetic mutations that disrupt the ability of individual myosin motors to form cross-bridges with actin and contribute to overall contraction.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	It is estimated that DCM afflicts about one million people in the United States alone, of which approximately 400,000 have heritable DCM and approximately 100,000 patients are ISM+. We plan to initially target patients that represent a subset of all DCM patients that are ISM+, a group we estimate represents approximately 12,000 patients.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Current Standard of Care for Patients with Dilated Cardiomyopathy
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Similar to HCM, there are currently no approved therapeutic products indicated for the treatment of DCM. Patients are typically prescribed one or more drugs indicated for the treatment of heart failure generally, such as digoxin, diuretics, beta blockers, renin-angiotensin-neprilysin system inhibitors or antagonists and aldosterone antagonists. By treating various signs and symptoms of heart disease and addressing some of the compensatory mechanisms described above, these drugs may reduce overall morbidity and mortality; however, none of the treatments address the underlying cause of disease or modify disease progression. Surgical options available to DCM patients include heart transplantation and use of an ICD, a biventricular pacemaker or a left ventricular assist device, or LVAD.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Preclinical Data for DCM-1 Program
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Compounds in our DCM-1 program are intended to improve contractility in isolated human heart cells by increasing the velocities of contraction and relaxation. These compounds likewise have been observed to cause strong increases in contractility in animal models at doses above the expected therapeutic range without adverse events or impact on cardiac rhythms.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	18
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage19"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU19">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	DCM-1 Candidate Increases Stroke Volume with a Balanced Decrease in Heart Rate
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817371608316251.JPG" TITLE="" ALT="" STYLE="WIDTH:719PX;HEIGHT:294PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Anticipated Development Plan for DCM-1 Program
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In our preclinical development program for DCM-1, we have selected a development candidate and are performing IND enabling studies, including toxicology and safety studies. We anticipate that we will initiate Phase 1 clinical trials for our DCM-1 program in the first half of 2017 after an IND becomes effective.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In our clinical development program for our DCM-1 candidate, we envision SAD and MAD trials in healthy volunteers, which will use a biomarker strategy to evaluate left ventricular contractility, similar to our approach for MYK-461, to establish early proof of mechanism.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Additional Potential Extensions of our Platform
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Beyond HCM and heritable DCM, we are researching defects caused by mutations in proteins that result in other heritable cardiomyopathies such as restrictive cardiomyopathy and left ventricular non-compaction in order to generate precision therapies for those diseases. We believe that the fundamental mechanisms we are targeting in the heart may have applicability in the broader heart failure population. The chemistries we develop to target various components of the sarcomere may also be applicable to skeletal disorders where we can define a parallel linkage between disease-causing mutations in non-cardiac muscle proteins and their resulting biomechanical defects.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Sanofi Collaboration
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In August 2014, we entered into a license and collaboration agreement with Aventis Inc., a wholly-owned subsidiary of Sanofi S.A., for the research, development and potential commercialization of pharmaceutical products for the treatment, prevention and diagnosis of HCM and DCM, as well as potential additional indications. For purposes of this presentation, we refer to Sanofi as our co-party to the Collaboration Agreement.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Collaboration Agreement covers three main research programs: MYK-461 (or HCM-1), HCM-2 and DCM-1. Under the Collaboration Agreement, we are responsible for conducting research and development activities pursuant to mutually agreed research and development plans through early human efficacy studies, except for certain specified research activities to be conducted by Sanofi as set forth in the research plan. The proof-of-concept studies contemplated by the Collaboration Agreement are expected to be conducted on a staggered basis.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU20">
</A>
	Prior to the completion of proof of concept, or POC, studies, we will be responsible for development activities for each product. Following the completion of the POC studies, Sanofi will be responsible for worldwide development activities for DCM only. Under the Collaboration Agreement, we retained U.S. rights to MYK-461 and HCM-2, as well as co-commercialization rights to DCM-1 in the United States, at our option. We have granted to Sanofi: (i)&#160;worldwide rights to commercialize DCM-1; and (ii)&#160;regulatory and commercialization rights outside the United States for the two HCM programs. Sanofi also has the option to co-promote the MYK-461 and HCM-2 programs in the United States only in the event of a potential expanded cardiovascular disease indication outside of the
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	19
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage20"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	genetically targeted indications for MYK-461 and HCM-2. We will collaborate with Sanofi through the
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	use of various committees, each of which are comprised of three representatives selected by us and three representatives selected by Sanofi, to manage the overall collaboration and coordinate the research of the compounds, as well as monitor, coordinate t
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	he development of the compounds and products and monitor and oversee the commercialization activities of the compound and products.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The initial term of the research program is set to end on December&#160;31, 2018. On or before September&#160;1, 2016, we are required to provide Sanofi with all material information for Sanofi to determine if certain criteria have been satisfied, and prior to December&#160;31, 2016 Sanofi is then required to provide us with notice of whether it will continue the collaboration. If such notice is not provided or if Sanofi provides notice of its intent to discontinue the collaboration, the Collaboration Agreement will terminate. Sanofi agreed that if it provided notice of its intent to continue the collaboration, the Collaboration Agreement will remain in effect and Sanofi will be required to make a one-time payment to us of $45.0 million, or the Continuation Payment, together with an additional payment in consideration for the purchase of capital stock as described below. If Sanofi provides notice prior to December&#160;31, 2016 that we have not met the criteria, the parties are required to negotiate an amendment to the financial terms of the Collaboration Agreement. If such an amendment is mutually agreed, Sanofi will be required to continue the collaboration and make a payment to us; otherwise the Collaboration Agreement will terminate. Upon termination, we will be granted all rights required to continue to research, develop and commercialize the collaboration programs.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are required to use diligent efforts to develop, and following the applicable regulatory approval in the United States, to commercialize at least one MYK-461 product and one HCM-2 product in the United States. Sanofi is required to use diligent efforts to develop, and following the applicable regulatory approval in any of France, Germany, Italy, Spain, the United Kingdom, China, Japan and the United States, or the Major Market Countries, to commercialize at least one DCM-1 product in each Major Market Country, at least one MYK-461 product in each Major Market Country (other than the United States) and at least one HCM-2 product in each Major Market Country (other than the United States).
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Under the Collaboration Agreement, we granted Sanofi several co-exclusive, royalty-bearing licenses, as well as an exclusive (even with regards to us), royalty-bearing license to certain of our intellectual property and our rights in jointly-owned intellectual property created under the collaboration, to develop and manufacture, and to commercialize in the territories licensed to Sanofi, the compounds and products subject to the collaboration, as well as any companion diagnostics we may develop for such products. In addition, Sanofi granted to us several co-exclusive, royalty-bearing licenses, as well as an exclusive (even with regards to Sanofi), royalty-bearing license to certain of Sanofi&#8217;s intellectual property and its rights in jointly owned intellectual property, created under the collaboration, to develop and manufacture, and to commercialize in the retained territories, the applicable compounds and products, as well as companion diagnostics for such products.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Under the Collaboration Agreement, we were originally eligible to receive up to $200.0 million in upfront and milestone payments, equity investments and research and development support. To date, of such amount, we have received from Sanofi an initial non-refundable upfront cash payment of $35.0 million and equity investments totaling $24.0 million across multiple financing rounds, including an investment in our initial public offering. The total payments we were originally eligible to receive also includes the $45.0 million Continuation Payment, a $25.0 million milestone-based payment contingent on the submission of an IND for any DCM-1 product in a Major Market Country, and an obligation from Sanofi to purchase an additional $40.0 million of our capital stock if Sanofi provides notice of its intent to continue the collaboration prior to December&#160;31, 2016. Under the Collaboration Agreement, Sanofi&#8217;s obligation to purchase the additional $40.0&#160;million of our capital stock (which was reduced by $5.0 million for its purchase of the Series B redeemable convertible preferred stock) terminated in connection with the consummation of our initial public offering (IPO). Additionally, we are eligible to receive up to $45.0 million of approved in-kind research and clinical activities.&nbsp;&nbsp;We are also eligible to receive from Sanofi tiered royalties ranging from the mid-single digits to the mid-teens on net sales of certain products under the Collaboration Agreement, and we have agreed to pay Sanofi tiered royalties ranging from the mid-single digits to the low teens on net sales of MYK-461 and HCM-2 products in the United States.&nbsp;&nbsp;The royalties payable under the Collaboration Agreement are subject to certain offsets and reductions. In addition to these amounts, Sanofi may also be responsible for certain additional costs and expenses relating to the collaboration, including a percentage of the registration program costs for MYK-461 and the HCM-2 and DCM-1 programs.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU21">
</A>
	Unless earlier terminated during the initial research term as described above, the Collaboration Agreement will continue on a country-by-country and product-by-product basis until the expiration of the applicable royalty term for the applicable product in the applicable country, subject to certain exceptions. Sanofi may, upon written notice to us prior to December&#160;31, 2016, terminate the Collaboration Agreement in its entirety effective December&#160;31, 2016. The Collaboration Agreement will be deemed terminated on December&#160;31, 2018 with respect to all compounds and products from a program for which POC studies have not been completed unless Sanofi agrees before such date to fund up to an aggregate of $15.0 million for the applicable program. Additionally, at any time after December&#160;31, 2018, Sanofi may, upon prior written notice to us, terminate the Collaboration Agreement for convenience in its entirety or on a region-by-region or program-by-program basis with respect to selected regions. The Collaboration Agreement is also subject to termination by either party upon a material breach by the other party, subject to a notice and cure period, or upon a
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	20
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage21"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	bankruptcy, insolvency or similar event affecting the o
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ther party. We also have the right to terminate the Collaboration Agreement in the event of certain patent challenges by Sanofi or its affiliates.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Intellectual Property
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our commercial success depends in part on our ability to obtain and maintain proprietary protection for our drug candidates, novel biological discoveries, screening and drug development technology and other know-how, to operate without infringing on the proprietary rights of others and to prevent others from infringing our proprietary rights. Our policy is to seek to protect our proprietary position by, among other methods, filing U.S. and foreign patent applications related to our proprietary technology, inventions and improvements that are important to the development and implementation of our business. We also rely on trade secrets, know-how, continuing technological innovation and potential in-licensing of intellectual property to develop and maintain our proprietary position.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As for the pharmaceutical products we develop and commercialize, as a normal course of business, we intend to pursue composition-of-matter patents, where possible, and dosage and formulation patents, as well as method-of-use patents on novel indications for known compounds. We also seek patent protection with respect to novel biological discoveries, including new targets. We may also pursue patents with respect to our proprietary screening and drug development processes and technology. We may also seek patent protection, either alone or jointly with our collaborators, as our collaboration agreements may dictate.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our patent estate includes 2 issued U.S. patents, 4 pending patent applications, 2 pending Patent Cooperation Treaty, or PCT, applications, 34 international patent applications and 1 additional U.S. provisional application, all of which are exclusively owned by us, with claims relating to all of our current clinical-stage drug candidates. With respect to our lead drug candidates in the HCM program, we exclusively own one issued U.S. patent, one pending U.S. patent application, and 34 international patent applications relating to the chemical composition of MYK-461 and use thereof.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Individual patents extend for varying periods depending on the date of filing of the patent application and the legal term of patents in the countries in which they are obtained. Generally, patents issued for applications filed in the United States are effective for twenty years from the earliest effective filing date. In addition, in certain instances, a patent term can be extended to recapture a portion of the term effectively lost as a result of the FDA regulatory review period. However, the restoration period cannot be longer than five years and the total patent term including the restoration period must not exceed 14 years following FDA approval. The duration of foreign patents varies in accordance with provisions of applicable local law, but typically is also twenty years from the earliest effective filing date. Our allowed patent applications are expected to expire in 2034. However, the actual protection afforded by a patent varies on a product by product basis, from country to country, and depends upon many factors, including the type of patent, the scope of its coverage, the availability of regulatory related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patent.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Furthermore, the patent positions of biotechnology and some pharmaceutical products and processes like those we may develop and commercialize are generally uncertain and involve complex legal and factual questions. No consistent policy regarding the breadth of claims allowed in such patents has emerged to date in the United States. The patent situation outside the United States is even more uncertain. Changes in either the patent laws or in interpretations of patent laws in the United States and other countries can diminish our ability to protect our inventions and enforce our intellectual property rights and more generally could affect the value of intellectual property. Accordingly, we cannot predict the breadth of claims that may be granted or enforced in our patents or in third-party patents. The biotechnology and pharmaceutical industries are characterized by extensive litigation regarding patents and other intellectual property rights. Our ability to maintain and solidify our proprietary position for our drugs and technology will depend on our success in obtaining effective claims and enforcing those claims once granted. We do not know whether any of the patent applications that we may file or license from third parties will result in the issuance of any patents. The issued patents that we own or may receive in the future may be challenged, invalidated or circumvented, and the rights granted under any issued patents may not provide us with proprietary protection or competitive advantages against competitors with similar technology. Furthermore, our competitors may be able to independently develop and commercialize similar drugs or duplicate our technology, business model or strategy without infringing our patents.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Because of the extensive time required for clinical development and regulatory review of a drug we may develop, it is possible that, before any of our drugs can be commercialized, any related patent may expire or remain in force for only a short period following commercialization, thereby reducing any advantage of any such patent.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU22">
</A>
	In addition to patents, we rely upon unpatented trade secrets and know-how and continuing technological innovation to develop and maintain our competitive position. We seek to protect our proprietary information, in part, using confidentiality agreements with our commercial partners, collaborators, employees and consultants and invention assignment agreements with our employees. We also have confidentiality agreements or invention assignment agreements with our commercial partners and selected consultants. These agreements are designed to protect our proprietary information and, in the case of the invention assignment agreements, to grant us
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	21
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage22"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ownership of technologies that are developed through a relationship with a third party. These agreements may be breached, and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become know
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	n or be independently discovered by competitors. To the extent that our commercial partners, collaborators, employees and consultants use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resultin
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	g know-how and inventions.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our commercial success will also depend in part on not infringing upon the proprietary rights of third parties. It is uncertain whether the issuance of any third-party patent would require us to alter our development or commercial strategies, or our drugs or processes, obtain licenses or cease certain activities. Our breach of any license agreements or failure to obtain a license to proprietary rights that we may require to develop or commercialize our future drugs may have a material adverse impact on us.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, substantial scientific and commercial research has been conducted for many years in the areas in which we have focused our development efforts, which has resulted in third parties having a number of issued patents and pending patent applications. Patent applications in the United States and elsewhere are published only after eighteen months from the priority date. The publication of discoveries in the scientific or patent literature frequently occurs substantially later than the date on which the underlying discoveries were made. Therefore, patent applications relating to drugs similar to MYK-461 and any future drugs, discoveries or technologies we might develop may have already been filed by others without our knowledge.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Manufacturing
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We do not own or operate, and currently have no plans to establish, any manufacturing facilities. We currently depend on third-party contract manufacturing organizations, or CMOs, for all of our requirements of raw materials, drug substance and drug product for our preclinical research and our ongoing clinical trial of MYK-461. We have not entered into long-term agreements with our current CMOs. We intend to continue to rely on CMOs for later-stage development and commercialization of MYK-461, as well as the development and commercialization of any other product candidates that we may identify. Although we rely on CMOs, we have personnel and third-party consultants with extensive manufacturing experience to oversee the relationships with our contract manufacturers.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We believe the synthesis of the drug substance for MYK-461 is reliable and reproducible from readily available starting materials, and the synthetic routes are amenable to large-scale production and do not require unusual equipment or handling in the manufacturing process. We have obtained an adequate supply of the drug substance for MYK-461 from our first CMO to satisfy our immediate clinical and preclinical demands. We have implemented improvements to our drug substance manufacturing process to further facilitate production capacity adequate to meet future development and commercial demands.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Drug product formulation development for MYK-461 is in progress. We have contracted with a third-party manufacturer capable of both formulation development and drug product manufacturing through early commercialization. We may identify a second drug product manufacturer in the future to add additional capacity and redundancy to our supply chain. In our ongoing SAD clinical trials of MYK-461, we are utilizing a suspension formulation. We have developed and manufactured multiple strengths of an immediate release tablet for use in the MAD trial. For future development and commercialization, we intend to develop a refined tablet formulation and may develop alternate formulations for the adolescent and children/infant populations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Sales and Marketing
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have exclusive U.S. commercial rights to two of our three current programs (MYK-461 and HCM-2) and U.S. co-promotion rights to DCM-1 subject to the collaboration with Sanofi, and have worldwide rights to LUS-1 and our future programs. We believe that we can maximize the value of our products by retaining substantial commercialization rights to our product candidates and, where appropriate, entering into collaborations for specific therapeutic indications or geographic territories.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our current strategy is to market our initial HCM and DCM products using a dedicated, direct sales force focused on cardiomyopathy specialists and targeted cardiologists&#160;in the United States. These physicians are typically affiliated with leading hospitals and medical centers and tend to have well-established referral networks. We believe they represent a concentrated prescriber base that can be appropriately managed with a specialty care sales model.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Competition
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The biotechnology and pharmaceutical industries are characterized by rapidly advancing technologies, intense competition and a strong emphasis on proprietary products. While we believe that our scientific knowledge, technology and development experience, our precision medicine platform and our pioneering culture provide us with competitive advantages, we face potential competition from many different sources, including major pharmaceutical, specialty pharmaceutical and biotechnology companies, academic institutions, governmental agencies and public and private research institutions. Any therapeutic candidates that we successfully develop and commercialize will compete with existing products and new products that may become available in the future.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	22
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage23"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU23">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Many of our competitors, either alone or with their strategic partners, have substantially greater financial, technical and human resources than we do and significantly greater experience in the discovery and developme
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	nt of product candidates, obtaining FDA and other regulatory approvals of treatments and the commercialization of those treatments. Accordingly, our competitors may be more successful than us in obtaining approval for treatments and achieving widespread ma
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	rket acceptance.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In the field of heart failure drug development, our principal competitors include Amgen Inc., Bayer AG, Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG&#160;&amp; Co. KG, Gilead Sciences, Inc., Novartis AG and Takeda Pharmaceutical Company Limited. Specific to our initial drug discovery and development focus areas, it is believed that Gilead Sciences, Inc., Heart Metabolics Limited and Novartis AG have ongoing programs in HCM and that Array BioPharma Inc., Kasiak Research Pvt Ltd., Novartis AG, Vericel Corp. and Zensun (Shanghai) Sci. &amp;Tech. Co., Ltd. have ongoing programs in DCM. Additionally, there may be other companies pursuing therapeutic candidates from which we face current or future competition.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Government Regulation
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Government authorities in the United States at the federal, state and local levels, and in other countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, marketing, export and import of drug products such as those we are developing.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	A number of different regulatory agencies may be involved, depending on the product at issue, and the type and stage of activity. These include the FDA, the Drug Enforcement Administration, or DEA, the Centers for Medicare and Medicaid Services, or CMS, other federal agencies, state boards of pharmacy, state controlled substance agencies and more.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	U.S. Government Regulation
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Drug Development Process
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In the United States, the FDA is a primary regulator of drugs under the Federal Food, Drug, and Cosmetic Act, or the FDCA, and implementing regulations. The process of obtaining regulatory approvals and compliance with applicable federal, state, local and foreign statutes and regulations require the expenditure of substantial time and financial resources. Failure to comply with applicable requirements at any time during the drug development process, approval process, or after approval, may subject us to adverse consequences and administrative or judicial sanctions, any of which could have a material adverse effect on us. These sanctions could include refusal to approve pending applications; withdrawal of or restrictions on an approval; imposition of a clinical hold or other limitation on research; warning letters; product seizures; total or partial suspension of development, production, or distribution; or injunctions, fines, disgorgement, civil penalties or criminal prosecution.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The process required before a drug may be marketed in the United States generally involves the following:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	completion of preclinical, also known as preclinical, laboratory tests, animal studies and formulation studies conducted according to Good Laboratory Practice, or GLP, requirements, animal welfare laws and other applicable regulations;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	submission to the FDA of an IND which must become effective before clinical trials, meaning trials in human subjects, may begin in the United States, obtaining similar authorizations in other jurisdictions where clinical research will be conducted and maintaining these authorizations on a continuing basis throughout the time that trials are performed and new data are collected;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	performance of adequate and well-controlled clinical trials according to Good Clinical Practice, or GCP, requirements to demonstrate whether a proposed drug is safe and effective for its intended use;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	preparation and submission to the FDA of a marketing authorization application, such as an NDA, and submitting similar marketing authorization applications in other jurisdictions where commercialization will be pursued;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	satisfactory completion of an FDA inspection of the manufacturing facility or facilities at which the product will be produced to assess compliance with current good manufacturing practice, or cGMP, requirements to assure that the facilities, methods and controls are adequate to preserve the product&#8217;s identity, strength, quality and purity; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	FDA review and approval of the NDA or other marketing authorization application.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The development, testing and approval process requires substantial time, effort and financial resources and bears significant, inherent risk that the individual products will not exhibit the relevant safety, effectiveness, or quality characteristics. We cannot be certain that any approvals for our product candidates will be granted on a timely basis, or with the specific terms that we desire, if at all.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	23
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage24"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU24">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	An IND is a request for authorization from the FDA to adminis
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ter an investigational drug product to humans. The central focus of an IND submission is on the general investigational plan and the protocol(s) for human studies. The IND also includes results of animal studies or other human studies, as appropriate, as w
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ell as manufacturing information, analytical data and any available clinical data or literature to support the use of the investigational new drug. An IND must become effective before human clinical trials may begin. An IND will automatically become effect
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ive 30&#160;days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to the proposed clinical trials. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	concerns or questions before clinical trials can begin. Accordingly, submission of an IND may or may not result in the FDA allowing clinical trials to commence.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Clinical trials involve the administration of the investigational drug to human subjects under the supervision of qualified investigators in accordance with GCP, which include the requirement that all research subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety, and the efficacy criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. Additionally, approval must also be obtained from each clinical trial site&#8217;s institutional review board, or IRB, or ethics committee before the trials may be initiated, and the IRB or ethics committee must monitor the study until completed.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Clinical trials typically are conducted in three sequential phases that may overlap or be combined:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-STYLE:ITALIC;">
	Phase 1
</FONT>
	. The drug initially is introduced into a small number of patients or healthy human volunteers and information is collected pertaining to the drug&#8217;s safety, dosage tolerance, absorption, metabolism, distribution and elimination. These trials are designed to determine the metabolism and pharmacologic actions, side effects with increasing doses and if possible, early evidence of effectiveness.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-STYLE:ITALIC;">
	Phase 2
</FONT>
	. These trials include controlled clinical trials initiated in a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the effectiveness of the drug candidate for a particular indication in patients with the disease or condition under study, and to determine common short-term side effects and risks associated with the drug.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<FONT STYLE="FONT-STYLE:ITALIC;">
	Phase 3
</FONT>
	. Clinical trials are expanded and controlled trials undertaken to further evaluate dosage, clinical efficacy and safety in an expanded patient population at geographically dispersed clinical trial sites. These clinical trials are intended to gather additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk profile of the drug candidate and provide an adequate basis for physician labeling and regulatory approval.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Progress reports related to clinical trials must be submitted at least annually to the FDA and participating IRBs, and more frequent safety reports must be submitted to the FDA and to investigators for serious and unexpected suspected adverse events, and certain other purposes. Phase 1, Phase 2 and Phase 3 trials may not be completed successfully within a specified period, if at all. The FDA or the sponsor may suspend a clinical trial at any time for a variety of reasons, including a finding that the healthy volunteers or patients are being exposed to an unacceptable health risk or that the investigational product apparently lacks efficacy. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with applicable requirements or if the drug candidate has been associated with unexpected serious harm to healthy volunteers or patients. Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a DSMB, or data safety monitoring board or committee. The DSMB reviews safety information and provides recommendations to the sponsor for whether a trial may move forward at designated check points based on access to certain data from the study. As the sponsor, we may also suspend or terminate a clinical trial based on evolving business objectives and/or competitive climate.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We estimate that it generally takes 10 to 15 years, or possibly longer, to discover, develop and bring to market a new pharmaceutical product in the United States. Several years may be needed to complete each phase, including discovery, preclinical, Phase 1, 2 or 3, or marketing authorization.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU25">
</A>
	At times during the development of a new drug product, sponsors are given opportunities to meet with the FDA. This commonly occurs prior to submission of an IND, at the end of Phase 2 trials, and before an NDA is submitted. Meetings at other times may also be requested. These meetings provide an opportunity for the sponsor to share information about the data gathered to date, for the FDA to provide advice, and for the sponsor and the FDA to reach agreement on the next phase of development. A pediatric study plan must be submitted within sixty days of the end of the Phase 2 meeting. Concurrent with clinical trials, companies usually complete additional animal studies and develop additional information about the chemistry and physical characteristics of the drug candidate and finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the drug candidate, and the manufacturer must develop methods for confirming the identity, quality, purity and potency of the final products. Additionally, appropriate packaging
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	24
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage25"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	must be selected and tested and stability trials must be conducted to demo
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	nstrate that the drug candidate does not undergo unacceptable deterioration over its shelf-life and distribution pathway.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Disclosure of Clinical Trial Information
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Sponsors of clinical drug trials (other than Phase 1 trials) are required to register and disclose certain clinical trial information. Information related to the product, comparator, patient population, phase of investigation, trial sites and investigators and other aspects of the clinical trial is made public as part of the registration. Sponsors are also obligated to disclose the results of their clinical trials after completion. Disclosure of the results of certain trials may be delayed until the new product or new indication being studied has been approved. However, there are evolving rules and increasing requirements for publication of trial-related information, and it is possible that data and other information from trials involving drugs that never garner approval could in the future be required to be disclosed. In addition, publication policies of major medical journals mandate certain registration and disclosures as a pre-condition for potential publication, even when this is not presently mandated as a matter of law. Competitors may use this publicly available information to gain knowledge regarding the progress of development programs.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	New Drug Application Review and Approval Processes
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The results of drug candidate development, preclinical studies and clinical trials, along with descriptions of the manufacturing process, analytical tests conducted on the drug candidate, proposed labeling and other relevant information are submitted to the FDA as part of an NDA, requesting approval to market the drug candidate for one or more proposed indications. Data can come from company-sponsored clinical trials intended to test the safety and effectiveness of a use of a product, or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and effectiveness of the investigational drug product to the satisfaction of the FDA.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The cost of preparing and submitting an NDA is substantial. Under federal law, NDAs are subject to substantial application user fees and the sponsor of an approved NDA is also subject to annual product and establishment user fees. Under the Prescription Drug User Fee Act, or PDUFA, as amended, each NDA must be accompanied by a user fee. The FDA adjusts the PDUFA user fees on an annual basis. According to the FDA&#8217;s fee schedule, effective through September&#160;30, 2016, the user fee for each NDA application requiring clinical data is $2,374,200.&nbsp;&nbsp;For fiscal year 2016, PDUFA also imposes an annual product fee for drugs ($114,450), and an annual establishment fee ($585,200) on facilities used to manufacture prescription drugs. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The FDA reviews each NDA to ensure that it is sufficiently complete for substantive review before it may be filed. Once the submission is accepted for filing, the FDA begins an in-depth review. The FDA&#8217;s goal is to review applications within ten months of the filing date or, if the application relates to an unmet medical need in a serious or life-threatening indication, six months from the filing date. The review process is often significantly extended by FDA requests for additional information or clarification. The FDA reviews an NDA to determine, among other things, whether a drug candidate is safe and effective for its intended use and indication for use and whether its manufacturing is cGMP-compliant. The FDA may refer the NDA to an advisory committee consisting of a panel of external experts for review and recommendation as to whether the NDA should be approved and under what conditions. The FDA is not bound by the recommendation of an advisory committee, but it typically follows such recommendations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	After the FDA evaluates the NDA and conducts inspections of manufacturing facilities where the drug product and/or its active pharmaceutical ingredient will be produced, it may issue an approval letter or a Complete Response Letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. A Complete Response Letter indicates that the review cycle of the application is complete and the application is not ready for approval. A Complete Response Letter may require additional clinical data and/or an additional pivotal Phase 3 clinical trial(s), and/or other significant, expensive and time-consuming requirements related to clinical trials, preclinical studies or manufacturing. Even if such additional information is submitted, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. The FDA could also approve the NDA with a Risk Evaluation and Mitigation Strategy, or REMS, plan to mitigate risks, which could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling, development of adequate controls and specifications, or a commitment to conduct one or more post-market studies or clinical trials. Such post-market testing may include Phase 4 clinical trials and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU26">
</A>
	The approval process is lengthy and difficult and the FDA may refuse to approve an NDA if the applicable criteria are not satisfied, or it may require additional clinical or other data. Even if such data are submitted, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. Data obtained from clinical trials are not always conclusive and the FDA may interpret data differently than we interpret the same data. The FDA will issue a Complete Response Letter if the agency decides not to approve
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	25
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage26"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	the NDA in
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	its present form. The deficiencies identified may be minor, for example, requiring labeling changes, or major, for example, requiring additional clinical trials. Additionally, the Complete Response Letter may include recommended actions that the applicant
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	might take to place the application in a condition for approval. If a product receives regulatory approval, the approval may be limited to specific diseases, dosages, or indications for use, which could restrict the commercial value of the product. Furthe
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	r, the FDA may require that certain contraindications, warnings or precautions be included in the product labeling. In addition, the FDA may require post-approval trials, sometimes referred to as Phase 4 clinical trials, to further assess a drug&#8217;s safety a
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	nd effectiveness after NDA approval and may require testing and surveillance programs to monitor the safety of approved products that have been commercialized.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Expedited Development and Review Programs
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The FDA has various programs, including fast track, priority review, accelerated approval, and breakthrough therapy designation, that are intended to increase agency interactions, expedite or facilitate the process for reviewing drug candidates, and/or provide for initial approval on the basis of surrogate endpoints. We believe that our product candidates may qualify for some of these expedited development and review programs. Even if a drug candidate qualifies for one or more of these programs, the FDA may later decide that the drug candidate no longer meets the conditions for qualification.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Fast Track program is intended to expedite or facilitate the process for reviewing new drugs that meet certain criteria. Specifically, new drugs are eligible for Fast Track designation if they are intended to treat a serious or life-threatening disease or condition and demonstrate the potential to address unmet medical needs for the disease or condition. Fast Track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of a new drug may request the FDA to designate the drug as a Fast Track product at any time during the clinical development of the product. Unique to a Fast Track product, the FDA may consider for review sections of the marketing application on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the application, the FDA agrees to accept sections of the application and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the application.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any product submitted to the FDA for marketing, including under a Fast Track program, may be eligible for other types of FDA programs intended to expedite development and review, such as priority review and accelerated approval. Any product is eligible for priority review if it has the potential to provide safe and effective therapy where no satisfactory alternative therapy exists or a significant improvement in the treatment, diagnosis or prevention of a disease compared to marketed products. The FDA will attempt to direct additional resources to the evaluation of an application for a new drug designated for priority review in an effort to facilitate the review. Additionally, a product may be eligible for accelerated approval. Drug candidates studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may receive accelerated approval, which means that they may be approved on the basis of adequate and well-controlled clinical studies establishing that the product has an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit, or on the basis of an effect on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity or prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require that a sponsor of a drug receiving accelerated approval perform adequate and well-controlled post-marketing clinical studies. Failure to conduct required post-approval trials, or the inability to confirm a clinical benefit during post-marketing trials, may allow the FDA to withdraw the drug from the market on an expedited basis. In addition, the FDA presently requires as a condition for accelerated approval pre-approval of promotional materials, which could adversely impact the timing of the commercial launch of the product. Fast Track designation, priority review and accelerated approval do not change the standards for approval but may expedite the development or approval process.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Food and Drug Administration Safety and Innovation Act of 2012, or FDASIA, also amended the FDCA to require FDA to establish breakthrough therapy designation. A drug can be designated as a breakthrough therapy if it is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that it may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. A sponsor may request that a drug be designated as a breakthrough therapy at any time during the clinical development of the product. If so designated, FDA shall act to expedite the development and review of the product&#8217;s marketing application, including by meeting with the sponsor throughout the product&#8217;s development, providing timely advice to the sponsor to ensure that the development program to gather preclinical and clinical data is as efficient as practicable, involving senior managers and experienced review staff in a cross-disciplinary review, assigning a cross-disciplinary project lead for the FDA review team to facilitate an efficient review of the development program and to serve as a scientific liaison between the review team and the sponsor, and taking steps to ensure that the design of the clinical trials is as efficient as practicable.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	26
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage27"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU27">
</A>
<FONT STYLE="FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Post-Approval Requirements
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any products for which we may receive future FDA approval are subject to continuing regulation by the FDA, including, among other things, record-keeping requirements, reporting and analysis of adverse experiences with the product, providing the FDA with updated safety, efficacy and quality information, product sampling and distribution requirements, maintaining up-to-date labels, warnings, and contraindications, and complying with promotion and advertising requirements. Products may be promoted only for the approved indications and in accordance with the approved label; products cannot be promoted for unapproved, or off-label, uses, although physicians may prescribe drugs for off-label uses in accordance with the practice of medicine. Manufacturers must continue to comply with cGMP requirements, which are extensive and require considerable time, resources and ongoing investment to ensure compliance. In addition, changes to manufacturing processes often require prior FDA approval before being implemented and other types of changes to the approved product, such as adding new indications and additional labeling claims, are also subject to further FDA review and approval. In addition, the FDA may require testing and surveillance programs to monitor the effect of approved products that have been commercialized, and the FDA has the power to prevent or limit further marketing of a product based on the results of these post-marketing programs. Manufacturers and other entities involved in the manufacturing and distribution of approved products are required to register their establishments with the FDA and certain state agencies, and are subject to periodic inspections for compliance with cGMP and other laws. FDA and state inspections may identify compliance issues at manufacturing that may disrupt production or distribution or may require substantial resources to correct.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory standards is not maintained or if problems occur after the product reaches the market, such as adverse events, the existence or severity of which was unknown when the product was approved. Later discovery of previously unknown problems with a product may result in restrictions on the product or complete withdrawal from the market. Further, the failure to maintain compliance with regulatory requirements may result in administrative or judicial actions, such as fines, warning letters, holds on clinical trials, product recalls or seizures, product detention or refusal to permit the import or export of products, refusal to approve pending applications or supplements, restrictions on marketing or manufacturing, injunctions or civil or criminal payments or penalties.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	From time to time, new legislation is enacted that changes the statutory provisions governing the approval, manufacturing, and marketing of products regulated by the FDA. In addition, FDA regulations and guidance may be revised or reinterpreted by the agency in ways that may significantly affect our business and our products. It is impossible to predict whether further legislative or regulatory or policy changes will occur or be implemented and what the impact of such changes, if any, may be.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Patent Term Restoration and Marketing Exclusivity
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Depending upon the timing, duration, and specifics of FDA approval of the use of our drug candidates, some of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent term to be extended up to five years as compensation for patent term effectively lost due to the FDA&#8217;s pre-market approval requirements. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14 years from the product&#8217;s approval date. The patent term restoration period is generally one-half the time between the effective date of an IND and the submission date of an NDA, plus the time between the submission date of an NDA and the approval of that application, except that the review period is reduced by any time during which the applicant failed to exercise due diligence. Only one patent applicable to an approved drug is eligible for the extension. Extensions are not granted as a matter of right and the extension must be applied for prior to expiration of the patent and within a 60 day period from the date the product is first approved for commercial marketing. The U.S. Patent and Trademark Office, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. Where a product contains multiple active ingredients, if any one active ingredient has not been previously approved, it can form the basis of an extension of patent term provided the patent claims that ingredient or the combination.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In the future, we may apply for patent term restoration for some of our presently owned patents to add patent life beyond their current expiration date, depending on the expected length of clinical trials and other factors involved in the submission of the relevant NDA; however, there can be no assurance that any such extension will be granted to us.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU28">
</A>
	Market exclusivity provisions under the FDCA also can delay the submission or the approval of certain applications. The specific scope varies, but fundamentally the FDCA provides a five-year period of non-patent marketing exclusivity within the United States to the first applicant to gain approval of an NDA for a new chemical entity never previously approved by the FDA either alone or in combination. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the compound responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review an abbreviated new drug application, or ANDA, or a 505(b)(2) NDA submitted by another company for another version of such drug where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement. The FDCA also provides three years of marketing exclusivity for an NDA, 505(b)(2) NDA, or supplement to an existing NDA if new clinical
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	27
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage28"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	investigations, other than bioavailability trials, t
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	hat were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example, for new indications, dosages, or strengths of an existing drug. This three-year exclusivity covers only the conditions a
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ssociated with the new clinical investigations and does not prohibit the FDA from approving ANDAs for drugs containing the original active agent. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an appl
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	icant submitting a full NDA would be required to conduct or obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Pediatric Information and Exclusivity
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Under the FDCA, NDAs and certain supplements to NDAs must contain data adequate to assess the safety and effectiveness of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the drug is safe and effective. FDASIA, which was signed into law on July&#160;9, 2012, amended the FDCA to require that a sponsor who is planning to submit a marketing application for a drug or biological product that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial Pediatric Study Plan, or PSP, within 60 days of an end-of-phase 2 meeting or as may be agreed between the sponsor and the FDA. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials, and/or other clinical development programs.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Orphan Drug Designation and Exclusivity
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Under the Orphan Drug Act, the FDA may grant orphan drug designation to drug candidates intended to treat a rare disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States and for which there is no reasonable expectation that costs of research and development of the drug for the indication can be recovered by sales of the drug in the United States. Orphan drug designation must be requested before submitting an NDA. After the FDA grants orphan drug designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. Although there may be some increased communication opportunities, orphan drug designation does not convey any advantage in or shorten the duration of the regulatory review and approval process.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If a drug candidate that has orphan drug designation subsequently receives the first FDA approval for the disease for which it has such designation, the product is entitled to orphan drug exclusivity, which means that the FDA may not approve any other applications to market the same drug for the same indication for seven years, except in very limited circumstances, such as if the second applicant demonstrates the clinical superiority of its product or the manufacturer of the product with exclusivity is unable to assure sufficient quantities of the product. Orphan drug exclusivity does not prevent the FDA from approving a different drug for the same disease or condition, or the same drug for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the NDA application user fee. Orphan drug exclusivity could block the approval of our drug candidates for seven years if a competitor obtains approval of the same product as defined by the FDA or if our drug candidate is determined to be contained within the competitor&#8217;s product for the same indication or disease.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As in the United States, we may apply for designation of a drug candidate as an orphan drug for the treatment of a specific indication in the European Union before the application for marketing authorization is made. Orphan drugs in the European Union enjoy economic and marketing benefits, including up to 10 years of market exclusivity for the approved indication unless another applicant can show that its product is safer, more effective or otherwise clinically superior to the orphan designated product.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The FDA and foreign regulators expect holders of exclusivity for orphan drugs to assure the availability of sufficient quantities of their orphan drugs to meet the needs of patients. Failure to do so could result in the withdrawal of marketing exclusivity for the orphan drug.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Pharmaceutical Coverage, Pricing, and Reimbursement
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	United States
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU29">
</A>
	Significant uncertainty exists as to the coverage and reimbursement status of any products for which we obtain regulatory approval. In the United States and markets in other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use our products unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of our products. Sales of any products for which we receive regulatory approval for commercial sale will therefore depend, in
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	28
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage29"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	part, on the availability of coverage and adequate reimbursement from third-party payors. Third-party payors include government authorities, managed care providers, private health insurers and other organizations.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Even if the FDA approves NDAs for our drug candidates, sales of our products will depend, in part, on the availability of coverage and reimbursement by third-party payors, such as government health programs, commercial or private insurance, and managed care organizations. The process for determining whether a payor will provide coverage for a drug product may be separate from the process for setting the reimbursement rate that the payor will pay for the drug product once coverage is approved. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the FDA-approved drugs for a particular indication. A decision by a third-party payor not to cover our product candidates could reduce physician utilization of our products once approved and have a material adverse effect on our sales, results of operations and financial condition. Moreover, a payor&#8217;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development. Additionally, coverage and reimbursement for new products can differ significantly from payor to payor. One third-party payor&#8217;s decision to cover a particular product or service does not ensure that other payors will also provide coverage for the product or service, or will provide coverage at an adequate reimbursement rate. As a result, the coverage determination process will require us to provide scientific and clinical support for the use of our products to each payor separately and will be a time-consuming process.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The marketability of any products for which we receive regulatory approval for commercial sale may suffer if the government and third-party payors fail to provide adequate coverage and reimbursement. In addition, an increasing emphasis on cost containment measures in the United States has increased and we expect will continue to increase the pressure on pharmaceutical pricing. Third-party payors are increasingly challenging the prices charged for products and services, examining the medical necessity and reviewing the cost-effectiveness of drugs, medical devices and medical services, in addition to questioning safety and efficacy. If these third-party payors do not consider our products to be cost-effective compared to other available therapies, they may not cover our products after FDA approval or, if they do, the level of payment may not be sufficient to allow us to sell our products at a profit. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	European Union
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In Europe and many other foreign countries, the success of our drug candidates we may develop depends largely on obtaining and maintaining government reimbursement, because in many foreign countries patients are unlikely to use prescription pharmaceutical products that are not reimbursed by their governments. Negotiating reimbursement rates in foreign countries can delay the commercialization of a pharmaceutical product and generally results in a reimbursement rate that is lower than the net price that companies can obtain for the same product in the United States.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In some countries, such as Germany, commercial sales of a product can begin while the reimbursement rate that a company will receive in future periods is under discussion. In other countries, a company must complete the reimbursement discussions prior to the commencement of commercial sales of the pharmaceutical product. The requirements governing drug pricing vary widely from country to country. For example, the European Union provides options for its member states to restrict the range of drugs for which their national health insurance systems provide reimbursement and to control the prices of drugs for human use. A member state may approve a specific price for the drug or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the drug on the market. Recently, many countries in the European Union have increased the amount of discounts required on pharmaceuticals and these efforts could continue as countries attempt to manage healthcare expenditures, especially in light of the severe fiscal and debt crises experienced by many countries in the European Union. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our products, if approved in those countries.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Other Healthcare Laws and Compliance Requirements
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition to FDA restrictions on marketing of pharmaceutical products, pharmaceutical companies also are subject to various federal and state laws pertaining to healthcare fraud and abuse, including anti-kickback laws and false claims laws, and the reporting of payments to physicians and teaching hospitals. In addition, we may be subject to patient privacy regulation by both the federal government and the states in which we conduct our business. If our operations are found to be in violation of any of such laws or any other governmental regulations that apply to us, we may be subject to penalties, including, without limitation, administrative, civil and criminal penalties, damages, fines, disgorgement, contractual damages, reputational harm, diminished profits and future earnings, the curtailment or restructuring of our operations, exclusion from participation in federal and state healthcare programs and individual imprisonment, any of which could adversely affect our ability to operate our business and our financial results.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	29
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage30"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU30">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In March 2010, the Patient Protection and Affordable Health Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, collectively, PP
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ACA, was enacted, which includes measures that have or will significantly change the way health care is financed by both governmental and private insurers. Among the provisions of PPACA of greatest importance to the pharmaceutical industry are the followin
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	g:
</FONT>
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	The Medicaid Drug Rebate Program requires pharmaceutical manufacturers to enter into and have in effect a national rebate agreement with the Secretary of the Department of Health and Human Services, a condition for states to receive federal matching funds for the manufacturer&#8217;s outpatient drugs furnished to Medicaid patients. Effective in 2010, PPACA made several changes to the Medicaid Drug Rebate Program, including increasing pharmaceutical manufacturers&#8217; rebate liability by raising the minimum basic Medicaid rebate on most branded prescription drugs and biologic agents from 15.1% of average manufacturer price, or AMP, to 23.1% of AMP and adding a new rebate calculation for &#8220;line extensions&#8221; (i.e., new formulations, such as extended release formulations) of solid oral dosage forms of branded products, as well as potentially impacting their rebate liability by modifying the statutory definition of AMP. PPACA also expanded the universe of Medicaid utilization subject to drug rebates by requiring pharmaceutical manufacturers to pay rebates on Medicaid managed care utilization as of 2010 and by expanding the population potentially eligible for Medicaid drug benefits. The Centers for Medicare and Medicaid Services, or CMS, have proposed to expand Medicaid rebate liability to the territories of the United States as well. In addition, PPACA provides for the public availability of retail survey prices and certain weighted average AMPs under the Medicaid program. The implementation of this requirement by the CMS may also provide for the public availability of pharmacy acquisition of cost data, which could negatively impact our sales.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	In order for a pharmaceutical product to receive federal reimbursement under the Medicare Part B and Medicaid programs or to be sold directly to U.S. government agencies, the manufacturer must extend discounts to entities eligible to participate in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the AMP and Medicaid rebate amounts reported by the manufacturer. Effective in 2010, PPACA expanded the types of entities eligible to receive discounted 340B pricing, although, under the present state of the law, with the exception of children&#8217;s hospitals, these newly eligible entities will not be eligible to receive discounted 340B pricing on orphan drugs when used for the orphan indication. In addition, as 340B drug pricing is determined based on AMP and Medicaid rebate data, the revisions to the Medicaid rebate formula and AMP definition described above could cause the required 340B discount to increase.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Effective in 2011, PPACA imposed a requirement on manufacturers of branded drugs and biologic agents to provide a 50% discount off the negotiated price of branded drugs dispensed to Medicare Part D patients in the coverage gap (i.e., &#8220;donut hole&#8221;).
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Effective in 2011, PPACA imposed an annual, nondeductible fee on any entity that manufactures or imports certain branded prescription drugs and biologic agents, apportioned among these entities according to their market share in certain government healthcare programs, although this fee would not apply to sales of certain products approved exclusively for orphan indications.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	As part of efforts to further transparency of payments made by pharmaceutical companies to physicians, PPACA required manufacturers to track certain financial arrangements with physicians and teaching hospitals, including any &#8220;transfer of value&#8221; made or distributed to such entities, as well as any investment interests held by physicians and their immediate family members. Manufacturers were required to begin reporting this information to CMS beginning in 2014. Annual reporting is required and records of payments are publicly available for review on the CMS website.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	As of 2010, a new Patient-Centered Outcomes Research Institute was established pursuant to PPACA to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research. The research conducted by the Patient-Centered Outcomes Research Institute may affect the market for certain pharmaceutical products.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	PPACA created the Independent Payment Advisory Board, or IPAB, which has authority to recommend certain changes to the Medicare program to reduce expenditures by the program that could result in reduced payments for prescription drugs. However, the IPAB implementation has been not been clearly defined. PPACA provided that under certain circumstances, IPAB recommendations will become law unless Congress enacts legislation that will achieve the same or greater Medicare cost savings.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	PPACA established the Center for Medicare and Medicaid Innovation within CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drug spending. Funding has been allocated to support the mission of the Center for Medicare and Medicaid Innovation from 2011 to 2019.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Anti-Kickback Laws
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU31">
</A>
	U.S. federal laws, including the federal Anti-Kickback Statute, prohibit fraud and abuse involving state and federal healthcare programs, such as Medicare and Medicaid. These laws are interpreted broadly and enforced aggressively by various federal agencies, including CMS, the Department of Justice, and the Office of Inspector General for the U.S. Department of Health and Human Services, or HHS, and various state agencies. These anti-kickback laws prohibit, among other things, any person from knowingly and
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	30
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage31"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	willfully offering, paying, soliciting, receiving, or providing remuneration, di
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	rectly or indirectly, in exchange for or to induce either the referral of an individual, or the furnishing, arranging for, or recommending of an item or service that is reimbursable, in whole or in part, by a federal healthcare program. Remuneration is bro
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	adly defined to include anything of value, such as cash payments, gifts or gift certificates, discounts, or the furnishing of services, supplies, or equipment. The Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical m
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	anufacturers on one hand and prescribers, purchasers and formulary managers on the other. The anti-kickback laws are broad and prohibit many arrangements and practices that are lawful in businesses outside of the healthcare industry. A person or entity nee
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	d not have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The penalties for violating the anti-kickback laws can be severe. The sanctions include criminal and civil penalties, and possible exclusion from the federal healthcare programs. Many states have adopted laws similar to the federal anti-kickback laws, and some apply to items and services reimbursable by any payor, including third-party payors.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Federal and State Prohibitions on False Claims
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The federal False Claims Act imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false, fictitious or fraudulent claim for payment to, or approval by, the federal government or knowingly making, using, or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government. Under the False Claims Act, a person acts knowingly if he has actual knowledge of the information or acts in deliberate ignorance or in reckless disregard of the truth or falsity of the information. Although we would not submit claims directly to government payors, manufacturers can be held liable under the False Claims Act if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims by, for example, providing inaccurate billing or coding information to customers or promoting a product off-label. In addition, our future activities relating to the reporting of wholesaler or estimated retail prices for our products, the reporting of prices used to calculate Medicaid rebate information and other information affecting federal, state, and third-party reimbursement for our products, and the sale and marketing of our products, are subject to scrutiny under this law.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Actions under the False Claims Act may be brought by the Attorney General or as a qui tam action by a private individual on behalf of the federal government who shares in any amounts paid by the defendant to the government in connection with the action. The number of filings under these provisions has increased significantly in recent years. Conduct that violates the False Claims Act may also lead to exclusion from the federal healthcare programs. Further, violations of the False Claims Act can result in very significant monetary penalties and treble damages. In addition, the civil monetary penalties statute imposes penalties against any person who is determined to have presented or caused to be presented a claim to a federal health program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent. Many states have enacted similar laws modeled after the False Claims Act that apply to items and services reimbursed under Medicaid and other state healthcare programs, and, in several states, such laws apply to claims submitted to all payors. Given the significant size of actual and potential settlements, it is expected that the government authorities will continue to devote substantial resources to investigating healthcare providers&#8217; and manufacturers&#8217; compliance with applicable fraud and abuse laws.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Federal Prohibitions on Healthcare Fraud and False Statements Related to Healthcare Matters
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, created new federal criminal statutes that prohibit, among other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the U.S. federal Anti-Kickback Statute, PPACA broadened the reach of certain criminal healthcare fraud statutes created under HIPAA by amending the intent requirement such that a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Health Insurance Portability and Accountability Act
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU32">
</A>
	We may also be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their respective implementing regulations, including the final omnibus rule published on January 26, 2013, impose specified requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#8217;s privacy and security standards directly applicable to &#8220;business associates,&#8221; defined as independent contractors or agents of covered entities that create, receive, maintain or transmit protected health information in connection with providing a service for or on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorney&#8217;s fees and costs associated
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	31
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage32"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	with pursuing federal civil actions. In addition, state laws govern the privacy and securit
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	y of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same requirements, thus complicating compliance efforts.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Physician Payment Sunshine Act
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	There has been a recent trend of increased federal and state regulation of payments made to physicians and other healthcare providers. The Physician Payment Sunshine Act requires most pharmaceutical manufacturers to report annually to the Secretary of HHS payments or &#8220;transfers of value&#8221; made by that entity to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Over the next several years, we will need to dedicate significant resources to establish and maintain systems and processes in order to comply with these regulations. Failure to comply with the reporting requirements can result in significant civil monetary penalties of up to an aggregate of $150,000 per year and up to an aggregate of $1.0 million per year for &#8220;knowing failures.&#8221; Covered manufacturers were required to begin collecting data on August&#160;1, 2013 and submit reports on aggregate payment data to the government for the first reporting period (August&#160;1, 2013 &#8211; December&#160;31, 2013) by March&#160;31, 2014, and were required to report detailed payment data for the first reporting period and submit legal attestation to the completeness and accuracy of such data by June&#160;30, 2014. Thereafter, covered manufacturers covered manufacturers must submit reports by the 90th&#160;day of each subsequent calendar year. In addition, certain states require implementation of compliance programs and compliance with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, impose restrictions on marketing practices, and/or tracking and reporting of gifts, compensation and other remuneration or items of value provided to physicians and other healthcare professionals and entities. Similar laws have been enacted or are under consideration in foreign jurisdictions, including France which has adopted the Loi Bertrand, or French Sunshine Act, which became effective in 2013.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Non-U.S. Healthcare Laws
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	To the extent that any of our product candidates, once approved, are sold in a foreign country, we may be subject to similar foreign laws and regulations, which may include, for instance, applicable post-marketing requirements, including safety surveillance, anti-fraud and abuse laws, and implementation of corporate compliance programs and reporting of payments or other transfers of value to healthcare professionals.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Healthcare Reform
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and other third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medical products. By way of example, in the United States, the Medicare Prescription Drug Improvement and Modernization Act of 2003, or MMA, changed the way Medicare covers and pays for pharmaceutical products. The legislation expanded Medicare coverage for outpatient drug purchases by those covered by Medicare under a new Part D and introduced a new reimbursement methodology based on average sales prices for Medicare Part B physician-administered drugs. As a result of this legislation and the expansion of federal coverage of drug products, there is additional pressure to contain and reduce costs. While the MMA applies only to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates, and any reduction in reimbursement that results from the MMA may result in a similar reduction in payments from private payors. These cost reduction initiatives and other provisions of the MMA could decrease the coverage and reimbursement that we receive for any approved products, and could seriously harm our business.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, in March 2010, PPACA was enacted, which, among other things, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, extended the Medicaid Drug Rebate Program to utilization of prescriptions of individuals enrolled in Medicaid managed care plans, imposed mandatory discounts for certain Medicare Part D beneficiaries, subjected drug manufacturers to new annual fees based on pharmaceutical companies&#8217; share of sales to federal healthcare programs and imposed an annual excise tax of 2.3% on any entity that manufactures or imports medical devices.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	On August&#160;2, 2011, the Budget Control Act of 2011 created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2&#160;trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. This included aggregate reductions of Medicare payments to providers of 2%&#160;per fiscal year, which went into effect on April&#160;1, 2013 and will stay in effect through 2024 unless additional Congressional action is taken. On January&#160;2, 2013, the American Tax Payer Relief Act was signed into law, which, among other things, further reduced Medicare payments to several providers, including hospitals.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	32
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage33"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU33">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit t
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	he amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our drugs once approved or additional pricing pressures.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Employees
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31, 2015, we had 61 full-time employees. Of these employees, 44 are engaged in research and development. Our employees are not represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Facilities
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We lease approximately 34,409 square feet of office space in South San Francisco, California under a lease that expires on January&#160;19, 2020. We believe that our existing facilities and other available properties will be sufficient for our needs for the foreseeable future.
</P>
</EFX_BUSINESS>
<EFX_LEGAL_PROCEEDINGS>
<A NAME="FIS_LEGAL_PROCEEDINGS"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Legal Proceedings
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are not a party to any material legal proceedings at this time. From time to time, we may be subject to various legal proceedings and claims that arise in the ordinary course of our business activities. Although the results of litigation and claims cannot be predicted with certainty, as of the date of this report, we do not believe we are party to any claim or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Corporate Information
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our principal executive offices are located at 333 Allerton Avenue, South San Francisco, CA 94080, and our telephone number is (650) 741-0900.&nbsp;&nbsp;Our website address is
<FONT STYLE="FONT-STYLE:ITALIC;FONT-SIZE:11PT;TEXT-DECORATION:UNDERLINE;">
	www.myokardia.com
</FONT>
	.&nbsp;&nbsp;We do not incorporate the information on or accessible through our website into this Annual Report on Form 10-K, and you should not consider any information on, or that can be accessed through, our website a part of this Annual Report on Form 10-K.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;">
	We use various trademarks and trade names in our business, including without limitation our corporate name and logo. All other trademarks or trade names, including without limitation corporate names and logos, referred to in this report are the property of their respective owners. Solely for convenience, the trademarks and trade names in this report may be referred to without the&#160;
<SUP STYLE="FONT-SIZE:85%; VERTICAL-ALIGN:TOP">
	&#174;
</SUP>
	&#160;and&#160;
</FONT>
<FONT STYLE="FONT-STYLE:ITALIC;BACKGROUND-COLOR:#FFFFFF;">
	&#8482;
</FONT>
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;">
	symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto
</FONT>
<FONT STYLE="COLOR:#000000;">
	.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We qualify as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. As an emerging growth company, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. We would cease to be an emerging growth company on the date that is the earliest of: (i) the last day of the fiscal year in which we have total annual gross revenues of $1 billion or more; (ii) December 31, 2020; (iii) the date on which we have issued more than $1 billion in nonconvertible debt during the previous three years; or (iv) the date on which we are deemed to be a large accelerated filer under the rules of the SEC.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Information About Segments and Geographic Areas
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:6PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In accordance with The Financial Accounting Standards Board (or FASB) Accounting Standards Codification, or ASC, Topic 280, Segment Reporting, we have determined that we operate and manage our business as one reportable and operating segment. Decisions regarding our overall operating performance and allocation of our resources are assessed on a consolidated basis. Our operations and assets are predominantly located in the United States.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Available Information
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:6PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU34">
</A>
	We post our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, on the Investors &amp; Media section of our public website (www.myokardia.com) as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. In addition, you can read our SEC filings over the Internet at the SEC&#8217;s website at www.sec.gov. The contents of these websites are not incorporated into this Annual Report on Form 10-K. Further, our
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	33
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage34"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	references to the URLs for these websites are intended to be inactive textual references only. You may also read and copy any document we file with the SEC
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	at its public reference facility at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference facilities.
</FONT>
</P>
</EFX_LEGAL_PROCEEDINGS>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<EFX_RISK_FACTORS>
<A NAME="FIS_RISK_FACTORS"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 1
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	A
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_1A_RISK_FACTORS">
</A>
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_RISKFACTORS_106588">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_1A_RISK_FACTORS">
</A>
	RISK FACTORS
<FONT STYLE="FONT-WEIGHT:NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_RISKFACTORS_106588">
</A>
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	You should consider carefully the following risk factors, together with all the other information in this report, including our consolidated financial statements and notes thereto, and in our other public filings with the SEC.&nbsp;&nbsp;
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;COLOR:#000000;">
	The occurrence of any of the following risks could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this report and those we may make from time to time. You should consider all of the risk factors described when evaluating our business.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risks Related to Our Limited Operating History, Financial Condition and Capital Requirements
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our limited operating history may make it difficult for you to evaluate the success of our business to date and to assess our future viability.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are a very early-stage company. We were incorporated and commenced operations in June 2012. Our operations to date have been limited to organizing and staffing our company, business planning, raising capital, developing our technology, creating and expanding on our precision medicine platform, identifying potential product candidates and undertaking preclinical studies and commencing Phase 1 clinical trials for our most advanced product candidate, MYK-461. We have not yet demonstrated our ability to successfully complete the clinical development of a product candidate, including the completion of any clinical trials designed to show the efficacy of a product candidate, obtain marketing approvals, manufacture a commercial scale medicine, or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful commercialization. Typically, it takes many years to develop a new medicine from the time it is discovered to when it is available for treating patients. Consequently, any predictions you make about our future success or viability may not be as accurate as they could be if we had a longer operating history.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, as a new business, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. We will need to transition from a company with a research focus to a company capable of supporting larger scale clinical development and commercial activities. If we are not successful in such a transition, our business, results and financial condition will be harmed.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have a history of significant losses and may not achieve or sustain profitability and, as a result, you may lose all or part of your investment.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our lead product candidate, MYK-461, is in the early stages of clinical testing and we must conduct significant additional clinical trials before we can seek the regulatory approvals necessary to begin commercial sales of any product candidates. We have incurred operating losses in each year since our inception due to costs incurred in connection with our research and development activities and general and administrative costs associated with our operations. Our net loss for the years ended December&#160;31, 2014 and 2015 was $16.8&#160;million and $22.9 million, respectively. As of December 31, 2015, we had an accumulated deficit of $64.7 million. We expect to incur increasing losses for several years, as we continue our research activities and conduct development of, and seek regulatory approvals for, our initial product candidates, and commercialize any approved drugs. If our product candidates fail in clinical trials or do not gain regulatory approval, or if our product candidates do not achieve market acceptance, we will not be profitable. If we fail to become and remain profitable, or if we are unable to fund our continuing losses, you could lose all or part of your investment.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have never generated any revenue from product sales and may never be profitable.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our ability to generate revenue and achieve profitability depends on our ability, alone or with strategic collaborators, to successfully complete the development of, and obtain the regulatory approvals necessary to commercialize, our product candidates. We do not anticipate generating revenues from product sales for the foreseeable future, if ever. Our ability to generate future revenue from product sales depends heavily on our success in:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	completing research and preclinical and clinical development of our product candidates;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:4PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:4PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:4PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	seeking and obtaining regulatory approvals to market product candidates for which we complete clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	developing a sustainable, scalable, reproducible and transferable manufacturing process for our product candidates;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	34
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage35"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU35">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	establishing and maintaining supply and manufacturing relationships with third parties that can provide adequate (in amount and quality) products and services to support clinical development and
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	the market demand, if any, for our product candidates, if approved;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	launching and commercializing product candidates for which we obtain regulatory approval, either through a collaboration or, if launched independently, by establishing a sales force, marketing and distribution infrastructure;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	obtaining market acceptance of our product candidates and the use of precision medicine as a viable treatment option for cardiovascular diseases;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	addressing any competing technological and market developments;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	implementing additional internal systems and infrastructure, as needed;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	identifying and validating new product candidates from our platform;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	maintaining our existing collaboration agreement with Sanofi and negotiating favorable terms in any new collaboration, licensing or other arrangements into which we may enter;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	maintaining, protecting and expanding our portfolio of intellectual property rights, including patents, trade secrets and know-how; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	attracting, hiring and retaining qualified personnel who are suitable to our culture and mission.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Even if one or more of the product candidates that we are developing is approved for commercial sale, we anticipate incurring significant costs associated with commercializing any approved product candidate. Our expenses could increase beyond our expectations if we are required by the U.S. Food and Drug Administration, or the FDA, the European Medicines Agency, or the EMA, or other regulatory agencies, domestic or foreign, to perform clinical trials and other studies in addition to those that we currently anticipate. Even if we are able to generate revenues from the sale of any approved products, we may not become profitable and may need to obtain additional funding to continue operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We will need to raise additional funding, which may not be available on acceptable terms, or at all. Failure to obtain this necessary capital when needed may force us to delay, limit or terminate our product development efforts or other operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are currently advancing MYK-461, our lead product candidate, through clinical development, and conducting preclinical discovery and development activities in our other programs. Drug development is expensive, and we expect our research and development expenses to increase substantially in connection with our ongoing activities, particularly as we advance our product candidates in clinical trials.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31, 2015, our cash and cash equivalents were $112.3 million. In October 2015, we sold 6,253,125 shares of common stock in our initial public offering, the net proceeds of which totaled approximately $55.6 million, after deducting underwriting discounts, commissions and offering costs. We intend to use our cash and cash equivalents to fund the clinical development of MYK-461 through the completion of Phase 2 clinical trials, the advancement of our ongoing preclinical, discovery and research programs and the expansion of our platform, including SHaRe, as well as for working capital and general corporate purposes. However, our operating plan may change as a result of many factors currently unknown to us, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings, government or other third-party funding, marketing and distribution arrangements and other collaborations, strategic and licensing arrangements or a combination of these approaches. In any event, we will require additional capital to obtain regulatory approval for, and to commercialize, MYK-461 and our other product candidates. Even if we believe we have sufficient funds for our current or future operating plans, we may seek additional capital if market conditions are favorable or if we have specific strategic considerations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our funding requirements and the timing of our need for additional capital are subject to change based on a number of factors, including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the rate of progress and the cost of our clinical trials of MYK-461;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the number of product candidates that we intend to develop using our precision medicine platform;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the costs of research and preclinical studies to support the advancement of other product candidates into clinical development;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the timing of, and costs involved in, seeking and obtaining approvals from the FDA and comparable foreign regulatory authorities, including the potential by the FDA or comparable regulatory authorities to require that we perform more studies than those that we current expect;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to receive funding under our collaboration with Sanofi, and the timing of receipt of any such funding;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	35
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage36"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU36">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	the costs of preparing to manufacture MYK-461 on a larger scale;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the costs of commercialization activities if MYK-461 or any future product candidate is approved, including the formation of a sales force;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the degree and rate of market acceptance of any products launched by us or our partners;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our need and ability to hire additional personnel;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our ability to enter into additional collaboration, licensing, commercialization or other arrangements and the terms and timing of such arrangements; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the emergence of competing technologies or other adverse market developments.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our product candidates. In addition, we cannot guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our shares to decline. The sale of additional equity or convertible securities would dilute all of our stockholders. The incurrence of indebtedness would result in increased fixed payment obligations and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. We could also be required to seek funds through arrangements with collaborative partners or otherwise at a different stage than otherwise would be desirable and we may be required to relinquish rights to some of our technologies or product candidates or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results and prospects.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our research or development programs or the commercialization of any product candidates or be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially and adversely affect our business, financial condition and results of operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risks Related to Our Precision Medicine Platform and the Discovery and Development of Our Product Candidates
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The precision medicine approach we are taking to discover and develop drugs for heritable cardiovascular diseases is novel and may never lead to marketable products.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have concentrated our therapeutic product research and development efforts on the application of precision medicine to the treatment of heritable cardiovascular diseases, and our future success depends on the successful development of products based on our precision medicine platform and the continued development of this platform. We believe we are the first company to apply precision medicine to the treatment of cardiovascular disease, and neither we nor any other company has received regulatory approval to market therapeutics specifically targeting any form of heritable cardiomyopathy. The scientific discoveries that form the basis for our efforts to discover and develop product candidates are novel, and the scientific evidence to support the feasibility of developing product candidates based on these discoveries is both preliminary and limited. If we do not successfully develop and commercialize product candidates based upon our technological approach, we will not become profitable and the value of our common stock may decline.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Further, our focus solely on precision medicine for the development of drugs for heritable cardiomyopathies as opposed to multiple, more proven technologies for drug development increases the risks associated with the ownership of our common stock. If we are not successful in developing any product candidates using our precision medicine platform, we may be required to change the scope and direction of our product development activities. In that case, we may not be able to identify and implement successfully an alternative product development strategy, which would materially and adversely affect our business, financial condition and results of operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We depend heavily on the success of MYK-461, our lead product candidate. Other than MYK-461, all of our other programs are in discovery or preclinical development. Preclinical testing and clinical trials of our product candidates may not be successful. If we are unable to commercialize our product candidates or experience significant delays in doing so, our business will be materially harmed.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU37">
</A>
	We have invested a significant portion of our efforts and financial resources in the identification of our lead product candidate, MYK-461, for the treatment of hypertrophic cardiomyopathy, or HCM. We are currently evaluating MYK-461 in early-stage clinical trials for HCM, and if MYK-461 fails to demonstrate safety or efficacy to the satisfaction of the FDA or other comparable regulatory authorities, we will need to identify other product candidates or target indications, or both, for clinical development. All of our other
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	36
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage37"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	programs are still in discovery or preclinical development. Our ability to generate revenue from product sales, which we do not expect will occur for many years, if ever, wil
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	l depend heavily on the successful development and eventual commercialization of MYK-461 or other product candidates that we may identify from our precision medicine platform.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The success of MYK-461 and any other product candidates that we discover and develop will depend on many factors, including the following:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	successful enrollment in, and completion of, clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	receipt of marketing approvals from applicable regulatory authorities;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	establishing commercial manufacturing capabilities or making arrangements with third-party manufacturers;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	obtaining and maintaining patent and trade secret protection and non-patent exclusivity for our medicines;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	launching commercial sales of our products, if and when approved, whether alone or in collaboration with others;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	acceptance of our products, if and when approved, by patients, the medical community and third-party payors;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	effectively competing with other therapies;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	a continued acceptable safety profile of our products following approval;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	enforcing and defending intellectual property rights and claims; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	achieving desirable medicinal properties for the intended indications.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If we do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize our product candidates, which would materially harm our business.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Preclinical and clinical drug development involves a lengthy and expensive process with an uncertain outcome, and observations and results from earlier studies and trials may not be applicable or predictive in future clinical trials.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Preclinical and clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the preclinical development or clinical trial process. The results of preclinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. For example, although our preclinical observations and data from our Phase 1 single ascending dose clinical trial of MYK-461 in healthy volunteers support our hypothesis that MYK-461 has the potential to reduce cardiac muscle contractility and our belief that the results of that Phase&#160;1 clinical trial have demonstrated proof of mechanism, we have not completed clinical trials of MYK-461 in larger populations, including patients with HCM. In addition, our precision medicine platform is based on a translational medicine approach. Translational medicine, or the application of basic scientific findings to develop therapeutics that promote human health, is subject to a number of inherent risks. In particular, scientific hypotheses formed from preclinical observations may prove to be incorrect, and the data generated in animal models or observed in limited patient populations may be of limited value, and may not be applicable in clinical trials conducted under the controlled conditions required by applicable regulatory requirements and our protocols. For example, although MYK-461 has been observed to reduce cardiac contractility as measured by certain established biomarkers in our first Phase 1 clinical trial, the predictive value of these biomarkers in HCM patients may prove to be less than anticipated in subsequent, larger clinical trials. The initial clinical data from our Phase 1 clinical trials of MYK-461 are preliminary in nature, based on limited doses and a small sample size, and the clinical development of MYK-461 is not complete. Early positive data may not be repeated or observed in ongoing or future trials involving our product candidates. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical trials. There is a high failure rate for drugs and biologics proceeding through clinical trials, particularly in the field of cardiovascular medicine. A number of companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in clinical development even after achieving promising results in earlier studies, and any such setbacks in our clinical development could have a material adverse effect on our business and operating results.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may not be successful in our efforts to identify or discover potential product candidates.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The success of our business depends primarily upon our ability to identify, develop and commercialize therapeutics for the treatment of genetic cardiovascular diseases based on our precision medicine approach. A key element of our strategy is to use our precision medicine platform to identify and study compounds that can be used to correct or offset the abnormal contraction caused by HCM and dilated cardiomyopathy, or DCM. Our research programs may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development for a number of reasons, including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the research methodology used may not be successful in identifying appropriate biomarkers or potential product candidates;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our initial hypotheses based on our preclinical or early clinical observations may not be supported by later clinical results;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	37
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage38"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU38">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	potential product candidates may, on further study, be sh
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	own to have harmful side effects or may have other characteristics that may make the products unmarketable or unlikely to receive marketing approval; or
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	research programs to identify new product candidates require substantial technical, financial and human resources. We may choose to focus our efforts and resources on a potential product candidate that ultimately proves to be unsuccessful.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If we are unable to identify suitable compounds for preclinical and clinical development, we may be forced to abandon our development efforts for a research program or programs and we will not be able to obtain product revenues in future periods, which likely would result in significant harm to our financial position and adversely impact our stock price.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may not be able to successfully use the Sarcomeric Human Cardiomyopathy Registry, or SHaRe, to identify or recruit patients for our clinical trials or to develop targeted precision therapeutics for the treatment of heritable cardiomyopathies.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We rely, and expect to continue to rely, on genetic and clinical data gathered through SHaRe to provide us with insight into risk profiles and disease progression in heritable cardiomyopathies. Although the body of information in SHaRe is growing, we may face challenges collecting additional data through SHaRe in the future for a variety of reasons, including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	insufficient funding to support the research necessary to generate patient data for SHaRe;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.53%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our failure to maintain existing relationships and establish new relationships with clinical investigators and research institutions whose activities support SHaRe and provide us with access patient data;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.53%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our failure to maintain or increase interest in SHaRe within our target patient communities; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.53%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	third parties may generate competing databases to which we do not have access.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Additionally, the predictive value of the information generated through SHaRe to date may be limited. Although we expect to use this data to define and identify patient subgroups most likely to respond to our product candidates, our initial hypotheses regarding this data may prove to be incorrect, or our patient selection strategies based on our analysis of this data may fail to yield suitable patients for evaluation in our clinical trials or suitable indications and product candidates for clinical development.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may encounter substantial delays in our clinical trials or we may fail to demonstrate safety and efficacy to the satisfaction of applicable regulatory authorities.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Before obtaining marketing approval from regulatory authorities for the sale of our product candidates, we must conduct extensive clinical trials to demonstrate the safety and efficacy of the product candidates in humans. Clinical testing is expensive, time-consuming and uncertain as to outcome. We cannot guarantee that any clinical trials will be conducted as planned or completed on schedule, if at all. A failure of one or more clinical trials can occur at any stage of testing. Although we have clinical trials ongoing for MYK-461, and although we are planning to initiate clinical trials for additional product candidates, we may experience delays in our ongoing clinical trials and we do not know whether planned clinical trials will begin on time, need to be redesigned, enroll patients on time or be completed on schedule, if at all. Additionally, we believe that our precision medicine approach should eliminate the need for MYK-461 to undergo the large outcomes-based studies that are often required for cardiovascular drugs as a condition to regulatory approval by the FDA or other regulatory authorities. However, regulatory authorities may nevertheless require us to conduct additional trials or generate additional data, including potential trials studying the interaction of our product candidates with other therapeutics commonly administered in the patient populations we are seeking to treat, which would increase the time and cost of our clinical development process.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Clinical trials can be delayed for a variety of reasons, including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	delays in reaching a consensus with regulatory agencies on trial design;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	delays in reaching agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	delays in obtaining required Institutional Review Board, or IRB, approval at each clinical trial site;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	delays in recruiting suitable patients to participate in our clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	imposition of a clinical hold by regulatory agencies, after an inspection of our clinical trial operations or trial sites;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	failure by our CROs, other third parties or us to adhere to clinical trial requirements;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	failure by us or our CROs or other third-party contractors to perform clinical trials in accordance with the FDA&#8217;s good clinical practice, or GCP, requirements or applicable regulatory guidelines in other countries;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	delays in the testing, validation, manufacturing and delivery of our product candidates to the clinical sites;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	38
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage39"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU39">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	delays in having patients complete participation in a study or return for post-treatment follow-up;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	clinical trial sites deviating from a trial protocol or dropping out of a trial;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	clinical trial subjects failing to comply with the trial regimen or dropping out of a trial;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	adding new clinical trial sites;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	failure to manufacture or supply sufficient quantities of product candidates for use in clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;LETTER-SPACING:-0.1PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;LETTER-SPACING:-0.1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;LETTER-SPACING:-0.1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;LETTER-SPACING:-0.1PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	occurrence of serious adverse events associated with the product candidate that are viewed to outweigh its potential benefits; or
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	changes in regulatory requirements and guidance that require amending or submitting new clinical protocols.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We could encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions in which such trials are being conducted, or suspension or termination is recommended by the Data Safety Monitoring Board, or DSMB, for such trial or by the FDA or other regulatory authorities. Such authorities may impose such a suspension or termination due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any inability to successfully complete preclinical and clinical development could result in additional costs to us or impair our ability to generate revenues from product sales, regulatory and commercialization milestones and royalties. In addition, if we make manufacturing or formulation changes to our product candidates, we may need to conduct additional studies to bridge our modified product candidates to earlier versions. Clinical trial delays could also shorten any periods during which we may have the exclusive right to commercialize our product candidates or allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business and results of operations. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If the results of our clinical trials are inconclusive or if there are safety concerns or adverse events associated with our product candidates, we may:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	be delayed in obtaining marketing approval for our product candidates, if at all;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	obtain approval for indications or patient populations that are not as broad as intended or desired;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	obtain approval with labeling that includes significant use or distribution restrictions or safety warnings;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	be subject to changes in the way the product is administered;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	be required to perform additional clinical trials to support approval or be subject to additional post-marketing testing requirements;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	have regulatory authorities withdraw their approval of the product or impose restrictions on its distribution in the form of a modified risk evaluation and mitigation strategy, or REMS;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	be subject to the addition of labeling statements, such as warnings or contraindications;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	be sued;&#160;or
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	experience damage to our reputation.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may find it difficult to enroll patients in our clinical trials, which could delay or prevent clinical trials of our product candidates.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Identifying and qualifying patients to participate in clinical trials of our product candidates is critical to our success. The timing to commence and complete our clinical trials depends on the speed at which we can recruit patients to participate in testing our product candidates. If patients are unwilling to participate in our clinical trials because of a lack of familiarity with our approach to the treatment of cardiovascular diseases, negative publicity from adverse events in biotechnology or the fields of precision medicine or cardiovascular disease or for other reasons, including competitive clinical trials for similar patient populations, our timelines for recruiting patients, conducting clinical trials and obtaining regulatory approval of potential products may be delayed. These delays could result in increased costs, delays in advancing our product development, delays in testing the effectiveness of our technology or termination of our clinical trials altogether.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	39
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage40"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU40">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may not be able to identify, recruit and enroll a sufficient number of patients, or those with required or desired characteristics to achieve diversity in a study, to complete our clinical trials in a timely manner. Patient enrollment is
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	affected by factors including:
</FONT>
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	severity of the disease under investigation;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	design of the clinical trial protocol;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	size and nature of the patient population;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	eligibility criteria for the clinical trial in question;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	perceived risks and benefits of the product candidate under study in relation to other available therapies, including any new drugs that may be approved for the indications we are investigating;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	proximity and availability of clinical trial sites for prospective patients;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	availability of competing therapies and clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	efforts to facilitate timely enrollment in clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	patient referral practices of physicians; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	ability to monitor patients adequately during and after treatment.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In particular, each of the conditions in which we plan to evaluate our current product candidates is a rare genetic disorder with limited patient pools from which to draw for clinical trials. To date, the HCM and DCM patient populations have not been extensively evaluated in clinical trials. As a result, enrollment in our planned clinical trials is difficult to predict and may take longer or cost more than we anticipate.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We plan to seek initial marketing approval in the United States. We may not be able to initiate or continue clinical trials if we cannot enroll a sufficient number of eligible patients to participate in the clinical trials required by the FDA or other regulatory agencies. Our ability to successfully initiate, enroll and complete a clinical trial in any foreign country is subject to numerous risks unique to conducting business in foreign countries, including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	difficulty in establishing or managing relationships with CROs and physicians;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	different standards for the conduct of clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our inability to locate qualified local consultants, physicians and partners; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the potential burden of complying with a variety of foreign laws, medical standards and regulatory requirements, including the regulation of pharmaceutical and biotechnology products and treatment.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If we have difficulty enrolling a sufficient number of patients to conduct our clinical trials as planned, we may need to delay, limit or terminate ongoing or planned clinical trials, any of which would have an adverse effect on our business.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any of our product candidates may cause adverse effects or have other properties that could delay or prevent their regulatory approval, limit the scope of any approved label or market acceptance or result in other significant negative consequences following marketing approval, if any.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Adverse events or other unintended side effects caused by our product candidates could cause us, IRBs or ethics committees, clinical trial sites or regulatory authorities to interrupt, delay or halt clinical trials and could result in the denial of regulatory approval. For example, through additional studies, we may determine that although MYK-461 has been shown to be specific to striated muscle, which includes both skeletal and cardiac muscle, and selective for cardiac muscle, it may target myosin in skeletal muscle, which could result in unintended side effects. To date, we have observed a total of nine clinical adverse events, all mild in severity, in our SAD Phase 1 clinical trial of MYK-461 in 48 healthy volunteers. Results of our trials could reveal a high and unacceptable severity and prevalence of these or other side effects in subjects treated with MYK-461. If the adverse events we have observed are deemed to be unacceptable or other unacceptable side effects are observed in any subsequent preclinical studies or clinical trials of our product candidates, our trials could be suspended or terminated and the FDA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of our product candidates for any or all targeted indications. Any drug-related side effects could affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may harm our business, financial condition and prospects significantly.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	40
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage41"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU41">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Further, if any of our future products, if and when approved for commercial sale, cause serious or unexpected side effects, a number of potentially significant negative con
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	sequences could result, including:
</FONT>
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	regulatory authorities may withdraw their approval of the product or impose restrictions on its distribution in the form of a REMS or provide a medication guide outlining the risks of such side effects for distribution to patients;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	regulatory authorities may require the addition of labeling statements, such as warnings or contraindications;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	we may be required to change the way the product is administered or conduct additional clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	we could be sued and held liable for harm caused to patients; or
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our reputation may suffer.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any of these events could prevent us or our partners from achieving or maintaining market acceptance of the affected product and could substantially increase the costs of commercializing our future products and impair our ability to generate revenues from the commercialization of these products.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risks Related to Government Regulation
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We currently do not have regulatory approval to market any of our product candidates. The regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time consuming and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The time required to obtain approval by the FDA, EMA and comparable foreign authorities is unpredictable but typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions. We have not obtained regulatory approval for any product candidate and it is possible that none of our existing product candidates or any product candidates we may seek to develop in the future will ever obtain regulatory approval.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our product candidates could fail to receive regulatory approval for many reasons, including the following:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a product candidate is safe and effective for its proposed indication;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	we may be unable to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the data collected from clinical trials of our product candidates may not be sufficient to support the submission of a New Drug Application, or NDA, or other submission or to obtain regulatory approval in the United States or elsewhere;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the FDA or comparable foreign regulatory authorities may fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	This lengthy approval process as well as the unpredictability of future clinical trial results may result in our failing to obtain regulatory approval to market MYK-461 or any other product candidate we may develop, which would significantly harm our business, results of operations and prospects.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, even if we were to obtain approval, regulatory authorities may approve any of our product candidates for fewer or more limited indications than we request, may not approve the price we intend to charge for our products, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could materially harm the commercial prospects for our product candidates.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	41
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage42"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU42">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Even if we complete the necessary preclinical studies and clinical trials, we cannot predict when or if we will obtain regulatory approval to commercialize a product candidate or the approval may be for a more limite
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	d indication than we expect.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We cannot commercialize a product until the appropriate regulatory authorities have reviewed and approved the product candidate. Even if our product candidates demonstrate safety and efficacy in clinical trials, the regulatory agencies may not complete their review processes in a timely manner, or we may not be able to obtain regulatory approval. Additional delays may result if an FDA Advisory Committee or other regulatory authority recommends non-approval or restrictions on approval. In addition, we may experience delays or rejections based upon additional government regulation from future legislation or administrative action, or changes in regulatory agency policy during the period of product development, clinical trials and the review process. Regulatory agencies also may approve a treatment candidate for fewer or more limited indications than requested or may grant approval subject to the performance of post-marketing studies. In addition, regulatory agencies may not approve the labeling claims that are necessary or desirable for the successful commercialization of our treatment candidates. If we are unable to obtain regulatory approval for our product candidates for use in the treatment of heritable cardiomyopathies, our business may suffer.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Failure to obtain marketing approval in international jurisdictions would prevent our products from being marketed in such jurisdictions.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In order to market and sell our products in the European Union and many other jurisdictions, we or our third-party collaborators must obtain separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain FDA approval. The regulatory approval process outside the United&#160;States generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries outside the United States, it is required that the product be approved for reimbursement before the product can be approved for sale in that country. We or these third parties may not obtain approvals from regulatory authorities outside the United States on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. However, the failure to obtain approval in one jurisdiction may negatively impact our ability to obtain approval in other jurisdictions. We may not be able to file for marketing approvals, and even if we do, we may not obtain necessary approvals to commercialize our medicines in any market.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Even if we receive regulatory approval for any of our product candidates, we will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense. Additionally, our product candidates, if approved, could be subject to labeling and other restrictions and market withdrawal and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our products.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any product candidate for which we obtain marketing approval, along with the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to extensive and ongoing regulatory requirements and review by the FDA and other regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, Current Good Manufacturing Practice, or cGMP, requirements relating to quality control, quality assurance and corresponding maintenance of records and documents, and requirements regarding the distribution of samples to physicians and recordkeeping. For example, the holder of an approved NDA is obligated to monitor and report adverse events and any failure of a product to meet the specifications in the NDA. The holder of an approved NDA must also submit new or supplemental applications and obtain FDA approval for certain changes to the approved product, product labeling or manufacturing process.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, product manufacturers and their facilities are subject to payment of user fees and continual review and periodic inspections by the FDA and other regulatory authorities for compliance with cGMP, and adherence to commitments made in the NDA.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the medicine.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The FDA closely regulates the post-approval marketing and promotion of medicines to ensure that they are marketed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA imposes stringent restrictions on manufacturers&#8217; communications regarding off-label use and if we do not market our medicines for their approved indications, we may be subject to enforcement action for off-label marketing.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	42
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage43"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU43">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, later discovery of previously unknown problems with our medicines, manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various results, in
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	cluding:
</FONT>
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	restrictions on the labeling, marketing or manufacturing of the product;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	restrictions on distribution or use of the product;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	requirements to conduct post-marketing clinical trials or holds on ongoing or planned clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	warning or untitled letters;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	withdrawal of the medicines from the market;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	refusal by the FDA or comparable foreign regulatory authorities to approve pending applications or supplements to approved applications that we submit;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	mandatory or voluntary recalls;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	fines, restitution or disgorgement of profits or revenue;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	suspension or withdrawal of marketing approvals;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	refusal to permit the import or export of our medicines;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	product seizure or detention; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	injunctions or the imposition of civil or criminal penalties.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The FDA&#8217;s policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained, which would adversely affect our business, prospects and ability to achieve or sustain profitability.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. The occurrence of any event or penalty described above may inhibit our ability to commercialize our product candidates and generate revenues.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may seek one or more special designations from regulatory authorities for our product candidates, including Breakthrough Therapy Designation, Fast Track Designation or Orphan Drug Designation. These designations may not lead to a faster development or regulatory review or approval process, and it does not increase the likelihood that our product candidates will receive marketing approval.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may seek one or more special designations from regulatory authorities for our product candidates, including Breakthrough Therapy Designation, Fast Track Designation or Orphan Drug Designation.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	A breakthrough therapy is defined as a product that is intended, alone or in combination with one or more other products, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically important endpoints, such as substantial treatment effects observed early in clinical development. For products that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Products designated as breakthrough therapies by the FDA can also be eligible for accelerated approval.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If a product is intended for the treatment of a serious or life-threatening condition and the product demonstrates the potential to address unmet medical needs for this condition, the product sponsor may apply for Fast Track Designation.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Regulatory authorities in some jurisdictions, including the United States and Europe, may designate drugs for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000 individuals annually in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States. In the United States, Orphan Drug Designation entitles a party to incentives such as tax advantages and user-fee waivers.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU44">
</A>
	The FDA has broad discretion whether or not to grant these designations, so even if we believe a particular product candidate is eligible for a particular designation, we cannot assure you that the FDA would decide to grant it. Accordingly, even if we believe one
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	43
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage44"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	of our product candidates meets the criteria for a desig
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	nation, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a particular designation for a product candidate may not result in a faster development process, review or approval compared to products considere
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	d for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify as breakthrough therapies, the FDA may later decide that the products no longer meet the c
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	onditions for qualification and rescind the breakthrough designation. Further, the FDA may withdraw Fast Track Designation if it believes that the designation is no longer supported by data from a clinical development program.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risks Related to Our Reliance on Third Parties
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are substantially dependent upon our collaboration agreement with Sanofi for the development and eventual commercialization of MYK-461 and any product candidates from our HCM-2 and DCM-1 programs. If this collaboration is unsuccessful or is terminated, we may be unable to commercialize certain product candidates and we will not receive additional funding from this relationship
<FONT STYLE="FONT-STYLE:NORMAL;">
	.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We depend upon our license and collaboration agreement with Aventis Inc., a wholly-owned subsidiary of Sanofi S.A., which we refer to as the Collaboration Agreement, for financial and scientific resources related to the clinical development and commercialization of product candidates under our MYK-461, HCM-2 and DCM-1 programs. While Sanofi has obligations to fund various research and development activities under the collaboration and with respect to the commercialization of product candidates in selected territories under certain programs under the Collaboration Agreement, our ability to receive funding from this relationship will depend upon the ability and willingness of Sanofi to successfully meet its responsibilities under our Collaboration Agreement and continue the collaboration. We may not receive some or all of the financial and scientific resources that we currently expect to receive under our Collaboration Agreement.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our ability to generate additional funding from our Collaboration Agreement may be impaired by several factors including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Sanofi may elect not to continue the term of our research collaboration beyond December&#160;31, 2016;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Sanofi may shift its priorities and resources away from our programs due to a change in business strategies, or a merger, acquisition, sale or downsizing of its company or business unit;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Sanofi may cease development and commercialization activities in therapeutic areas which are the subject of our collaboration;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Sanofi may change the success criteria for a particular program or potential product candidate, thereby delaying or ceasing development of such program or candidate;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Sanofi may exercise its rights to terminate the collaboration; or
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	a dispute may arise between us and Sanofi concerning financial obligations or the research, development or commercialization of a program or product candidate, resulting in a delay in payments or termination of a program and possibly resulting in costly litigation or arbitration which may divert management attention and resources.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Specifically, with respect to termination, the initial term of the research program under our Collaboration Agreement with Sanofi is set to end on December&#160;31, 2018. If, however, prior to December&#160;31, 2016 Sanofi does not provide us with notice of its intent to continue the collaboration or if Sanofi provides notice of its intent to discontinue the collaboration, the research collaboration will terminate on December&#160;31, 2016. Additionally, at any time after December&#160;31, 2018, Sanofi may, upon prior written notice to us, terminate the collaboration agreement for convenience in its entirety or on a region-by-region or program-by-program basis with respect to selected regions. The Collaboration Agreement is also subject to termination by either party upon a material breach by the other party, subject to a notice and cure period, or upon a bankruptcy, insolvency or similar event affecting the other party.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If our Collaboration Agreement with Sanofi is terminated, then, depending on the event:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the development of our product candidates subject to the collaboration agreement may be terminated or significantly delayed;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our cash expenditures could increase significantly if it is necessary for us to hire additional employees and allocate internal resources to the development and commercialization of product candidates that were previously funded, or expected to be funded, by Sanofi;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	we would bear all of the risks and costs related to the further development and commercialization of product candidates that were previously the subject of the Collaboration Agreement;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	in order to fund further development and commercialization, we may need to seek out and establish alternative strategic collaborations with third-party partners, which may not be possible; or
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	44
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage45"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU45">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	we may not be able to do so on terms which are acceptable to us, in which case it may be necessary for us to limit t
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	he size or scope of one or more of our programs or increase our expenditures and seek additional funding by other means.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any of these events would have a material adverse effect on our results of operations and financial condition.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We expect to rely on third parties to conduct some or all aspects of our protocol development, research and preclinical and clinical testing, and these third parties may not perform satisfactorily.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We do not expect to independently conduct all aspects of our protocol development, research and preclinical and clinical testing. We currently rely, and expect to continue to rely, on third parties with respect to these items.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any of these third parties may terminate their engagements with us at any time. If we need to enter into alternative arrangements, it could delay our product development activities. Our reliance on these third parties for research and development activities will reduce our control over these activities but will not relieve us of our responsibility to ensure compliance with all required regulations and study protocols. For product candidates that we develop and commercialize on our own, we will remain responsible for ensuring that each of our Investigational New Drug, or IND, enabling studies and clinical trials are conducted in accordance with the study plan and protocols. We and our third-party contractors and CROs are required to comply with GCP regulations, which are regulations and guidelines enforced by the FDA, the Competent Authorities of the Member States of the European Economic Area, or EEA, and comparable foreign regulatory authorities for all products in clinical development. Regulatory authorities enforce these GCP requirements through periodic inspections of trial sponsors, principal investigators and trial sites. If we or any of our third-party contractors or CROs fail to comply with applicable GCP requirements, the clinical data generated in our clinical trials may be deemed unreliable and the FDA, EMA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials complies with GCP regulations. In addition, our clinical trials must be conducted with product produced under cGMP regulations. Our failure to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our studies in accordance with regulatory requirements or our stated study plans and protocols, we will be delayed in completing, or may not be able to complete, the preclinical and clinical studies required to support future IND submissions and approval of our product candidates. Any of these events could lead to clinical study delays or failure to obtain regulatory approval, or impact our ability to successfully commercialize future products. Some of these events could be the basis for FDA action, including injunction, recall, seizure or total or partial suspension of production.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We contract with third parties for the manufacture of our product candidates for preclinical testing and expect to continue to do so for clinical trials and for commercialization. This reliance on third parties increases the risk that we will not have sufficient quantities of our product candidates or medicines or that such supply will not be available to us at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We do not have any manufacturing facilities. We currently rely, and expect to continue to rely, on third-party manufacturers for the manufacture of our product candidates for preclinical and clinical testing and for the commercial supply of any of these product candidates for which we or our collaborators obtain marketing approval. To date, we have obtained materials for MYK-461 for our Phase 1 clinical trials from third-party manufacturers. We do not have a long term supply agreement with the third-party manufacturers, and we purchase our required drug supply on a purchase order basis. We may be unable to establish any agreements with third-party manufacturers or to do so on acceptable terms.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Reliance on third-party manufacturers entails risks to which we would not be subject if we manufactured the product candidates ourselves, including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the inability to negotiate manufacturing agreements with third parties under commercially reasonable terms;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	reduced control as a result of using third-party manufacturers for all aspects of manufacturing activities;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	reliance on the third party for regulatory compliance, quality assurance, and safety and pharmacovigilance reporting;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the possible breach of the manufacturing agreement by the third party;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	disruptions to the operations of our third-party manufacturers or suppliers caused by conditions unrelated to our business or operations, including the bankruptcy of the manufacturer or supplier.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	45
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage46"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU46">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The facilities used by our contract manufacturers to manuf
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	acture any of our future products must be approved by the FDA pursuant to inspections that will be conducted after we submit an NDA to the FDA. We do not control the manufacturing process of, and are completely dependent on, our contract manufacturing part
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ners for compliance with the cGMP regulation for manufacture of both active drug substances and finished drug products. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory req
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	uirements of the FDA or others, they will not be able to secure and/or maintain regulatory approval for their manufacturing facilities. In addition, we have no control over the ability of our contract manufacturers to maintain adequate quality control, qua
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	lity assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority does not approve these facilities for the manufacture of our product candidates or if it withdraws any such approval in the future, we may need to find alternat
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ive manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market our product candidates, if approved. Third-party manufacturers may not be able to comply with cGMP, regulations or similar regul
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	atory requirements outside the United States. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including fines, injunctions, civil penalties, delays, suspensi
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	on or withdrawal of approvals, license revocation, seizures or recalls of product candidates or medicines, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our medicines and harm our busine
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ss and results of operations.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any products that we may develop may compete with our other product candidates and products and the products of third parties for access to manufacturing facilities. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any performance failure on the part of our existing or future manufacturers could delay clinical development or marketing approval. We do not currently have arrangements in place for a redundant supply of bulk drug substances. If any one of our current contract manufacturer cannot perform as agreed, we may be required to replace that manufacturer. Although we believe that there are several potential alternative manufacturers who could manufacture our product candidates, we may incur added costs and delays in identifying and qualifying any such replacement.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our current and anticipated future dependence upon others for the manufacture of our product candidates or medicines may adversely affect our future profit margins and our ability to commercialize any medicines that receive marketing approval on a timely and competitive basis.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risks Related to Our Intellectual Property
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If we are unable to obtain and maintain patent protection for our medicines and technology, or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize medicines and technology similar or identical to ours, and our ability to successfully commercialize our medicines and technology may be adversely affected.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our commercial success will depend, in part, on our ability to obtain and maintain patent protection in the United States and other countries with respect to our proprietary products and technology. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our novel technologies and medicines that are important to our business. To date, we own 2 issued patents that cover our proprietary technology or product candidates. We cannot be certain that we will secure any additional rights to any issued patents with claims that cover any of our proprietary technology or product candidates.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The patent prosecution process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Although we enter into non-disclosure and confidentiality agreements with parties who have access to patentable aspects of our research and development output, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach the agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition to seeking patents for some of our technology and medicines, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. With respect to our proprietary molecularly targeted small molecule drugs, we consider trade secrets and know-how to be our primary intellectual property. Trade secrets and know-how can be difficult to protect. In particular, we anticipate that with respect to our precision medicine platform, these trade secrets and know-how will over time be disseminated within the industry through independent development, the publication of journal articles describing the methodology, and the movement of personnel skilled in the art from academic to industry scientific positions.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	46
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage47"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU47">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We seek to protect these trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborator
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	s, CROs, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these efforts, any of these parties may breach the
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expen
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	sive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently devel
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	oped by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor or other third pa
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	rty, our competitive position would be harmed.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Third-party claims of intellectual property infringement may prevent or delay our development and commercialization efforts.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our commercial success depends in part on our avoiding infringement of the patents and proprietary rights of third parties. There is a substantial amount of litigation, both within and outside the United States, involving patent and other intellectual property rights in the biotechnology and pharmaceutical industries, including patent infringement lawsuits, interferences, oppositions and&#160;
<FONT STYLE="FONT-STYLE:ITALIC;">
	inter partes
</FONT>
	&#160;reexamination proceedings before the U.S. PTO, and corresponding foreign patent offices. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are pursuing development candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our product candidates may be subject to claims of infringement of the patent rights of third parties.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Third parties may assert that we are employing their proprietary technology without authorization. There may be third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our product candidates. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that our product candidates may infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. If any third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of any of our product candidates, any molecules formed during the manufacturing process or any final product itself, the holders of any such patents may be able to block our ability to commercialize such product candidate unless we obtained a license under the applicable patents, or until such patents expire.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Similarly, if any third-party patents were held by a court of competent jurisdiction to cover aspects of our formulations, processes for manufacture or methods of use, including combination therapy, the holders of any such patents may be able to block our ability to develop and commercialize the applicable product candidate unless we obtained a license or until such patent expires. In either case, such a license may not be available on commercially reasonable terms or at all.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Parties making claims against us may obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize one or more of our product candidates. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Parties making claims against us may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have material adverse effect on our ability to raise additional funds or otherwise have a material adverse effect on our business, results of operations, financial condition and prospects.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, which could be expensive, time-consuming and unsuccessful.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Competitors may infringe our patents or the patents of our licensors. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours or our licensors is not valid, is unenforceable and/or is not infringed, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. Interference proceedings provoked by third parties or brought by us may be necessary to determine the priority of inventions with respect to our patents or patent applications or those of our licensors. An adverse result in any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or interpreted narrowly and could put our patent applications at risk of not issuing.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU48">
</A>
	An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	47
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage48"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our defense of litigation or interference proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. We may not be able to prevent, alone or with our licensors, misappropriation of our i
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ntellectual property rights, particularly in countries where the laws may not protect those rights as fully as in the United States.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may also be subject to claims that former employees, collaborators or other third parties have an ownership interest in our patents or other intellectual property. In the future, we may have ownership disputes arising, for example, from conflicting obligations of consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or ownership. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issued patents covering our product candidates could be found invalid or unenforceable if challenged in court.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If we or one of our licensing partners initiated legal proceedings against a third party to enforce a patent covering one of our product candidates, the defendant could counterclaim that the patent covering our product candidate is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the U.S. PTO, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, post grant review, and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings). Such proceedings could result in revocation or amendment to our patents in such a way that they no longer cover our product candidates. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our product candidates. Such a loss of patent protection would have a material adverse impact on our business.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As is common in the biotechnology and pharmaceutical industry, we employ individuals who were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any of our employee&#8217;s former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely impact our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risks Related to Commercialization and the Market for Our Product Candidates
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If the market opportunities for our product candidates are smaller than we believe they are or if we are unable to market our products to expanded patient populations, our revenues may be adversely affected and our business may suffer.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU49">
</A>
	We focus our research and product development efforts on treatments for heritable cardiomyopathies, and our targeted indications are rare genetic diseases. In particular, we estimate that approximately 630,000 people in the United States have a form of HCM, and that approximately 400,000 people in the United States have a form of heritable DCM. Our projections of both the number of people who have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with our product candidates, are based on estimates derived from primary research with physicians and payors, analysis of medical
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	48
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage49"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	journals and peer-re
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	viewed literature, the work of third-party consultants and other publicly- or non-publicly-available data sources. These estimates may prove to be incorrect and new studies may change the estimated incidence or prevalence of our targeted disease indication
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	s. The number of patients in the United States, Europe and elsewhere may turn out to be lower than expected, may not be otherwise amenable to treatment with our products, and new patients may become increasingly difficult to identify or gain access to, all
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	of which would adversely affect our results of operations and our business.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Additionally, because the target patient populations of our product candidates are small, we must be able to successfully identify patients and achieve a significant market share to achieve or maintain profitability and growth. Although we plan to use SHaRe to identify and select patients who are suitable for treatment with our products, if approved, we may not be able to identify or target a sufficient number of patients through SHaRe or our sales and marketing efforts to achieve the necessary market share.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Even if any of our product candidates receive marketing approval, they may fail to achieve the degree of market acceptance by physicians, patients, healthcare payors and others in the medical community necessary for commercial success.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If any of our product candidates receive marketing approval, they may nonetheless fail to gain sufficient market acceptance by physicians, patients, healthcare payors and others in the medical community. For example, current treatments such as beta blockers, non-dihydropyridine calcium channel blockers and disopyramide are well-established in the medical community, and doctors may continue to rely on these treatments. If our product candidates do not achieve an adequate level of acceptance, we may not generate significant product revenues and we may not become profitable. The degree of market acceptance of our product candidates, if approved for commercial sale, will depend on a number of factors, including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	efficacy and potential advantages compared to alternative treatments;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the ability to offer our medicines for sale at competitive prices;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	convenience and ease of administration compared to alternative treatments;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the strength of marketing and distribution support;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	sufficient third-party coverage or reimbursement; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the prevalence and severity of any side effects.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If we are unable to establish sales and marketing capabilities or enter into agreements with third parties to market and sell our product candidates, we may be unable to generate any revenues.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have no experience marketing or selling our product candidates. To successfully commercialize any products that may result from our development programs, we will need to develop these capabilities, either on our own or with others. We may enter into collaborations with other entities to utilize their mature marketing and distribution capabilities, but we may be unable to enter into marketing agreements on favorable terms, if at all. If our future collaborations do not commit sufficient resources to commercialize our future products, if any, and we are unable to develop the necessary marketing capabilities on our own, we will be unable to generate sufficient product revenue to sustain our business. We will be competing with many companies that currently have extensive and well-funded marketing and sales operations. Without an internal team or the support of a third party to perform marketing and sales functions, we may be unable to compete successfully against these more established companies.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The insurance coverage and reimbursement status of newly-approved products targeting small patient populations is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for our product candidates, if approved, could limit our ability to market those products and decrease our ability to generate revenue.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The availability and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford expensive treatments, such as endothelin receptor antagonists used in the treatment of certain cardiovascular diseases. Sales of our product candidates will depend substantially, both domestically and abroad, on the extent to which the costs of our product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. Additionally, therapies directed at small patient populations, such as our product candidates, may be more expensive, and reimbursement options for these therapies may be more limited. If reimbursement or coverage is not available, or is available only to limited levels, we may not be able to successfully commercialize our product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	49
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage50"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU50">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	There is significant uncertainty related to the insurance coverage and reimbursement of newly approved
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	products and for products whose targeted patient populations are small. In the United States, the principal decisions about reimbursement for new medicines are typically made by the Centers for Medicare&#160;&amp; Medicaid Services, or CMS, an agency within the U.
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S. Department of Health and Human Services, as CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare. Private payors tend to follow CMS to a substantial degree. It is difficult to predict what CMS or third-part
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	y payors will decide with respect to reimbursement and coverage for fundamentally novel products such as ours, as there is no body of established practices and precedents for these new products. Reimbursement agencies in Europe may be more conservative tha
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	n CMS.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Europe, Canada, and other countries may put pressure on the pricing and usage of our product candidates. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. In general, the prices of medicines under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for medicines, but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the United States, the reimbursement for our products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Moreover, increasing efforts by governmental and third-party payors, in the United States and abroad, to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for new products approved and, as a result, they may not cover or provide adequate payment for our product candidates. We expect to experience pricing pressures in connection with the sale of any of our product candidates, due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risk Related to Our Business and Industry
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may be subject to healthcare laws, regulation and enforcement, and our failure to comply with these laws could harm our results of operations and financial conditions.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Although we do not currently have any products on the market, if we obtain FDA approval for any of our product candidates and begin commercializing those products in the United States, our operations may be directly, or indirectly through our customers and third-party payors, subject to various U.S. federal and state fraud and abuse, patient privacy laws and other healthcare regulatory laws, and to additional healthcare, statutory and regulatory requirements and enforcement by foreign regulatory authorities in jurisdictions in which we conduct our business. Healthcare providers, physicians and others play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. These laws may impact, among other things, our proposed sales, marketing and education programs and constrain the business of financial arrangements and relationships with healthcare providers, physicians and other parties through which we market, sell and distribute our products for which we obtain marketing approval. The laws that may affect our ability to operate include:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the U.S. federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving or paying any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service, for which payment may be made, in whole or in part, under U.S. federal and state healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the U.S. federal False Claims Act, which imposes criminal and civil penalties, including through civil whistleblower or qui tam actions, against individuals or entities for knowingly presenting, or causing to be presented, to the U.S. federal government, claims for payment or approval that are false or fraudulent or from knowingly making a false statement to avoid, decrease or conceal an obligation to pay money to the U.S. federal government. In addition, the government may assert that a claim including items and services resulting from a violation of the U.S. federal Anti-Kickback Statute constitutes a false of fraudulent claim for purposes of the False Claims Act;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the U.S. federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which imposes criminal and civil liability for knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items or services; similar to the U.S. federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	50
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage51"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU51">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and its implementing regulations, and as amended again by the final HIPAA omnibus rule, Modifications to the HIPAA Privacy, Secur
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ity, Enforcement and Breach Notification Rules Under HITECH and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules, published in January 2013, which imposes certain obligations, including mandatory contractual terms, with
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	respect to safeguarding the privacy, security and transmission of individually identifiable health information without appropriate authorization on covered entities subject to the rule, such as health plans, healthcare clearinghouses and healthcare provid
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ers as well as their business associates that perform certain services involving the use or disclosure of individually identifiable health information;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the U. S. Federal Food, Drug, and Cosmetic Act, or FDCA, which prohibits, among other things, the adulteration or misbranding of drugs, biologics and medical devices;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the U. S. legislation commonly referred to as the Physician Payments Sunshine Act, enacted as part of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively PPACA, and its implementing regulations, which requires certain manufacturers of drugs, devices, biologics and medical supplies that are reimbursable under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program to report annually to CMS, information related to payments and other transfers of value to physicians, other healthcare providers, and teaching hospitals, as well as ownership and investment interests held by physicians and other healthcare providers and their immediate family members;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	analogous state laws and regulations, including: state anti-kickback and false claims laws, which may apply to our business practices, including but not limited to, research, distribution, sales and marketing arrangements and claims involving healthcare items or services reimbursed by any third-party payor, including private insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the U. S. federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; and state laws and regulations that require drug;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	manufacturers to file reports relating to pricing and marketing information, which requires tracking gifts and other remuneration and items of value provided to healthcare professionals and entities, and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	European and other foreign law equivalents of each of the laws, including reporting requirements detailing interactions with and payments to healthcare providers.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of the laws described above or any other governmental laws and regulations that may apply to us, we may be subject to significant penalties, including civil, criminal and administrative penalties, damages, fines, exclusion from U.S. government funded healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations. If any of the physicians or other providers or entities with whom we expect to do business is found not to be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs and imprisonment. If any of the above occur, it could adversely affect our ability to operate our business and our results of operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We face significant competition from other biotechnology and pharmaceutical companies, and our operating results will suffer if we fail to compete effectively.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our competitors may develop drugs that are less expensive, safer, or more effective, which may diminish or eliminate the commercial success of any drugs that we may commercialize.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our competitors may:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	develop drug candidates and market drugs that are less expensive or more effective than our future drugs;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	commercialize competing drugs before we or our partners can launch any drugs developed from our drug candidates;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	initiate or withstand substantial price competition more successfully than we can;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	have greater success in recruiting skilled scientific workers from the limited pool of available talent;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	more effectively negotiate third-party licenses and strategic collaborations; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	take advantage of acquisition or other opportunities more readily than we can.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	51
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage52"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU52">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We will compete for market share against larg
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	e pharmaceutical and biotechnology companies and smaller companies that are collaborating with larger pharmaceutical companies, new companies, academic institutions, government agencies and other public and private research organizations. Many of these com
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	petitors, either alone or together with their partners, may develop new drug candidates that will compete with ours, as these competitors may, and in certain cases do, operate larger research and development programs or have substantially greater financial
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	resources than we do. Our competitors may also have significantly greater experience in:
</FONT>
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	developing product candidates;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	undertaking preclinical testing and clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	building relationships with key customers and opinion-leading physicians;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	obtaining and maintaining FDA and other regulatory approvals of product candidates;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	formulating and manufacturing drugs; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	launching, marketing and selling drugs.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If our competitors market drugs that are less expensive, safer or more effective than our potential drugs, or that reach the market sooner than our potential drugs, we may not achieve commercial success. In addition, the life sciences industry is characterized by rapid technological change. Because our research approach integrates many technologies, it may be difficult for us to stay abreast of the rapid changes in each technology. If we fail to stay at the forefront of technological change we may be unable to compete effectively. Our competitors may render our technologies obsolete by advances in existing technological approaches or the development of new or different approaches, potentially eliminating the advantages in our drug discovery process that we believe we derive from our research approach and proprietary technologies.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Public opinion and heightened regulatory scrutiny of precision medicine for the treatment of cardiovascular disease may impact public perception of our product candidates or adversely affect our ability to conduct our business or obtain regulatory approvals for our product candidates.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Precision medicine remains a novel technology, particularly in the field of cardiovascular disease, with no products approved to date in the United&#160;States that are specifically targeted at correcting the underlying biomechanical defects in cardiac contractility associated with HCM and DCM. Public perception may be influenced by claims that these therapies are unproven or unsafe, and our product candidates may not gain the acceptance of the public or the medical community. In particular, our success will depend upon physicians, who specialize in the treatment of those diseases that our product candidates target, prescribing treatments that involve the use of our product candidates in lieu of, or in addition to, existing treatments they are already familiar with and for which greater clinical data may be available. More restrictive government regulations or negative public opinion could have an adverse effect on our business or financial condition and may delay or impair the development and commercialization of our product candidates or demand for any products we may develop. Adverse events in our clinical trials, even if not ultimately attributable to our product candidates, and the resulting publicity, could result in increased governmental regulation, unfavorable public perception, potential regulatory delays in the testing or approval of our potential product candidates, stricter labeling requirements for those product candidates that are approved and a decrease in demand for any such product candidates.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Healthcare legislative reform measures may have a material adverse effect on our business and results of operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In the United States, the EU, and other foreign jurisdictions, there have been a number of legislative and regulatory changes to the healthcare system that could affect our future results of operations. In particular, there have been and continue to be a number of initiatives at the United States federal and state levels that seek to reduce healthcare costs and improve the quality of healthcare. For example, PPACA changes the way healthcare is financed by both governmental and private insurers and significantly impacts the U.S. pharmaceutical and biotechnology industries. PPACA, among other things, subjects biologic products to potential competition by lower-cost biosimilars, addresses a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increases the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program to individuals enrolled in Medicaid managed care organizations, establishes annual fees and taxes on manufacturers of certain branded prescription drugs and biologic agents, and a new Medicare Part&#160;D coverage gap discount program, in which manufacturers must agree to offer 50% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part&#160;D. At this time, the full effect that PPACA would have on our business remains unclear.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU53">
</A>
	In addition, other legislative changes have been proposed and adopted in the United States since PPACA was enacted. On August&#160;2, 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	52
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage53"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several governm
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ent programs. This includes aggregate reductions of Medicare payments to providers of 2%&#160;per fiscal year. These reductions went into effect on April&#160;1, 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2024 un
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	less additional Congressional action is taken. On January&#160;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging center
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	s and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. These new laws may result in additional reductions in Medicare and other health care funding,
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	which could have a material adverse effect on our customers and accordingly, our financial operations.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop new payment and delivery models, such as bundled payment models. The U.S. federal government has set a goal of moving 50% of Medicare payments into these &#8220;Alternative Payment Models&#8221; by the end of 2018. We expect that additional U.S. federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that the U.S. federal government will pay for healthcare products and services, which could result in reduced demand for our product candidates or additional pricing pressures.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our future success depends on our ability to retain key employees and consultants, including our scientific advisors and founders, and to attract, retain and motivate qualified personnel.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are highly dependent on our scientific advisors and founders and the principal members of our executive team, the loss of whose services may adversely impact the achievement of our objectives. While we have entered into employment agreements with each of our executive officers, any of them could leave our employment at any time, as all of our employees are &#8220;at will&#8221; employees. Recruiting and retaining other qualified employees, consultants and advisors for our business, including scientific and technical personnel, will also be critical to our success. There is currently a shortage of skilled executives and scientific experts in our industry, which is likely to continue. As a result, competition for skilled personnel is intense and the turnover rate can be high. We may not be able to attract and retain personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies, as well as from academic and research institutions, for individuals with similar skill sets. In addition, any failure of our programs to succeed in preclinical studies or clinical trials may make it more challenging to recruit and retain qualified personnel. The inability to recruit or the loss of the services of any executive, key employee, consultant or advisor may impede the progress of our research, development and commercialization objectives.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We will need to expand our organization and we may experience difficulties in managing this growth, which could disrupt our operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31, 2015, we had 61 full-time employees. As we mature, we expect to expand our full-time employee base and to hire more consultants and contractors. Our management may need to divert a disproportionate amount of its attention away from our day-to-day activities and devote a substantial amount of time to managing these growth activities. We may not be able to effectively manage the expansion of our operations, which may result in weaknesses in our infrastructure, operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. Our expected growth could require significant capital expenditures and may divert financial resources from other projects, such as the development of additional product candidates. If our management is unable to effectively manage our growth, our expenses may increase more than expected, our ability to generate and/or grow revenues could be reduced, and we may not be able to implement our business strategy. Our future financial performance and our ability to commercialize product candidates and compete effectively will depend, in part, on our ability to effectively manage any future growth.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Because we have limited financial and managerial resources, we focus on research programs and product candidates that we identify for specific indications. As a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial medicines or profitable market opportunities. Our spending on current and future research and development programs and product candidates for specific indications may not yield any commercially viable medicines. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	53
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage54"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU54">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our anticipated international operations may expose us to business, regulatory, political, operational, financial, pricing and reimbursement and economic risks associated with doing business outside of t
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	he United States.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have a wholly-owned Australian subsidiary through which we plan to conduct clinical trials in Australia. Our business strategy also contemplates potential additional international operations as we seek to continue the development of MYK-461 and other product candidates that we have or may identify, seek regulatory approval for our product candidates, and commercialize any product candidates that are approved outside the United States. If any product candidates for which we have retained worldwide commercial rights are approved, we may hire sales representatives and conduct physician and patient group outreach activities outside of the United States. Doing business internationally involves a number of risks, including but not limited to:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	multiple, conflicting, and changing laws and regulations such as privacy regulations, tax laws, export and import restrictions, employment laws, regulatory requirements, and other governmental approvals, permits, and licenses;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	failure by us to obtain and maintain regulatory approvals for the use of our products in various countries;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	complexities and difficulties in obtaining protection for and enforcing our intellectual property rights;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	difficulties in staffing and managing foreign operations;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	complexities associated with managing multiple payor reimbursement regimes, government payors, or patient self-pay systems;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	limits in our ability to penetrate international markets;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	financial risks, such as exposure to foreign currency exchange rate fluctuations and their impact on payments required in local currency;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	natural disasters, political and economic instability, including wars, terrorism, and political unrest, outbreak of disease, boycotts, curtailment of trade, and other business restrictions;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	certain expenses including, among others, expenses for travel, translation, and insurance; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	regulatory and compliance risks that relate to maintaining accurate information and control over sales and activities that may fall within the purview of the U.S. Foreign Corrupt Practices Act, its books and records provisions, or its anti-bribery provisions.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any of these factors could significantly harm our future international expansion and operations and, consequently, our results of operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials or other work-related injuries, this insurance may not provide adequate coverage against potential liabilities. In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or production efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our employees, independent contractors, principal investigators, CROs, consultants, vendors and collaboration partners may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU55">
</A>
	We are exposed to the risk that our employees, independent contractors, principal investigators, CROs, consultants, vendors and collaboration partners may engage in fraudulent conduct or other illegal activities. Misconduct by these parties could include intentional, reckless and/or negligent conduct or unauthorized activities that violate: (i)&#160;the regulations of the FDA, EMA and other regulatory authorities, including those laws that require the reporting of true, complete and accurate information to such authorities;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	54
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage55"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(ii)&#160;manufacturing stand
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ards; (iii)&#160;federal and state data privacy, security, fraud and abuse and other healthcare laws and regulations in the United States and abroad; or (iv)&#160;laws that require the reporting of true, complete and accurate financial information and data. In parti
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	cular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict o
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	r prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Activities subject to these laws could also involve the improper use of information obtained in the cou
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	rse of clinical trials or creating fraudulent data in our preclinical studies or clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. It is not always possible to identify and deter misconduct by employees a
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	nd other third parties, and the precautions we take to detect and prevent misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	failure to comply with such laws or regulations. Additionally, we are subject to the risk that a person could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defendin
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	g ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, possible exclusion
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	from participation in Medicare, Medicaid and other U.S. federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to opera
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	te our business and our results of operations.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Unfavorable global economic conditions could adversely affect our business, financial condition or results of operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets. The recent global financial crisis caused extreme volatility and disruptions in the capital and credit markets. A severe or prolonged economic downturn, such as the recent global financial crisis, could result in a variety of risks to our business, including, our ability to raise additional capital when needed on acceptable terms, if at all, and weakened demand for our product candidates. This is particularly true in Europe, which is undergoing a continued severe economic crisis. A weak or declining economy could also strain our suppliers, possibly resulting in supply disruption, or cause our customers to delay making payments for our services. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We or the third parties upon whom we depend may be adversely affected by earthquakes or other natural disasters and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Earthquakes or other natural disasters could severely disrupt our operations, and have a material adverse effect on our business, results of operations, financial condition and prospects. If a natural disaster, power outage or other event occurred that prevented us from using all or a significant portion of our headquarters, that damaged critical infrastructure, such as the manufacturing facilities of our third-party contract manufacturers, or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible for us to continue our business for a substantial period of time. The disaster recovery and business continuity plans we have in place currently are limited and are unlikely to prove adequate in the event of a serious disaster or similar event. We may incur substantial expenses as a result of the limited nature of our disaster recovery and business continuity plans, which, particularly when taken together with our lack of earthquake insurance, could have a material adverse effect on our business.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Product liability lawsuits against us could cause us to incur substantial liabilities and could limit commercialization of any medicines that we may develop.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical trials and will face an even greater risk if we commercially sell any medicines that we may develop. If we cannot successfully defend ourselves against claims that our product candidates or medicines caused injuries, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	decreased demand for any product candidates or medicines that we may develop;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	injury to our reputation and significant negative media attention;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	withdrawal of clinical trial participants;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	significant costs to defend the related litigation;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	substantial monetary awards to trial participants or patients;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	loss of revenue; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the inability to commercialize MYK-461 or any other product candidates that we may develop.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	55
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage56"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU56">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Although we maintain product liability insurance, including coverage for clinical trials that we sponsor, it may not be adequate to
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	cover all liabilities that we may incur. We anticipate that we will need to increase our insurance coverage as we commence additional clinical trials and if we successfully commercialize any product candidates. The market for insurance coverage is increas
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ingly expensive, and the costs of insurance coverage will increase as our clinical programs increase in size. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our internal computer systems, or those of our third-party CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of our operations.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Despite the implementation of security measures, our internal computer systems and those of our third-party CROs and other contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. While we have not experienced any such system failure, accident or security breach to date, if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our programs. For example, the loss of clinical trial data for our product candidates could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach results in a loss of or damage to our data or applications or other data or applications relating to our technology or product candidates, or inappropriate disclosure of confidential or proprietary information, we could incur liabilities and experience delays or disruptions to various aspects of our operations, including our financial reporting and the development of our product candidates.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have incurred substantial losses during our history and do not expect to become profitable in the near future. To the extent that we continue to generate taxable losses, unused losses will carry forward to offset future taxable income, if any, until such unused losses expire. Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or the Code if a corporation undergoes an &#8220;ownership change,&#8221; generally defined as a greater than 50 percentage point change (by value) in its equity ownership over a rolling three-year period, the corporation&#8217;s ability to use its pre-change net operating loss carryforwards, or NOLs, and other pre-change tax attributes (such as research tax credits) to offset its post-change income or taxes may be limited. While we have determined that an ownership change occurred in April 2015 in connection with our Series B redeemable convertible preferred stock financing, we do not believe that this ownership change will result in the expiration of any of our existing NOLs prior to utilization. We may experience subsequent shifts in our stock ownership, some of which are outside our control. As a result, if we earn net taxable income, our ability to use our pre-change net operating loss carryforwards to offset U.S. federal taxable income may be subject to limitations, which could potentially result in increased future tax liability to us. In addition, at the state level, there may be periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risk Related to Our Common Stock
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The market price of our common stock may be highly volatile.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The market price of our common stock is likely to be volatile. Our stock price could be subject to wide fluctuations in response to a variety of factors, including the following:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	adverse results or delays in preclinical studies or clinical trials;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	reports of adverse events in other products for the treatment of cardiovascular diseases or clinical trials of such products;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	a decision by Sanofi to terminate or cease moving forward with the Collaboration Agreement;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	inability to obtain additional funding;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	any delay in filing an IND or NDA for any of our product candidates and any adverse development or perceived adverse development with respect to the FDA&#8217;s review of that IND or NDA;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	failure to develop successfully and commercialize our product candidates;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	failure to maintain our existing strategic collaborations or enter into new collaborations;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	failure by us or our licensors and strategic collaborators to prosecute, maintain or enforce our intellectual property rights;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	changes in laws or regulations applicable to future products;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	inability to obtain adequate product supply for our product candidates or the inability to do so at acceptable prices;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	adverse regulatory decisions;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	introduction of new products, services or technologies by our competitors;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	failure to meet or exceed financial projections we may provide to the public or to the investment community;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	56
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage57"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU57">
</A>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	the perception of the pharmaceutical industry by the public, legislatures, regulators and the investment community;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	announcements of significant acquisitions, strategic partnerships, joint ventures or capital commitments by us, our strategic collaboration partner or our competitors;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	disputes or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	additions or departures of key scientific or management personnel;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	significant lawsuits, including patent or stockholder litigation;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	changes in the market valuations of similar companies;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	sales of our common stock by us or our stockholders in the future; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	trading volume of our common stock.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, companies trading in the stock market in general, and The NASDAQ Global Select Market, or NASDAQ, in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Future sales and issuances of our common stock or rights to purchase common stock, including pursuant to our equity incentive plans, could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Additional capital will be needed in the future to continue our planned operations. To the extent we raise additional capital by issuing equity securities, our stockholders may experience substantial dilution. We may sell common stock, convertible securities or other equity securities in one or more transactions at prices and in a manner we determine from time to time. If we sell common stock, convertible securities or other equity securities in more than one transaction, investors may be materially diluted by subsequent sales. These sales may also result in material dilution to our existing stockholders, and new investors could gain rights superior to our existing stockholders.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, sales of a substantial number of shares of our outstanding common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares of common stock intend to sell shares, could reduce the market price of our common stock. The lock-up agreements pertaining to our initial public offering, including those lock-up agreements signed by participants in the directed share program, which provided for the sale of up to 5% of the shares of common stock offered in our initial public offering, will expire on April 26, 2016 (subject to extension upon the occurrence of specified events).
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, as of December 31, 2015, there were 1,318,647 shares subject to outstanding options that will become eligible for sale in the public market to the extent permitted by any applicable vesting requirements, the lock-up agreements and Rules 144 and 701 under the Securities Act of 1933, as amended. Moreover, holders of an aggregate of approximately 17.4 million shares of our common stock will have rights, subject to certain conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Pursuant to our 2015 Stock Option and Incentive Plan, or the 2015 Plan, we have initially reserved 1,650,000 shares for issuance pursuant to stock options and other equity-based awards to be granted to our employees, directors and consultants. Beginning on January 1, 2017, the number of shares available for future grant under the 2015 Plan will automatically increase each year by up to 4% of all shares of our capital stock outstanding as of December&#160;31 of the prior calendar year, subject to the ability of our board of directors to take action to reduce the size of the increase in any given year. In addition, pursuant to our 2015 Employee Stock Purchase Plan, or the 2015 ESPP, we have initially reserved 255,000 shares for purchase by eligible employees. Beginning on January 1, 2017 and ending on January 1, 2025, the number of shares available for future issuance under the 2015 ESPP will automatically increase each year by up to the lesser of 3,000,000 shares of common stock or 1% of all shares of our capital stock outstanding as of December 31 of the prior calendar year, subject to the ability of our board of directors to take action to reduce the size of the increase in any given year. Currently, we plan to register the increased number of shares available for issuance under the 2015 Plan and the 2015 ESPP each year. If our board of directors elects to increase the number of shares available for future grant under these plans by the maximum amount each year, our stockholders may experience additional dilution, which could cause our stock price to fall.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	57
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage58"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU58">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our principal stockholders and managem
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ent own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of March 11, 2016, our executive officers, directors, five percent or greater stockholders and their affiliates beneficially own approximately 66.6% of our outstanding voting stock.&nbsp;&nbsp;These stockholders will have the ability to influence us through their ownership positions. These stockholders may be able to determine all matters requiring stockholder approval. For example, these stockholders, acting together, may be able to control elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your best interest as one of our stockholders.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have broad discretion in the use of our cash and cash equivalents and may not use them effectively.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our management will have broad discretion in the application of our existing cash and cash equivalents, including the net proceeds from our initial public offering, and you will not have the opportunity to assess whether our existing cash and cash equivalents are being used appropriately. Because of the number and variability of factors that will determine our use of our existing cash and cash equivalents, their ultimate use may vary substantially from their currently intended use. The failure by our management to apply these funds effectively could harm our business. Pending their use, we may invest our cash and cash equivalents in short-term, investment-grade, interest-bearing securities. These investments may not yield a favorable return to our stockholders.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research, about our business, our stock price and trading volume could decline.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The trading market for our common stock will depend, in part, on the research and reports that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently, and may never, publish research on our company. If no securities or industry analysts commence coverage of our company, the trading price for our stock would likely be negatively impacted. In the event that securities or industry analysts initiate coverage, if one or more of the analysts who cover us downgrade our stock or publish inaccurate or unfavorable research about our business, our stock price would likely decline. In addition, if our operating results fail to meet the forecasts of analysts, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are an &#8220;emerging growth company,&#8221; and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our common stock less attractive to investors.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our common stock held by non-affiliates exceeds $700.0&#160;million as of any June&#160;30 before that time or if we have total annual gross revenue of $1.0 billion or more during any fiscal year before that time, in which cases we would no longer be an emerging growth company as of the following December&#160;31 or, if we issue more than $1.0&#160;billion in non-convertible debt during any three-year period before that time, we would cease to be an emerging growth company immediately. Even after we no longer qualify as an emerging growth company, we may still qualify as a &#8220;smaller reporting company&#8221; which would allow us to take advantage of many of the same exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, or Section&#160;404, and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	58
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage59"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU59">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We will continue to incur increased costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As a public company, and particularly after we are no longer an emerging growth company, we incur and will continue to incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the Sarbanes-Oxley Act and rules subsequently implemented by the SEC and NASDAQ have imposed various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Pursuant to Section&#160;404, we will be required to furnish a report by our management on our internal control over financial reporting starting with our 2016 Annual Report on Form 10-K and an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, while we remain an emerging growth company, we will not be required to obtain an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section&#160;404 within the prescribed period, we will be engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section&#160;404. This could impair our ability to produce timely and accurate consolidated financial statements and result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our consolidated financial statements.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our quarterly operating results may fluctuate significantly or may fall below the expectations of investors or securities analysts, each of which may cause our stock price to fluctuate or decline.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We expect our operating results to be subject to quarterly fluctuations. Our net loss and other operating results will be affected by numerous factors, including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	variations in the level of expenses related to our precision medicine platform, our product candidates or our research and development programs;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	if any of our product candidates receives regulatory approval, the level of underlying demand for these product candidates;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	addition or termination of clinical trials or funding support;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	our execution of any new collaborative, licensing or similar arrangements, and the timing of payments we may make or receive under these arrangements.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	any intellectual property infringement lawsuit in which we may become involved; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	regulatory developments affecting our product candidates or those of our competitors.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If our quarterly operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. Furthermore, any quarterly fluctuations in our operating results may, in turn, cause the price of our stock to fluctuate substantially. We believe that quarterly comparisons of our financial results are not necessarily meaningful and should not be relied upon as an indication of our future performance.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be your sole source of gain.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have never declared or paid cash dividends on our capital stock. We currently intend to retain all of our future earnings, if any, to finance the growth and development of our business. In addition, the terms of any future debt agreements may preclude us from paying dividends. As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable future.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	59
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage60"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU60">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We could be subject to securities class action litigation.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant for us because pharmaceutical companies have experienced significant stock price volatility in recent years. If we face such litigation, it could result in substantial costs and a diversion of management&#8217;s attention and resources, which could harm our business.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Provisions in our amended and restated certificate of incorporation and amended and restated bylaws, as well as provisions of Delaware law, could make it more difficult for a third party to acquire us or increase the cost of acquiring us, even if doing so would benefit our stockholders or remove our current management.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law contain provisions that may have the effect of delaying or preventing a change in control of us or changes in our management. Our amended and restated certificate of incorporation and amended and restated bylaws, which will become effective immediately prior to the closing of this offering, include provisions that:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	authorize &#8220;blank check&#8221; preferred stock, which could be issued by our board of directors without stockholder approval and may contain voting, liquidation, dividend and other rights superior to our common stock;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	create a classified board of directors whose members serve staggered three-year terms;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	specify that special meetings of our stockholders can be called only by our board of directors, the chairperson of our board of directors, our chief executive officer or our president;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	prohibit stockholder action by written consent;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	provide that our directors may be removed only for cause and with the vote of the holders of 75% or more of our outstanding capital stock then entitled to vote at an election of directors;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even if less than a quorum;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	specify that no stockholder is permitted to cumulate votes at any election of directors;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	expressly authorize our board of directors to modify, alter or repeal our amended and restated bylaws; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.27%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8226;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	require supermajority votes of the holders of our common stock to amend specified provisions of our amended and restated certificate of incorporation and amended and restated bylaws.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&#160;203 of the Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Any provision of our amended and restated certificate of incorporation or amended and restated bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock.
</P>
</EFX_RISK_FACTORS>
<EFX_UNRESOLVED_STAFF_COMMENTS>
<A NAME="FIS_UNRESOLVED_STAFF_COMMENTS"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 1B.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_1B_UNRESOLSTAFFCOMMENTS">
</A>
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_UNRESOLVEDSTAFFCOM">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_1B_UNRESOLSTAFFCOMMENTS">
</A>
	UNRESOLVED STAFF COMMENTS
<FONT STYLE="FONT-WEIGHT:NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_UNRESOLVEDSTAFFCOM">
</A>
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="FIS_PROPERTIES">
</A>
<A NAME="FIS_PROPERTIES">
</A>
	None.
</P>
</EFX_UNRESOLVED_STAFF_COMMENTS>
<EFX_PROPERTIES>
<A NAME="FIS_PROPERTIES"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_ITEM2_604498">
</A>
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_ITEM2_604498">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_2_PROPERTIES">
</A>
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_PROPERTIES_225227">
</A>
<FONT STYLE="FONT-WEIGHT:NORMAL;">
</FONT>
<A NAME="MYOK-10K_20151231_HTM_ITEM_2_PROPERTIES">
</A>
	PROPERTIES
<FONT STYLE="FONT-WEIGHT:NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_PROPERTIES_225227">
</A>
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In September 2014, we leased approximately 34,409 square feet of office space in South San Francisco, California which serves as our corporate headquarters under a lease that expires on January&#160;19, 2020. We believe that our existing facilities and other available properties will be sufficient for our needs for the foreseeable future.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	60
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage61"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_ITEM3_314578">
</A>
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU61">
</A>
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_ITEM3_314578">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_3_LEAGALPROCEEDINGS">
</A>
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_LEGALPROCEEDINGS_8">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_3_LEAGALPROCEEDINGS">
</A>
	LEG
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	AL PROCEEDINGS
</FONT>
<FONT STYLE="FONT-WEIGHT:NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_LEGALPROCEEDINGS_8">
</A>
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="FIS_MINE_SAFETY_DISCLOSURE">
</A>
	We are not a party to any material legal proceedings at this time. From time to time, we may be subject to various legal proceedings and claims that arise in the ordinary course of our business activities. Although the results of litigation and claims cannot be predicted with certainty, we do not believe we are party to any claim or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because of
<A NAME="FIS_MINE_SAFETY_DISCLOSURE">
</A>
	defense and settlement costs, diversion of management resources and other factors.
</P>
</EFX_PROPERTIES>
<EFX_MINE_SAFETY_DISCLOSURE>
<A NAME="FIS_MINE_SAFETY_DISCLOSURE"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_ITEM4_604989">
</A>
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_ITEM4_604989">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_4_MINESAFETYDIS">
</A>
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_MINESAFETYDISCLOSU">
</A>
<FONT STYLE="FONT-WEIGHT:NORMAL;">
</FONT>
<A NAME="MYOK-10K_20151231_HTM_ITEM_4_MINESAFETYDIS">
</A>
	MINE SAFETY DISCLOSURES
<FONT STYLE="FONT-WEIGHT:NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_KBIO_20141231X10K_HTM_MINESAFETYDISCLOSU">
</A>
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="FIS_PART_II">
</A>
<A NAME="FIS_PART_II">
</A>
	None.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	61
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage62"></A>
</EFX_MINE_SAFETY_DISCLOSURE>
</EFX_PART_I>
<EFX_PART_II>
<A NAME="FIS_PART_II"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU62">
</A>
<A NAME="MYOK-10K_20151231_HTM_PART_II">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_PART_II">
</A>
	PART
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	II
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.8%;TEXT-INDENT:-6.8%;FONT-WEIGHT:BOLD;;FONT-SIZE:6PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.8%;TEXT-INDENT:-6.8%;FONT-WEIGHT:BOLD;;FONT-SIZE:6PT;">
	&nbsp;
</P>
<EFX_MARKET>
<A NAME="FIS_MARKET"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 5.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU">
</A>
	MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
</P>
</TD>
</TR>
</TABLE>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_2"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MARKET INFORMATION
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our common stock has been trading on The NASDAQ Global Select Market under the symbol &#8220;MYOK&#8221; since it began trading on October 29, 2015.&nbsp;&nbsp;Prior to this date, there was no public market for our common stock. The following table sets forth the high and low intraday sale prices per share of our common stock for the periods indicated as reported by The NASDAQ Global Select Market.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	High
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Low
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4th Quarter
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	16.76
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8.98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	HOLDERS OF COMMON STOCK
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of March 15, 2016, we had 27,016,081 shares of common stock outstanding held by approximately 75 stockholders of record. The approximate number of holders is based upon the actual number of holders registered in our records at such date and excludes holders in &#8220;street name&#8221; or persons, partnerships, associations, corporations, or other entities identified in security positions listings maintained by depository trust companies.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	STOCK PERFORMANCE GRAPH
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following graph illustrates a comparison of the total cumulative stockholder return on our common stock since October 29, 2015, which is the date our common stock first began trading on the NASDAQ Global Select Market, to two indices: the NASDAQ Composite Index and the NASDAQ Biotechnology Index. The stockholder return shown in the graph below is not necessarily indicative of future performance, and we do not make or endorse any predictions as to future stockholder returns. This graph shall not be deemed &#8220;soliciting material&#8221; or be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/03/18/0001564590-16-015044_G2016031817373049816252.JPG" TITLE="" ALT="" STYLE="WIDTH:479PX;HEIGHT:289PX;">
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_3"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.48%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$100 investment in stock or index
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Ticker
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	October 29,
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	December 31,
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.48%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MyoKardia, Inc. (MYOK)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.76%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOK
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	100
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:CALIBRI;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.76%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	132
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	NASDAQ Composite (&#94;IXIC)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.76%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	IXIC
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	100
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.76%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	99
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	NASDAQ Biotechnology (&#94;NBI)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.76%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	NBI
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	100
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.76%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	102
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	62
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage63"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU63">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	DIVIDEND POLICY
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have never declared or paid any cash dividends. We currently expect to retain all future earnings, if any, for use in the operation and expansion of our business, and therefore do not anticipate paying any cash dividends in the foreseeable future. &#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:UPPERCASE;FONT-SIZE:10PT;FONT-STYLE:NORMAL;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__CP_TEXT_1_6">
</A>
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;">
	Securities Authorized for Issuance under Equity Compensation Plans
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__CP_TEXT_1_7">
</A>
	Information about our equity compensation plans is incorporated herein by reference to Item&#160;12 of Part III of this Annual Report on Form 10-K.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	RECENT SALES OF UNREGISTERED SECURITIES
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	None.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	None.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	63
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
</EFX_MARKET>
<EFX_FINANCIAL_DATA>
<A NAME="FIS_FINANCIAL_DATA"></A>
<A NAME="eolPage64"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 6.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU64">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_6_SELECTED_CONSOLIDATED_FINANCIAL_D">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_6_SELECTED_CONSOLIDATED_FINANCIAL_D">
</A>
	SELECTED CONS
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	OLIDATED FINANCIAL DATA
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	You should read the selected historical financial data below in conjunction with the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and the consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_4"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:90%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:52.84%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;WIDTH:1.68%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.56%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:52.84%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(In thousands, except share and per share data)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;WIDTH:1.68%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.22%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.22%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.26%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:52.84%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:1.68%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:52.84%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Consolidated Statement of Operations Data:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:1.68%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:52.84%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Collaboration and license revenue
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:1.68%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14,199
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,916
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:52.84%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Operating expenses:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:1.68%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:52.84%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:1.68%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	28,393
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	18,296
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	11,603
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:52.84%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and administrative
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;WIDTH:1.68%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9,019
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,838
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.96%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,029
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:52.84%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total operating expenses
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;WIDTH:1.68%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	37,412
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	23,134
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.96%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	13,632
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:52.84%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Loss from operations
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:1.68%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(23,213
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(17,218
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(13,632
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:52.84%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Interest and other income, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:1.68%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(47
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:52.84%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in fair value of redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; stock call option liability
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;WIDTH:1.68%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	314
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	387
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.96%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	932
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:52.84%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss and comprehensive loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:1.68%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(22,946
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(16,829
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(12,700
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:52.84%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cumulative dividend relating to redeemable convertible
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:1.68%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(5,151
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2,864
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,087
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:52.84%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accretion of redeemable convertible preferred stock to
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; redemption value
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;WIDTH:1.68%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(158
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.96%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(179
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:52.84%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss attributable to common stockholders
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;WIDTH:1.68%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(28,195
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(19,851
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.96%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(13,966
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:52.84%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss per share attributable to common stockholders, basic
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; and diluted
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;WIDTH:1.68%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(4.48
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(11.30
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.96%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(11.98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:52.84%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Shares used to compute net loss per share attributable to
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; common stockholders, basic and diluted
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;WIDTH:1.68%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,292,800
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.04%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,756,900
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.96%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.48%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.18%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.08%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,165,867
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="BORDER-BOTTOM:SOLID 1PT;PADDING-BOTTOM:1PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-RIGHT:86.67%;TEXT-INDENT:0%;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_5"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:90%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:53.3%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.52%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.14%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:53.3%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.52%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.02%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.52%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.02%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.52%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.02%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:53.3%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:53.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Consolidated Balance Sheet Data:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:53.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash and cash equivalents
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	112,265
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	43,648
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,911
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:53.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Working capital
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	91,572
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	26,348
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(125
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:53.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	116,580
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	46,889
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,703
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:53.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable convertible preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	51,588
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	19,388
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:53.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accumulated deficit
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(64,685
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(36,906
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(17,247
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:53.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total stockholders&#8217; equity (deficit)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	93,873
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(36,906
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.52%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.02%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(17,247
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	64
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
</EFX_FINANCIAL_DATA>
<EFX_MANAGEMENTS_DISCUSSION>
<A NAME="FIS_MANAGEMENTS_DISCUSSION"></A>
<A NAME="eolPage65"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 7.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU65">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_7_MANAGEMENTS_DISCUSSION__ANALYSIS_">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_7_MANAGEMENTS_DISCUSSION__ANALYSIS_">
</A>
	MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS O
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	FINANCIAL CONDITION AND RESULTS OF OPERATIONS
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-STYLE:ITALIC;COLOR:#000000;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;">
	You should read the following discussion and analysis together with &#8220;Item&#160;6. Selected Consolidated Financial Data&#8221; and our financial statements and related notes included elsewhere in this Annual Report. The following discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those expressed or implied in any forward-looking statements as a result of various factors, including those set forth under the caption "Item&#160;1A. Risk Factors."
</FONT>
<FONT STYLE="COLOR:#000000;">
</FONT>
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Overview
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Our initial focus is on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. We have used our precision medicine platform to generate an initial pipeline of four therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy&#8212;hypertrophic cardiomyopathy, or HCM, and dilated cardiomyopathy, or DCM. We have discovered and advanced our lead product candidate, MYK-461, into Phase 1 clinical development. In our first Phase 1 clinical trial, we have demonstrated proof of mechanism, or the ability of MYK-461 to reduce cardiac muscle contraction, an important biomarker of disease. We intend to expand our approach to deliver treatments with disease-modifying potential for patients with other forms of genetically-driven heart failure.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Financial Overview
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have not generated net income from operations, and, as of December 31, 2015, we had an accumulated deficit of $64.7 million, primarily as a result of research and development and general and administrative expenses.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	To date, all of our revenue has been derived from non-refundable payments under the license and collaboration agreement we entered into with Aventis Inc., a wholly-owned subsidiary of Sanofi S.A., in August 2014, which we refer to as the Collaboration Agreement, and we have not yet generated any revenue from product sales. We have never been profitable and have incurred net losses in each year since commencement of our operations. We expect to incur significant and increasing losses from operations for the foreseeable future, and we can provide no assurance that we will ever generate significant revenue or profits.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Through December 31, 2015, we have financed our operations through an initial public offering, private placements of redeemable convertible preferred stock and payments received under the Collaboration Agreement. On October 29, 2015, we closed our initial public offering (IPO) of 6,253,125 shares of common stock at an offering price of $10.00 per share, resulting in net proceeds of approximately $55.6 million, after deducting underwriting discounts, commissions and offering costs. In April 2015, we received net proceeds of $45.8 million from the sale of shares of our Series B redeemable convertible preferred stock. As of December 31, 2015, we had cash and cash equivalents of $112.3 million, which we believe will be sufficient to fund our planned operations through at least the next twelve months.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have no manufacturing facilities, and all of our manufacturing activities are contracted out to a third party. Additionally, we currently utilize third-party clinical research organizations, or CROs, to carry out our clinical development and trials. We do not yet have a sales organization.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We expect to incur substantial expenditures in the foreseeable future for the advancement of our precision medicine platform and the discovery, development and potential commercialization of MYK-461, our lead product candidate, and additional product candidates that we intend to pursue. Specifically, we expect to continue to incur substantial expenses in connection with our existing Phase 1 clinical trials and any Phase&#160;2 and Phase&#160;3 clinical trials that we may conduct for MYK-461. We will need substantial additional funding to support our operating activities as we advance MYK-461 and other potential product candidates through clinical development, seek regulatory approval and prepare for, and if approved, proceed to commercialization. Adequate funding may not be available to us on acceptable terms, or at all.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	License and Collaboration Agreement with Sanofi
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In August 2014, we entered into the Collaboration Agreement with Aventis, Inc., a wholly-owned subsidiary of Sanofi S.A., that covers three main research programs: our first program in HCM (referred to as MYK- 461 or HCM-1), a second program in HCM (referred to as HCM-2) and our first program in DCM (referred to as DCM-1). For purposes of this presentation, we refer to Sanofi as our co-party to the Collaboration Agreement.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU66">
</A>
	Under the Collaboration Agreement, we are responsible for conducting research and development activities through early human efficacy studies, except for specified research activities to be conducted by Sanofi. Thereafter, we will lead worldwide
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	65
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage66"></A>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	development and U.S. commercial activities for the MYK-461 and HCM-2 programs, Sanofi will lead global development and commercial activities for DCM-1 and Sanofi will lead commercial
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	activities for the MYK-461 and HCM-2 programs where it has ex-U.S. commercialization rights. Sanofi also has the option to co-promote the MYK-461 and HCM-2 programs in the United States only in the event of a potential expanded cardiovascular disease indi
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	cation outside of the genetically targeted indications for MYK-461 and HCM-2. We have co-commercialization rights to DCM-1 in the United States, at our option.
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We are entitled to receive tiered royalties beginning in the mid-single digits to the mid-teens on net sales of certain HCM and DCM finished products outside the United States and on net sales of certain DCM finished products in the United States. Sanofi is eligible to receive tiered royalties beginning in the mid-single digits to the low teens on our net sales of certain HCM finished products in the United States.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Under the Collaboration Agreement, Sanofi also agreed to provide up to $200.0 million in upfront and milestone payments, equity investments and research and development support. To date, of such amount, we have received from Sanofi an initial non-refundable upfront cash payment of $35.0 million and equity investments of $10.0 million in exchange for Series&#160;A-1 redeemable convertible preferred stock, $5.0 million in exchange for Series&#160;B redeemable convertible preferred stock and $9.0 million in exchange for shares of our common stock in our initial public offering. The total payments we were originally eligible to receive also include a $45.0 million continuation payment, a $25.0 million milestone-based payment, and an obligation from Sanofi to purchase an additional $40.0 million of our capital stock if Sanofi provided notice of its intent to continue the collaboration prior to December&#160;31, 2016. Under the Collaboration Agreement, Sanofi&#8217;s obligation to purchase the additional $40.0 million of our capital stock (which was reduced by $5.0 million for its purchase of the Series&#160;B redeemable convertible preferred stock) terminated in connection with our initial public offering in October 2015. Additionally, we are eligible to receive up to $45.0 million of approved in-kind research and clinical activities.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Components of Operating Results
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Collaboration and License Revenue
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We generate revenue from the Collaboration Agreement with Sanofi for the development and commercialization of products under the collaboration.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Operating Expense
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and Development Expenses
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development expenses consist of salaries and benefits, including stock-based compensation, lab supplies and facility costs, as well as fees paid to CROs to conduct certain research and development activities on our behalf. Amounts incurred in connection with collaboration and license agreements are also included in research and development expense. Payments made prior to the receipt of goods or services to be used in research and development are capitalized until the goods or services are received.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and Administrative Expenses
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and administrative expenses consist principally of personnel-related costs, professional fees for legal, consulting, audit and tax services, market research, rent and other general operating expenses not otherwise classified as research and development expenses.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in Fair Value of Redeemable Convertible Preferred Stock Call Option Liability
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We determined that our obligation to issue additional shares of our redeemable convertible preferred stock represented a freestanding financial instrument. The freestanding redeemable convertible preferred stock call option liability was initially recorded at fair value, with fair value changes recognized as increases or reductions in the consolidated statements of operations and comprehensive loss. We continued to adjust the liability for changes in fair value until the issuance of Series B in April 2015 upon which it was reclassified to permanent equity with no further remeasurement required. We had recorded a preferred stock call option liability, net in September 2012 related to the Series A redeemable convertible preferred stock financing, which was extinguished in July 2014 at the time of the final closing of the Series A redeemable convertible preferred stock financing. We had recorded a redeemable convertible preferred stock call option liability in August 2014 related to the Collaboration Agreement, which was extinguished in April 2015 at the time of the closing of the Series B redeemable convertible preferred stock financing.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Critical Accounting Policies, Significant Judgments and Use of Estimates
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU67">
</A>
	This discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	66
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage67"></A>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	consolidated financial statements requires us to make es
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	timates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities t
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	hat are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that the accounting policies discussed below are critical to understanding our historical and future perfo
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	rmance, as these policies relate to the more significant areas involving management&#8217;s judgments and estimates.
</FONT>
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Revenue
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We may generate revenue from collaboration and license agreements for the development and commercialization of products. Collaboration and license agreements may include non-refundable upfront license fees, partial or complete reimbursement of research and development costs, contingent consideration payments based on the achievement of defined collaboration objectives and royalties on sales of commercialized products.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We recognize revenue when all four of the following criteria have been met:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(i)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	collectability is reasonably assured,
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(ii)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	delivery has occurred or services have been rendered,
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(iii)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	persuasive evidence of an arrangement exists, and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(iv)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	the fee is fixed or determinable.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Revenue under collaboration and license arrangements is recognized based on performance requirements of the contract. Collectability is assessed based on evaluation of payment criteria as stated in the contract as well as the creditworthiness of the collaboration partner. Determination of whether delivery has occurred or services rendered are based on management&#8217;s evaluation of the performance obligations as stated in the contract and progress made against those obligations. Evidence of an arrangement is deemed to exist upon execution of the contract. Fees are considered fixed and determinable when the amount payable to us is no longer subject to any acceptance, refund rights or other contingencies that would alter the fixed nature of the fees charged for the deliverables.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	License and collaboration agreements may contain multiple elements as evaluated under Accounting Standards Codification (ASC) 605-25,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Revenue Recognition&#8212;Multiple-Element Arrangements,
</FONT>
	including agreements to provide research and development services, and manufacturing and commercialization services, grants of licenses to intellectual property rights and know-how, as well as participation in development and/or commercialization committees. Each deliverable under the agreement is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has standalone value to the customer. The arrangement&#8217;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the following hierarchy: (i)&#160;vendor-specific objective evidence of the fair value of the deliverable, if it exists; (ii)&#160;third-party evidence of selling price, if vendor-specific objective evidence is not available or (iii)&#160;the best estimate of selling price if neither vendor-specific objective evidence or third-party evidence is available.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Upfront payments for licenses are evaluated to determine if the licensee can obtain standalone value from the license separate from the value of the research and development services and other deliverables in the arrangement to be provided by us. The assessment of multiple-element arrangements also requires judgment in order to determine the allocation of revenue to each deliverable and the appropriate period of time over which the revenue should be recognized. If we determine that the license does not have standalone value separate from the research and development services, the license and the services are combined as one unit of accounting and upfront payments are recorded initially as deferred revenue in the balance sheet. Revenue is then recognized on a straight-line basis over an estimated performance period that is consistent with the term of performance obligations, unless the Company determines there is a discernible pattern of performance other than straight-line, in which case the Company uses a proportionate performance method to recognize the revenue over the estimated performance period. If the license is determined to have standalone value, then the allocated consideration is recorded as revenue when the license or is delivered.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU68">
</A>
	License and collaboration agreements may also contain milestone payments that become due upon the achievement of certain milestones. We apply ASC 605-28,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Revenue Recognition&#8212;Milestone Method.
</FONT>
	Under the milestone method, payments that are contingent upon achievement of a substantive milestone are recognized in the period in which the milestone is achieved. Milestones are defined as an event that can only be achieved based on our performance, and there is substantive uncertainty about whether the event will be achieved at the inception of the arrangement. Events that are contingent only on the passage of time or only on counterparty performance are not considered milestones subject to this guidance. Further, the amounts received must relate solely to
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	67
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage68"></A>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	prior performance, be reasonable relative to all of the deliverables and payment terms within the agreement and commensurate our performance to
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	achieve the milestone.
</FONT>
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Preclinical Study and Clinical Trial Accruals
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our preclinical study and clinical trial accruals are a component of research and development expenses, and based on patient enrollment and related costs at clinical investigator sites as well as estimates for the services received and efforts expended pursuant to contracts with multiple research institutions and CROs that conduct and manage preclinical studies and clinical trials on our behalf.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We estimate preclinical study and clinical trial expenses based on the services performed, pursuant to contracts with research institutions and CROs that conduct and manage preclinical studies and clinical trials on our behalf. We estimate these expenses based on discussions with internal clinical management personnel and external service providers as to the progress or stage of completion of trials or services and the contracted fees to be paid for such services. If the actual timing of the performance of services or the level of effort varies from the original estimates, we will adjust the accrual accordingly. To date, there have been no material differences from our accrued preclinical study and clinical trial expenses to our actual preclinical and clinical expenses. Payments made to third parties under these arrangements in advance of the performance of the related services by the third parties are recorded as prepaid expenses until the services are rendered.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stock-Based Compensation Expense
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We account for stock-based compensation arrangements with employees in accordance with ASC 718,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Stock Compensation.
</FONT>
	ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all stock-based payments including stock options. Our determination of the fair value of stock options on the date of grant utilizes the Black-Scholes option-pricing model for stock options with time-based vesting, and is impacted by our common stock price as well as changes in assumptions regarding a number of highly complex and subjective variables. These variables include expected term that options will remain outstanding, expected common stock price volatility over the term of the option awards, risk-free interest rates and expected dividends.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The fair value is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period) on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated forfeitures. We estimate future forfeitures at the date of grant and revise the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Estimating the fair value of equity-settled awards as of the grant date using valuation models, such as the Black-Scholes option pricing model, is affected by assumptions regarding a number of complex variables. Changes in the assumptions can materially affect the fair value and ultimately how much stock-based compensation expense is recognized. These inputs are subjective and generally require significant analysis and judgment to develop.
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Expected Term&#8212;
<FONT STYLE="FONT-STYLE:NORMAL;">
	The expected term assumption represents the weighted average period that the stock-based awards are expected to be outstanding. We have elected to use the &#8220;simplified method&#8221; for estimating the expected term of the options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Expected Volatility&#8212;
<FONT STYLE="FONT-STYLE:NORMAL;">
	For all stock options granted to date, the volatility data was estimated based on a study of publicly traded industry peer companies. For purposes of identifying these peer companies, we considered the industry, stage of development, size and financial leverage of potential comparable companies.
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Expected Dividend&#8212;
<FONT STYLE="FONT-STYLE:NORMAL;">
	The Black-Scholes valuation model calls for a single expected dividend yield as an input. We currently have no history or expectation of paying cash dividends on its common stock.
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risk-Free Interest Rate&#8212;
<FONT STYLE="FONT-STYLE:NORMAL;">
	The risk-free interest rate is based on the yield available on U.S. Treasury zero-coupon issues similar in duration to the expected term of the equity-settled award.
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stock-based awards granted include time-based, performance and market-based stock options. Stock-based compensation expense for performance stock options is based on the probability of achieving certain performance criteria, as defined in the individual option grant agreement. We estimate the number of performance options ultimately expected to vest and recognize stock-based compensation expense for those options expected to vest when it becomes probable that the performance criteria will be met and the options vest. As of December 31, 2015, no stock-based compensation expense had been recorded in relation to any such options to purchase shares of common stock because achievement of the applicable performance criteria had not been considered probable.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	68
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage69"></A>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU69">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We estimated the fair value of the time-based and performance-based employee stock options using the Black-Scholes option-pricing model based on the date of grant with the following assumptions:
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_6"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:65.24%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.58%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:32.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:65.24%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.58%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.78%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.58%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.82%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:65.24%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.78%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.82%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:65.24%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risk-free interest rate
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.78%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.53%-1.94%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.82%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.7%-2.0%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:65.24%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Expected life (in years)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.78%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5.5-6.5
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.82%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6.0-6.1
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:65.24%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Volatility
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.78%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	79%-109%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.82%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	84%-94%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:65.24%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Dividend yield
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.78%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.58%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.82%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have also granted stock options to purchase common stock that vest upon the achievement of market-based stock price targets. For these options, we estimated the fair value on the original grant date using a Monte-Carlo simulation model, and since our IPO, we have recognized the stock-based compensation expense on a straight-line basis over the implicit service period as derived under that simulation.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition to the assumptions used in the Black-Scholes option-pricing model, we must also estimate a forfeiture rate to calculate the stock-based compensation expense for our awards. We will continue to use judgment in evaluating the expected volatility, expected terms, and forfeiture rates utilized for our stock-based compensation expense calculations on a prospective basis.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Following our initial public offering on October 29, 2015, the fair value of shares of our common stock underlying stock option grants is determined by our board of directors or the compensation committee thereof based on The NASDAQ Global Select market closing price of our common stock on the date of grant.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Estimated Fair Value of Redeemable Convertible Preferred Stock Call Option Liabilities
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We determined that our obligation to issue, and our investors&#8217; obligation to purchase, additional shares of redeemable convertible preferred stock represented a freestanding financial instrument, which we accounted for as a call option liability. The fair value of the redeemable convertible preferred stock call option liability was calculated based on significant inputs not observed in the market using an option pricing model with inputs as of the valuation measurement dates, including the fair value of our redeemable convertible preferred stock, the estimated volatility of the price of our redeemable convertible preferred stock, the expected term of the call option and the risk-free interest rates.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The freestanding convertible preferred stock call option liability was initially recorded at fair value, with fair value changes recognized as increases or reductions to other income (expense), net in the consolidated statement of operations and comprehensive loss. At the time of the exercise of the call option, any remaining value of the option was recorded as a capital transaction.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Estimating the fair value of call option liabilities using option pricing models is affected by assumptions regarding a number of complex variables. Changes in the assumptions can materially affect the fair value and ultimately how much other income (expense), net is recognized. These inputs are subjective and generally require significant analysis and judgment to develop. However, because these are non-cash income (expense) items, there has been no impact on liquidity or capital resources for any of the periods presented.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Income Taxes
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We provide for income taxes under the asset and liability method. Current income tax expense or benefit represents the amount of income taxes expected to be payable or refundable for the current year. Deferred income tax assets and liabilities are determined based on differences between the financial statement reporting and tax bases of assets and liabilities and net operating loss and credit carryforwards, and are measured using the enacted tax rates and laws that will be in effect when such items are expected to reverse. Deferred income tax assets are reduced, as necessary, by a valuation allowance when management determines it is more likely than not that some or all of the tax benefits will not be realized.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We account for uncertain tax positions in accordance with ASC 740-10,&#160;Accounting for Uncertainty in Income Taxes. We assess all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing authorities. Assessing an uncertain tax position begins with the initial determination of the position&#8217;s sustainability and is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and we will determine whether (i)&#160;the factors underlying the sustainability assertion have changed and (ii)&#160;the amount of the recognized tax benefit is still appropriate. The recognition and measurement of tax benefits requires significant judgment. Judgments concerning the recognition and measurement of a tax benefit might change as new information becomes available.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	69
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage70"></A>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU70">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December&#160;31, 2015, our total deferred tax assets were
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$24.8&#160;million. Due to our lack of earnings history and uncertainties surrounding our ability to generate future taxable income, the net deferred tax assets have been fully offset by a valuation allowance. The deferred tax assets were primarily comprised of
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	federal and state tax net operating losses, or NOLs. Utilization of NOLs may be limited by the &#8220;ownership change&#8221; rules, as defined in Section&#160;382 of the Code. Similar rules may apply under state tax laws. We determined that an ownership change occurred o
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	n April&#160;20, 2015, in connection with our Series B redeemable convertible preferred stock financing that resulted in an annual limitation, but that all NOLs generated prior to April&#160;20, 2015, can be utilized prior to expiration if we earn sufficient taxable
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	income. We determined that no ownership change occurred with our initial public offering in October 2015.&nbsp;&nbsp;Our ability to use our remaining NOLs may be further limited if we experience an ownership change in connection with any future offerings or as a re
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	sult of future changes in our stock ownership.
</FONT>
</P>
<EFX_RESULTS_OF_OPERATIONS>
<A NAME="FIS_RESULTS_OF_OPERATIONS"></A>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Results of Operations
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_7"></A>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Comparison of the Years Ended December&#160;31, 2014 and 2015
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table summarizes our results of operations during the periods indicated (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:25.96%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:11.76%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Increase/
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Decrease)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:CALIBRI;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:CALIBRI;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:CALIBRI;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Collaboration and license revenue
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14,199
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,916
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8,283
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Operating expenses:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	28,393
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	18,296
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,097
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and administrative
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9,019
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,838
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,181
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total operating expenses
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	37,412
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	23,134
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14,278
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Loss from operations
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(23,213
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(17,218
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(5,995
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Interest and other income (expense), net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(47
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(49
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in fair value of redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; stock call option liability
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	314
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	387
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(73
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss and comprehensive loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(22,946
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(16,829
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(6,117
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Collaboration and License Revenue
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Collaboration and license revenue increased by $8.3 million during the year ended December&#160;31, 2015, which was entirely attributable to revenue we recognized from the initial upfront payment of $35.0 million under the Collaboration Agreement with Sanofi we entered into in August 2014.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and Development Expenses
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development expenses increased $10.1 million, or 55%, from $18.3 million for 2014 to $28.4&#160;million for 2015. The increase in research and development expenses was primarily due to an increase of $7.0 million in clinical study and drug formulation and manufacturing costs, $2.5&#160;million in payroll expenses as a result of an increase in our employee headcount, $1.0 million in facilities costs and $0.7&#160;million in professional fees as we expanded our operations to begin preparations for our clinical trial, offset by a $0.9 million decrease in preclinical development costs. For the years ended December&#160;31, 2014 and 2015, substantially all of our research and development expenses related to our MYK-461 drug development activity and other preclinical product candidates.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and Administrative Expenses
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and administrative expenses increased $4.2 million, or 86%, from $4.8 million for 2014 to $9.0 million for 2015. The increase in general and administrative expenses was primarily due to an increase of $2.5 million in additional payroll expenses as a result of an increase in our employee headcount, $0.9 million in facilities and office costs as we expanded our infrastructure, and $0.2 million in market research costs.&nbsp;&nbsp;
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Interest and Other Income (Expense), Net
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Interest and other expense, net, was an expense of $47,000 for the year ended December 31, 2015 primarily due to forgiveness of a loan receivable.&nbsp;&nbsp;Interest and other income was $2,000 for the year ended December&#160;31, 2014 and related to interest earned on our outstanding cash balances.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	70
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage71"></A>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU71">
</A>
<FONT STYLE="FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in Fair Value of Redeemable Convertible Preferred Stock Call Option Liability
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The change in the fair value of the redeemable convertible preferred stock call option liability resulted in a gain of $0.3 million in 2015 and a gain of $0.4&#160;million in 2014. The gains recorded in 2015 and 2014 were primarily due to the changes in the fair value of the redeemable convertible preferred stock call option liability associated with the redeemable convertible preferred stock financings and the Collaboration Agreement.
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_8"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Comparison of the Years Ended December&#160;31, 2013 and 2014
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table summarizes our results of operations during the periods indicated (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;">
	&nbsp;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:25.96%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:11.76%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Increase/
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Decrease)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Collaboration and license revenue
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,916
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,916
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Operating expenses:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	18,296
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	11,603
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,693
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and administrative
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,838
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,029
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,809
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total operating expenses
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	23,134
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	13,632
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9,502
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Loss from operations
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(17,218
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(13,632
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(3,586
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Interest and other income (expense), net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in fair value of redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; stock call option liability
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	387
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	932
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(545
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss and comprehensive loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(16,829
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(12,700
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(4,129
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;MARGIN-LEFT:4.53%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Collaboration and License Revenue
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Collaboration and license revenue increased by $5.9 million during the year ended December&#160;31, 2014, which was entirely due to revenue we recognized from the initial upfront payment of $35.0 million under the Collaboration Agreement with Sanofi we entered into in August 2014.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.53%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and Development Expenses
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development expenses increased $6.7 million, or 58%, from $11.6 million for 2013 to $18.3&#160;million for 2014. The increase in research and development expenses was primarily due to an increase of $2.6&#160;million in payroll expenses for 2014 as a result of an increase in our employee headcount, a $1.5 million increase in preclinical development costs, a $0.9 million increase in manufacturing costs, a $0.9 million increase in clinical trial costs related to the preparation for our Phase 1 clinical trials and an increase of $0.7&#160;million in professional fees as we expanded our operations to begin preparations for our clinical trial. For the years ended December&#160;31, 2013 and 2014, substantially all of our research and development expenses related to our MYK-461 drug development activity and other preclinical product candidates.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:4.53%;TEXT-INDENT:0%;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:8PT;MARGIN-LEFT:4.53%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and Administrative Expenses
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and administrative expenses increased $2.8 million, or 138%, from $2.0 million for 2013 to $4.8 million for 2014. The increase in general and administrative expenses was primarily due to an increase in professional services expenses of $1.4 million incurred during the 2014 period, consisting of accounting, legal, and consulting costs, and additional payroll expenses of $0.9&#160;million as we expanded our infrastructure.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.53%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Interest and Other Income (Expense), Net
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Interest income was zero and $2,000 for the years ended December&#160;31, 2013 and 2014, respectively, related to interest earned on our outstanding cash balances.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;MARGIN-LEFT:4.53%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in Fair Value of Redeemable Convertible Preferred Stock Call Option Liability
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The change in the fair value of the redeemable convertible preferred stock call option liability was a gain of $0.9 million in 2013 and a gain of $0.4&#160;million in 2014. The income recorded in 2013 and 2014 was primarily due to a change in the fair value of the redeemable convertible preferred stock call option liability associated with the redeemable convertible preferred stock financings and the Collaboration Agreement.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	71
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage72"></A>
</EFX_RESULTS_OF_OPERATIONS>
<EFX_LIQUIDITY_CAPITAL>
<A NAME="FIS_LIQUIDITY_CAPITAL"></A>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU72">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Liquidity and Capital Resources
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Since our inception, we have financed our operations primarily through private placements of our equity securities, payments received in connection with the Collaboration Agreement, and our initial public offering. During 2014, we received net proceeds of $28.9 million from the sale of Series A and Series A-1 redeemable convertible preferred stock and, in August 2014, we received an upfront payment of $35.0 million from Sanofi in connection with the entry into the Collaboration Agreement. In April 2015, we received net proceeds of $45.8&#160;million from the sale of Series B redeemable convertible preferred stock.&nbsp;&nbsp;Pursuant to the IPO in October 2015, we received net proceeds of $55.6 million, net of underwriting discounts, commissions and offering costs, from our initial public offering and as of December 31, 2015, we had cash and cash equivalents of $112.3 million.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	To date, we have not generated any revenue from product sales. We do not know when, or if, we will generate any revenue from product sales and do not expect to generate significant revenue from product sales unless and until we obtain regulatory approval of and commercialize MYK-461 or other product candidates.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We expect that our existing cash and cash equivalents will provide sufficient funds to sustain operations through at least the next 12 months based on our existing business plan. However, we expect to incur substantial expenditures in the foreseeable future for the advancement of our precision medicine platform and the discovery, development and potential commercialization of MYK-461 and any additional product candidates. Specifically, we have incurred and we expect to continue to incur substantial expenses in connection with our Phase&#160;1 clinical trials for MYK-461 and any Phase&#160;2 or Phase 3 clinical trials that we may conduct. Furthermore, if our Phase&#160;1 and potential Phase&#160;2 and 3 clinical trials are successful, or our other product candidates enter clinical trials or the discovery stage, we will need to raise additional capital in order to further advance our product candidates towards regulatory approval.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We will continue to require additional financing to develop our product candidates and fund operations for the foreseeable future through equity or debt financings, collaborative or other arrangements with corporate sources, or through other sources of financing. Adequate additional funding may not be available to us on acceptable terms or at all. Our failure to raise capital as and when needed could have a negative impact on our financial condition and our ability to pursue our business strategies. We anticipate that we will need to raise substantial additional capital, the requirements of which will depend on many factors, including:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	the rate of progress and the cost of our clinical trials of MYK-461;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	the number of product candidates that we intend to develop using our precision medicine platform;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	the costs of research and preclinical studies to support the advancement of other product candidates into clinical development;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	the timing of, and costs involved in, seeking and obtaining approvals from the FDA and comparable foreign regulatory authorities, including the potential by the FDA or comparable regulatory authorities to require that we perform more studies than those that we current expect;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	our ability to receive funding under our collaboration with Sanofi, and the timing of receipt of any such funding;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	the costs of preparing to manufacture MYK-461 on a larger scale;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	the costs of commercialization activities if MYK-461 or any future product candidate is approved, including the formation of a sales force;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	the degree and rate of market acceptance of any products launched by us or our partners;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	our need and ability to hire additional personnel;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	our ability to enter into additional collaboration, licensing, commercialization or other arrangements and the terms and timing of such arrangements; and
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	the emergence of competing technologies or other adverse market developments.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU73">
</A>
	We may seek funds through borrowings or additional rounds of financing, including private or public equity or debt offerings and collaborative arrangements with corporate partners. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. If we are unable to raise additional funds when needed, we
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	72
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage73"></A>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	may be required to delay, reduce, or terminate some or all of our development programs and clinical trials. We may also be required to sell or license to others technologies, product candidates or programs that we would prefer to develop and co
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	mmercialize ourselves.
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_9"></A>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash Flows
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table sets forth the primary sources and uses of cash for each of the periods presented below (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:90%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:40.1%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.48%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net cash (used in) provided by:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Operating activities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(32,100
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	13,658
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(12,531
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Investing activities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,252
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(976
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,169
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Financing activities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	101,969
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	29,055
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,953
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.48%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net increase (decrease) in cash and cash equivalents
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	68,617
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	41,737
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2,747
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash Used in Operating Activities
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net cash used in operating activities was $32.1 million for the year ended December 31, 2015 as compared to net cash provided by operating activities for the year ended December 31, 2014 of $13.7 million. Cash used in operating activities in 2015 was primarily due to the use of funds in our operations that resulted in a net loss of $22.9 million, as well as changes in other operating assets and liabilities, including a decrease of $14.2 million in deferred revenue associated with the upfront cash payment received in August 2014 in connection with the Collaboration Agreement, offset by an increase in accounts payable and accrued liabilities of $4.2 million.&nbsp;&nbsp;Cash provided by operating activities in 2014 was primarily due to an increase of $28.4 million in deferred revenue associated with the upfront cash payment received in August 2014 in connection with the Collaboration Agreement, offset by the use of funds in our operations that resulted in a net loss of $16.8 million, as well as changes in other operating assets and liabilities, including an increase of accrued liabilities of $1.5 million.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net cash used in operating activities was $12.5 million in 2013 and net cash provided by operating activities was $13.7&#160;million in 2014. Cash used in operating activities in 2013 was primarily due to the use of funds in our operations related to the development of our product candidates. Cash provided by operating activities in 2014 was primarily due to an increase of $28.4 million in deferred revenue associated with the upfront cash payment received in August 2014 in connection with the Collaboration Agreement, offset by the use of funds in our operations that resulted in a net loss of $16.8 million, as well as changes in other operating assets and liabilities, including an increase of accrued liabilities of $1.5 million.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash Used in Investing Activities
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash used in investing activities for all periods presented consisted primarily of investments in equipment. During the year ended December&#160;31, 2014, we also had an increase in restricted cash due to requirements under lease obligations.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash Provided by Financing Activities
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash provided by financing activities was $102.0 million for the year ended December 31, 2015, compared to $29.1&#160;million in the year ended December 31, 2014. Cash provided by financing activities in the year ended December 31, 2015 consisted of net proceeds of $55.8 million received during the year from the initial public offering through the issuance of common stock. The Company accrued $0.2 million in offering costs as of December 31, 2015 which will decrease the net proceeds once paid. In addition, cash provided by financing activities during 2015 consisted of $45.8 million in net proceeds from the issuance of Series B redeemable convertible preferred stock. Cash provided by financing activities was $29.1 million in the year ended December&#160;31, 2014 consisting primarily of net proceeds from the issuance of Series A and Series A-1 redeemable convertible preferred stock.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash provided by financing activities was $11.0&#160;million in the year ended December&#160;31, 2013 as compared to $29.1 million in the year ended December&#160;31, 2014. Cash provided by financing activities in both years consisted primarily of net proceeds from the issuance of redeemable convertible preferred stock.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Contractual Obligations and Commitments
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December&#160;31, 2015, we have lease obligations consisting of an operating lease for our operating facility for approximately 34,400 square feet, which we executed in September 2014. The term of the lease commenced in January 2015 and expires in January 2020.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	73
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage74"></A>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU74">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table summarizes our contractual obligations as of December&#160;31, 2015 (in thousands):
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_10"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:53.14%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Payments due by period
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Less than
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1 year
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1 to 3
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	years
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4 to 5
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	years
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	After 5
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	years
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Lease obligations, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,360
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,522
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	80
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,962
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Off-Balance Sheet Arrangements
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Since our inception, we have not engaged in any off-balance sheet arrangements, as defined in the rules and regulations of the SEC. See Note 6, Commitments and Contingencies, to our consolidated financial statements appearing in this annual report on Form 10-K regarding our guarantees and indemnifications.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	JOBS Act Accounting Election
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Jumpstart Our Business Startups Act of 2012, or the JOBS Act, permits an &#8220;emerging growth company&#8221; such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We are choosing to &#8220;opt out&#8221; of this provision and, as a result, we will comply with new or revised accounting standards as required when they are adopted. This decision to opt out of the extended transition period under the JOBS Act is irrevocable. See Note 2, Summary of Significant Accounting Policies, to our consolidated financial statements appearing in this annual report on Form 10-K regarding recent accounting pronouncements.
</P>
</EFX_LIQUIDITY_CAPITAL>
</EFX_MANAGEMENTS_DISCUSSION>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<EFX_MARKET_RISK>
<A NAME="FIS_MARKET_RISK"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 7A.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_7A_QQDISCMARKETRISK">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_7A_QQDISCMARKETRISK">
</A>
	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The market risk inherent in our financial instruments represents the potential loss arising from adverse changes in interest rates or exchange rates. As of December 31, 2015, we had cash and cash equivalents of $112.3 million, consisting of interest-bearing money market accounts, which would be affected by changes in the general level of United States interest rates. However, due to the short-term maturities of our cash and cash equivalents and the low- risk profile of our investments, an immediate 100 basis point change in interest rates would not have a material effect on the fair value of our cash and cash equivalents.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In addition,
<FONT STYLE="COLOR:#000000;">
	we are also exposed to foreign currency exchange rate risk inherent in our contracts with research institutions and contract research organizations as certain services are performed by them outside the United States. W
</FONT>
	e have payments due to one Australian vendor in foreign currency. A significant movement in the Australian dollar may have a material impact on our financial position in the future.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We do not believe that inflation, interest rate changes or exchange rate fluctuations had a significant impact on our results of operations for any periods presented.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<BR>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	74
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
</EFX_MARKET_RISK>
<EFX_FINANCIAL_STATEMENTS>
<A NAME="FIS_FINANCIAL_STATEMENTS"></A>
<A NAME="eolPage75"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 8.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU75">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR">
</A>
	FINANCIAL STATEME
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	NTS AND SUPPLEMENTARY DATA
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our consolidated financial statements and the report of our independent registered public accounting firm are included in Item 15 of this Annual Report on Form&#160;10-K on pages&#160;F-1 through F-28.
</P>
</EFX_FINANCIAL_STATEMENTS>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<EFX_ACCOUNTING_CHANGES>
<A NAME="FIS_ACCOUNTING_CHANGES"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 9.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC">
</A>
	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	None.
</P>
</EFX_ACCOUNTING_CHANGES>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<EFX_CONTROL_AND_PROCEDURES>
<A NAME="FIS_CONTROL_AND_PROCEDURES"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 9A.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_9_A_CONTROLS_PROCEDURE_S">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_9_A_CONTROLS_PROCEDURE_S">
</A>
	CONTROLS AND PROCEDURES
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Evaluation of Disclosure Controls and Procedures
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their control objectives.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Our management, with the participation of our Chief Executive Officer and Vice President, Corporate Controller, has evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2015, the end of the period covered by this Annual Report on Form 10-K. Based upon such evaluation, our Chief Executive Officer and Vice President, Corporate Controller have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of such date.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Management&#8217;s Annual Report on Internal Control Over Financial Reporting
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	This Annual Report on Form&#160;10
<FONT STYLE="FONT-FAMILY:CAMBRIA MATH;">
	-
</FONT>
	K does not include a report of management&#8217;s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by the Jumpstart Our Business Startups Act, or JOBS Act, for emerging growth companies.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Changes in Internal Control Over Financial Reporting
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	There has been no change in our internal control over financial reporting during the year ended December&#160;31, 2015, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
</P>
</EFX_CONTROL_AND_PROCEDURES>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<EFX_OTHER_INFORMATION>
<A NAME="FIS_OTHER_INFORMATION"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 9B.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_9_B_OR_INFORMATION">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_9_B_OR_INFORMATION">
</A>
	OTHER INFORMATION
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	None.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<BR>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	75
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
</EFX_OTHER_INFORMATION>
</EFX_PART_II>
<A NAME="eolPage76"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<EFX_PART_III>
<A NAME="FIS_PART_III"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:11.67%;MARGIN-RIGHT:11.67%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_PART_III">
</A>
	PART III
</P>
<EFX_DIRECTORS_AND_OFFICERS>
<A NAME="FIS_DIRECTORS_AND_OFFICERS"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 10.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_10_DIROFFANDCORPGOV">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_10_DIROFFANDCORPGOV">
</A>
	DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Except as set forth below, the information required by this item will be contained in our definitive proxy statement to be filed with the SEC in connection with the Annual Meeting of Stockholders within 120 days after the conclusion of our fiscal year ended December 31, 2015, or the Proxy Statement, and is incorporated in this Annual Report on Form 10-K by reference.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We have adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A current copy of the code is posted on the Corporate Governance section of our website, which is located at&nbsp;&nbsp;www.myokardia.com. If we make any substantive amendments to, or grant any waivers from, the code of business conduct and ethics for our principal executive officer, principal financial officer, principal accounting officer, controller or persons performing similar functions, or any officer or director, we will disclose the nature of such amendment or waiver on our website or in a current report on Form 8-K.
</P>
</EFX_DIRECTORS_AND_OFFICERS>
<EFX_COMPENSATION>
<A NAME="FIS_COMPENSATION"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 11.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_11_EXECUTIVE_COMPENSATION">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_11_EXECUTIVE_COMPENSATION">
</A>
	EXECUTIVE COMPENSATION
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="FIS_SECURITY_OWNERS">
</A>
<A NAME="FIS_SECURITY_OWNERS">
</A>
	The information required by this item will be contained in the Proxy Statement and is incorporated in this Annual Report on Form 10-K by reference.
</P>
</EFX_COMPENSATION>
<EFX_SECURITY_OWNERS>
<A NAME="FIS_SECURITY_OWNERS"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 12.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF">
</A>
	SECURI
<A NAME="MYOK-10K_20151231_HTM_ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF">
</A>
	TY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="FIS_OFFICER_TRANSACTIONS">
</A>
<A NAME="FIS_OFFICER_TRANSACTIONS">
</A>
	The information required by this item will be contained in the Proxy Statement and is incorporated in this Annual Report on Form 10-K by reference.
</P>
</EFX_SECURITY_OWNERS>
<EFX_OFFICER_TRANSACTIONS>
<A NAME="FIS_OFFICER_TRANSACTIONS"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 13.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR">
</A>
	CERTAIN
<A NAME="MYOK-10K_20151231_HTM_ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR">
</A>
	RELATIONSHIPS AND RELATED PARTY TRANSACTIONS, AND DIRECTOR INDEPENDENCE
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The information required by this item will be contained in the Proxy Statement and is incorporated in this Annual Report on Form 10-K by reference.
</P>
</EFX_OFFICER_TRANSACTIONS>
<EFX_ACCOUNTANT_FEES>
<A NAME="FIS_ACCOUNTANT_FEES"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 14.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_14_PRINCIPAL_ACCOUNTANT_FEES_SERVIC">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_14_PRINCIPAL_ACCOUNTANT_FEES_SERVIC">
</A>
	PRINCIPAL ACCOUNTING FEES AND SERVICES
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The information required by this item will be contained in the Proxy Statement and is incorporated in this Annual Report on Form 10-K by reference.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	76
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage77"></A>
</EFX_ACCOUNTANT_FEES>
</EFX_PART_III>
<EFX_PART_IV>
<A NAME="FIS_PART_IV"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU76">
</A>
<A NAME="MYOK-10K_20151231_HTM_PART_IV">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_PART_IV">
</A>
	PART
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	IV
</FONT>
</P>
<EFX_EXHIBITS>
<A NAME="FIS_EXHIBITS"></A>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ITEM 15.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
<A NAME="MYOK-10K_20151231_HTM_ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH">
</A>
<A NAME="MYOK-10K_20151231_HTM_ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH">
</A>
	EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(a) The following documents are filed as part of this report:
</P>
</EFX_EXHIBITS>
</EFX_PART_IV>
<EFX_NOTES_TO_FINANCIAL_STATEMENT>
<A NAME="FIS_NOTES_TO_FINANCIAL_STATEMENT"></A>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1) FINANCIAL STATEMENTS
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:9.06%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Financial Statements&#8212;See Index to Consolidated Financial Statements at Item&#160;8 of this Annual Report on Form&#160;10-K, beginning on page F-1.
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2) FINANCIAL STATEMENT SCHEDULES
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:9.06%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Financial statement schedules have been omitted in this Annual Report on Form&#160;10-K because they are not applicable, not required under the instructions, or the information requested is set forth in the consolidated financial statements or related notes thereto.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(b) Exhibits.&#160;&#160;The exhibits listed in the accompanying index to exhibits are filed as part of, or incorporated by reference into, this Annual Report on Form&#160;10-K.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	77
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage78"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU77">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:12PT;;TEXT-INDENT:-12PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Report of Independent Registered Public Accounting Firm
</FONT>
</A>
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-LEFT:7.2PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:5%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-2
</P>
</TD>
</TR>
<TR STYLE="HEIGHT:6PT;">
<TD VALIGN="MIDDLE" STYLE="WIDTH:94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:1PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:1PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:1PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:12PT;;TEXT-INDENT:-12PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Consolidated Financial Statements
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="LINE-HEIGHT:2PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-LEFT:7.2PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:5%;">
<P STYLE="TEXT-ALIGN:RIGHT;LINE-HEIGHT:2PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:36PT;;TEXT-INDENT:-12PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_CONSOLIDATED_BALANCE_SHEETS">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Consolidated Balance Sheets
</FONT>
</A>
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-LEFT:7.2PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:5%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-3
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:36PT;;TEXT-INDENT:-12PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_CONSOLIDATED_STATEMENTS_OPERATIONS_COMPR">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Consolidated Statements of Operations and Comprehensive Loss
</FONT>
</A>
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-LEFT:7.2PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:5%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-4
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:36PT;;TEXT-INDENT:-12PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_CONSOLIDATED_STATEMENTS_REDEEMABLE_CONVE">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)
</FONT>
</A>
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-LEFT:7.2PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:5%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-5
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:36PT;;TEXT-INDENT:-12PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_CONSOLIDATED_STATEMENTS_CASH_FLOWS">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Consolidated Statements of Cash Flows
</FONT>
</A>
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-LEFT:7.2PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:5%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-6
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:36PT;;TEXT-INDENT:-12PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A HREF="#MYOK-10K_20151231_HTM_NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Notes to Consolidated Financial Statements
</FONT>
</A>
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-LEFT:7.2PT;PADDING-RIGHT:0PT;PADDING-TOP:0PT;PADDING-BOTTOM:0PT;WIDTH:5%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:1PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-7
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-1
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage79"></A>
</EFX_NOTES_TO_FINANCIAL_STATEMENT>
<EFX_AUDITORS_OPINION>
<A NAME="FIS_AUDITORS_OPINION"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU78">
</A>
<A NAME="MYOK-10K_20151231_HTM_REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	REPORT
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC">
</A>
	OF INDEPENDENT REGIST
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ERED PUBLIC ACCOUNTING FIRM
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	To the Board of Directors and Stockholders of
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MyoKardia, Inc.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In our opinion, the accompanying consolidated balance sheets and the related consolidated statements of operations and comprehensive loss, of redeemable convertible preferred stock and stockholders&#8217; equity (deficit), and of cash flows present fairly, in all material respects, the financial position of MyoKardia, Inc. and its subsidiary at December&#160;31, 2015 and December&#160;31, 2014, and the results of their operations and their cash flows for each of the three years in the period ended December&#160;31, 2015, in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ PricewaterhouseCoopers LLP
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	San Jose, California
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March 18, 2016
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-2
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage80"></A>
</EFX_AUDITORS_OPINION>
<EFX_BALANCE_SHEET>
<A NAME="FIS_BALANCE_SHEET"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU79">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_CONSOLIDATED_BALANCE_SHEETS">
</A>
<A NAME="MYOK-10K_20151231_HTM_CONSOLIDATED_BALANCE_SHEETS">
</A>
	Consolidated Balance Sheets
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(In thousands, except share and per share amounts)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:29.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.28%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Current assets:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash and cash equivalents
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	112,265
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	43,648
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Prepaid expenses and other current assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,282
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	430
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total current assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	113,547
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	44,078
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Property and equipment, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,744
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,423
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Other long term assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	289
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	388
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	116,580
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	46,889
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Liabilities, redeemable convertible preferred stock, and stockholders&#8217; equity (deficit)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Current liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accounts payable
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,143
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	886
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accrued liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,633
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,331
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable convertible preferred stock call option liability, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	314
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Deferred revenue
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14,199
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14,199
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total current liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	21,975
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	17,730
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Other long-term liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	732
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	278
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Deferred revenue&#8212;noncurrent
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14,199
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	22,707
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	32,207
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Commitments and contingencies (Note 6)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Series A redeemable convertible preferred stock, $0.0001 par value, zero and 38,500,000 shares,
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; authorized at December 31, 2015 and 2014, respectively; zero and 38,250,000 shares, issued and
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; outstanding at December 31, 2015 and 2014, respectively; liquidation value of zero and $42,006, at
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; December 31, 2015 and 2014, respectively
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	41,359
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Series A-1 redeemable convertible preferred stock, $0.0001 par value, zero and 6,666,667 shares,
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; authorized at December 31, 2015 and 2014, respectively; zero and 6,666,667 shares, issued and
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; outstanding at December 31, 2015 and 2014, respectively; liquidation value of zero and $10,327, at
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; December 31, 2015 and 2014, respectively
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,229
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stockholders&#8217; equity (deficit)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Common stock, $0.0001 par value, 150,000,000, and 65,000,000 shares authorized at December 31, 2015
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; and 2014, respectively; 27,053,156 and 3,634,434 shares, issued and outstanding at December 31, 2015
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; and 2014, respectively
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:67.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Additional paid-in capital
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	158,555
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accumulated deficit
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(64,685
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(36,906
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total stockholders&#8217; equity (deficit)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	93,873
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(36,906
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:67.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total liabilities, redeemable convertible preferred stock, and stockholders&#8217; equity (deficit)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.28%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	116,580
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	46,889
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_BALANCE_SHEET>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The accompanying notes are an integral part of these Consolidated Financial Statements
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-3
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage81"></A>
<EFX_INCOME_STATEMENT>
<A NAME="FIS_INCOME_STATEMENT"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU80">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_CONSOLIDATED_STATEMENTS_OPERATIONS_COMPR">
</A>
	Consolidated Statements
<A NAME="MYOK-10K_20151231_HTM_CONSOLIDATED_STATEMENTS_OPERATIONS_COMPR">
</A>
	of Operations and Comprehensive Loss
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(In thousands, except share and per share amounts)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:40.14%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Collaboration and license revenue
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14,199
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,916
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Operating expenses:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	28,393
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	18,296
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	11,603
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and administrative
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9,019
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,838
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,029
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total operating expenses
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	37,412
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	23,134
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	13,632
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Loss from operations
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(23,213
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(17,218
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(13,632
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Interest and other income, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(47
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in fair value of redeemable convertible preferred stock
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; call option liability
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	314
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	387
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	932
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss and comprehensive loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(22,946
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(16,829
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(12,700
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cumulative dividend relating to redeemable convertible
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(5,151
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2,864
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,087
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accretion of redeemable convertible preferred stock
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; to redemption value
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(158
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(179
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss attributable to common stockholders
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(28,195
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(19,851
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(13,966
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss per share attributable to common stockholders, basic and
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; Diluted
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(4.48
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(11.30
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(11.98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Weighted average number of shares used to compute net loss per share
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; attributable to common stockholders, basic and diluted
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,292,800
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,756,900
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,165,867
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_INCOME_STATEMENT>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The accompanying notes are an integral part of these Consolidated Financial Statements
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-4
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage82"></A>
<EFX_STOCKHOLDERS_EQUITY>
<A NAME="FIS_STOCKHOLDERS_EQUITY"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU81">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_CONSOLIDATED_STATEMENTS_REDEEMABLE_CONVE">
</A>
<A NAME="MYOK-10K_20151231_HTM_CONSOLIDATED_STATEMENTS_REDEEMABLE_CONVE">
</A>
	Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(In thousands, except share amounts)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:4PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:99%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:26.9%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="22" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:38.2%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable Convertible Preferred Stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:4.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Additional
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:4.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:26.9%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.62%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Series A
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.62%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Series A-1
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.62%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Series B
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.62%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Common Stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:4.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Paid-In
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:4.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accumulated
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:4.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stockholders&#8217;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:26.9%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Shares
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Amount
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Shares
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Amount
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Shares
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Amount
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Shares
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Amount
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Capital
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Deficit
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:4.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Equity/(Deficit)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	BALANCE&#8212;December 31, 2012
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8,600,000
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	7,648
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,794,554
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(3,382
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(3,382
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issuance
<FONT STYLE="FONT-FAMILY:CALIBRI;">
	&#160;
</FONT>
	of&#160;common&#160;stock&#160;in&#160;exchange&#160;for&#160;a&#160;note&#160;receivable
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	204,081
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	38
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	38
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issuance of Series A redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; stock, net of issuance costs of $15 and tranche liability of $161
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,650,000
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,474
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issuance of common stock and restricted stock
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; for stock option exercises
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,179,446
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Vesting of early exercised stock options and restricted stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	17
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	17
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Share-based compensation
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	41
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	41
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Dividends on redeemable convertible preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,087
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(101
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(986
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,087
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accretion of redeemable convertible preferred stock
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; to redemption value
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	179
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(179
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(179
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:26.9%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(12,700
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(12,700
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	BALANCE&#8212;December 31, 2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	19,250,000
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	19,388
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,178,081
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(17,247
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(17,247
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issuance of Series A redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; stock, net of issuance costs of $7 and tranche liability
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; of $288
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	19,000,000
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	19,282
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issuance of Series A-1 redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; stock, net of issuance costs of $104
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,666,667
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9,896
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issuance of common stock for stock option exercises
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	480,723
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Repurchase of early exercised stock options
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(24,370
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(8
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(8
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Vesting of early exercised stock options and restricted stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	104
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	104
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Share-based compensation
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	92
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	92
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Dividends on redeemable convertible preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,537
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	327
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(192
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2,672
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2,864
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accretion of redeemable convertible
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; preferred stock to redemption value
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	152
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(158
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(158
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:26.9%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(16,829
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(16,829
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	BALANCE&#8212;December 31, 2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	38,250,000
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	41,359
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,666,667
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,229
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,634,434
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(36,906
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(36,906
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issuance of Common Stock during initial public offering
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; (IPO), net of issuance costs of $6,903
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,253,125
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	55,626
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	55,627
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issuance of Series B redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp;&nbsp;&nbsp;stock, net of issuance costs of $163
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	17,068,646
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	45,837
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issuance of common stock for stock option exercises
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	352,978
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Vesting of early exercised stock options and restricted stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	177
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	177
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Repurchase of early exercised stock options
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(54,128
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(19
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(19
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Share-based compensation
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	516
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	516
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Dividends on redeemable convertible preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,541
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	663
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,947
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(416
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(4,735
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(5,151
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accretion of redeemable convertible preferred stock to
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; redemption value
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	73
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	12
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	12
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Conversion of Series A redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp;&nbsp;&nbsp;stock into common stock during IPO
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(38,250,000
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(43,973
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,408,162
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	43,972
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	43,973
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Conversion of Series A-1 redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp;&nbsp;&nbsp;stock into common stock during IPO
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(6,666,667
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(10,904
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,814,059
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,904
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,904
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:26.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Conversion of Series B redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp;&nbsp;&nbsp;stock into common stock during IPO
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(17,068,646
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(47,796
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,644,526
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	47,795
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:0.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	47,796
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:26.9%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(22,946
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(22,946
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:26.9%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	BALANCE&#8212;December 31, 2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	27,053,156
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	158,555
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(64,685
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:0.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:3.98%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:7.5PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	93,873
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_STOCKHOLDERS_EQUITY>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:2PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The accompanying notes are an integral part of these Consolidated Financial Statements
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:1PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:1PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:1PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-5
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage83"></A>
<EFX_CASH_FLOW>
<A NAME="FIS_CASH_FLOW"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU82">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_CONSOLIDATED_STATEMENTS_CASH_FLOWS">
</A>
<A NAME="MYOK-10K_20151231_HTM_CONSOLIDATED_STATEMENTS_CASH_FLOWS">
</A>
	Consolidated Statements of Cash Flows
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(In thousands)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:39.56%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash flows from operating activities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(22,946
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(16,829
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(12,700
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Adjustments to reconcile net loss to net cash provided by
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; (used in) operating activities:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stock-based compensation expense
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	516
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	92
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	41
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Depreciation and amortization
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	965
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	712
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	478
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Gain on disposal of equipment
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(4
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable convertible preferred stock call option liability,
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; net issued in connection with license and collaboration
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; agreement
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	686
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in fair value of redeemable convertible preferred
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; stock call option liability, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(314
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(387
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(932
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Changes in operating assets and liabilities:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:41.05PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Prepaid expenses and other current assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(852
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(198
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(122
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:41.05PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Other long term assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	39
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:41.05PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accounts payable
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,301
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(340
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	63
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:41.05PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accrued liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,940
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,540
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	378
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:41.05PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Other long term liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	454
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(16
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	263
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:41.05PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Deferred revenue
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(14,199
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	28,398
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:54.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net cash (used in) provided by operating activities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(32,100
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	13,658
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(12,531
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash flow from investing activities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Purchases of property and equipment
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,446
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(716
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,169
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Proceeds from sale of equipment
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	134
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Decrease (increase) in restricted cash
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	60
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(260
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:54.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net cash used in investing activities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,252
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(976
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,169
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash flow from financing activities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Proceeds from issuance of common stock during IPO, net of issuance costs
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	55,780
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Proceeds from issuance of Series A preferred stock, net of issuance costs
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	18,994
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,635
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Proceeds from issuance of Series A-1 preferred stock, net of issuance costs
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9,896
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Proceeds from issuance of Series B preferred stock, net of issuance costs
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	45,837
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Proceeds from exercise of stock options
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	352
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	165
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	318
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:54.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net cash provided by financing activities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	101,969
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	29,055
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,953
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net increase (decrease) in cash and cash equivalents
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	68,617
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	41,737
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2,747
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash and cash equivalents at beginning of period
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	43,648
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,911
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,658
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash and cash equivalents at end of period
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	112,265
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	43,648
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,911
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:56.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Non-cash investing and financing activities:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Unpaid IPO-related costs included in period-end accrued liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	153
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Vesting of early exercised options and restricted stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	177
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	104
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	17
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Unpaid portion of property and equipment purchases included in
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; period-end accounts payable
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	47
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	91
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	103
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Unpaid portion of property and equipment purchases included in
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; period-end accrued liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Loan issued in connection with restricted stock purchase agreement
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	38
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accretion of redeemable convertible preferred stock to redemption
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; Value
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	158
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	179
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:56.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accretion of dividends on redeemable convertible preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,151
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,864
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.6%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,087
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_CASH_FLOW>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The accompanying notes are an integral part of these Consolidated Financial Statements
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:6PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:1PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:8PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-6
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage84"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU83">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</FONT>
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN">
</A>
	Notes
<A NAME="MYOK-10K_20151231_HTM_NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN">
</A>
	to Consolidated Financial Statements
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:6PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:6PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1. Organization
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MyoKardia, Inc. (the &#8220;Company&#8221;) is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The Company&#8217;s initial focus is on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. The Company has used its precision medicine platform to generate an internal pipeline of four therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy&#8212;hypertrophic cardiomyopathy, or HCM, and dilated cardiomyopathy, or DCM. The Company has discovered and advanced its lead product candidate, MYK-461, into Phase 1 clinical trials. In the Company&#8217;s first Phase 1 clinical trial, it has demonstrated proof of mechanism, or the ability of MYK-461 to reduce cardiac muscle contraction, an important biomarker of disease. The Company intends to expand its approach to deliver treatments with disease-modifying potential for patients with other forms of genetically-driven heart failure. The Company was incorporated on June&#160;8, 2012 in Delaware and its corporate headquarters and operations are located in South San Francisco, California.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Through December 31, 2015, the Company has financed its operations through an initial public offering and private placements of redeemable convertible preferred stock and payments received under the Collaboration Agreement. On October 29, 2015, the Company completed its IPO of 6,253,125 shares of common stock at an offering price of $10.00 per share, resulting in net proceeds of approximately $55.6 million, after deducting underwriting discounts, commissions and offering costs. In April 2015, the Company received net proceeds of $45.8 million from the sale of shares of its Series B redeemable convertible preferred stock. As of December 31, 2015, the Company had cash and cash equivalents of $112.3 million, which it believes will be sufficient to fund its planned operations through at least the next twelve months.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company&#8217;s long-term success is dependent upon its ability to successfully develop, commercialize, and market its products, earn revenue, obtain capital when needed, and ultimately, to achieve profitable operations.
<FONT STYLE="BACKGROUND-COLOR:#FFFFFF;COLOR:#000000;">
	However, if anticipated operating results are not achieved in future periods, management believes that planned expenditures may need to be reduced in order to extend the time period over which the then-available resources would be able to fund operations. The Company will need to raise additional capital to fully implement its business plan.
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2. Summary of Significant Accounting Policies
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Basis of Presentation and Consolidation
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The consolidated financial statements of the Company include the Company&#8217;s accounts and have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;). During 2015, the Company established a wholly-owned foreign subsidiary in Australia. The consolidated financial statements include the Company&#8217;s accounts and those of its wholly-owned subsidiary. All intercompany accounts and transactions and balances have been eliminated during consolidation.
<FONT STYLE="COLOR:#000000;">
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The functional currency of the Company and its subsidiaries is the United States (&#8220;US&#8221;) Dollar. All intercompany accounts, transactions and balances have been eliminated during consolidation.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Use of Estimates
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The preparation of consolidated financial statements in conformity with US&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses in the consolidated financial statements and the accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, clinical trial accruals, fair value of redeemable convertible preferred stock call option liability, redeemable convertible preferred stock, income taxes and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Segments
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company operates and manages its business as one reportable and operating segment, which is the business of developing and commercializing therapeutics. The Company&#8217;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating and evaluating financial performance. All revenues have been earned in the United States of America, and all long-lived assets are maintained in the United States of America.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-7
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage85"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU84">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash and cash equivalents
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cash and cash equivalents consist of cash and other highly liquid investments with original maturities of three months or less from the date of purchase. At December&#160;31, 2015 and 2014, the Company&#8217;s cash and cash equivalents were comprised of funds held in checking accounts and interest bearing money market accounts.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Restricted Cash
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Restricted cash at December&#160;31, 2015 and 2014, comprises cash balances primarily held as security in connection with the Company&#8217;s facility lease agreement and are included in other long term assets on the consolidated balance sheets.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Fair Value Measurements
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Fair value accounting is applied for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis (at least annually). The carrying amount of the Company&#8217;s financial instruments, including note receivable, accounts payable and accrued expenses and other current liabilities approximate fair value due to their short-term maturities. The redeemable convertible preferred stock call option liability was carried at fair value until the Series B issuance in April 2015. At that time, the redeemable convertible preferred stock call option liability was reclassified to permanent equity with no further fair value measurement required.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Concentration of Credit Risk
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. All of the Company&#8217;s cash and cash equivalents are held at one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risk and Uncertainties
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company&#8217;s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company&#8217;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of results of clinical trials and reaching milestones, uncertainty of regulatory approval of the Company&#8217;s potential drug candidates, uncertainty of market acceptance of any of the Company&#8217;s product candidates that receive regulatory approval, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Products developed by the Company require approvals from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) or other international regulatory agencies prior to commercial sales. There can be no assurance that any of the Company&#8217;s product candidates will receive the necessary approvals. If the Company is denied approval, approval is delayed or the Company is unable to maintain approvals, it could have a materially adverse impact on the Company.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company expects to incur substantial operating losses for the next several years and will need to obtain additional financing in order to complete clinical trials and launch and commercialize any product candidates for which it receives regulatory approval. There can be no assurance that such financing will be available or will be on terms acceptable by the Company.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Property and Equipment
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets, ranging from two to five years. Leasehold improvements are amortized over the shorter of their estimated useful lives or the related lease term. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in the consolidated statement of operations and comprehensive loss.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Impairment of Long-Lived Assets
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU85">
</A>
	The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment charge would be recorded when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition are
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-8
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage86"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	less than its carrying amount. Impairment, if any, is assessed using discounted cash flows or other appropriate measures of fair value. Through December
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;31, 2015, there have been no such impairment charges.
</FONT>
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Deferred Offering Costs
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Deferred offering costs, consisting of legal, accounting and other fees and costs relating to the IPO were capitalized. The deferred offering costs were offset against the proceeds received upon the closing of the IPO. There was $2.5 million of deferred offering costs capitalized during 2015 and upon the completion of the IPO, these deferred offering costs were offset against the $58.2 million of proceeds received, net of underwriting discounts and commissions. As of December&#160;31, 2015 and 2014, there were no deferred offering costs capitalized in other long term assets on the consolidated balance sheets.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable Convertible Preferred Stock
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company recorded all shares of redeemable convertible preferred stock at their respective fair values on the dates of issuance. In the event of a change of control of the Company, proceeds were to be distributed in accordance with the liquidation preferences set forth in the amended and restated certificate of incorporation unless the holders of redeemable convertible preferred stock have converted their redeemable convertible preferred shares into common shares. Therefore, the redeemable convertible preferred stock was classified outside of stockholders&#8217; deficit on the accompanying consolidated balance sheets as events triggering the liquidation preferences are not solely within the Company&#8217;s control. The carrying value of each series of redeemable convertible preferred stock was being accreted to its respective redemption value through the Company&#8217;s IPO in October 2015 upon which it was converted to common stock.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable Convertible Preferred Stock Call Option
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company determined that the Company&#8217;s obligation to issue additional shares of the Company&#8217;s redeemable convertible preferred stock represented a freestanding financial instrument. The freestanding redeemable convertible preferred stock call option liability was initially recorded at fair value, with fair value changes recognized as increases or reductions in the consolidated statements of operations and comprehensive loss. The Company adjusted the liability for changes in fair value until the Series B issuance in April 2015. At that time, the redeemable convertible preferred stock call option liability was reclassified to permanent equity with no further fair value measurement required. The Company had recorded a redeemable convertible preferred stock call option liability, net in September 2012 related to the Series A redeemable convertible preferred stock financing, which was extinguished in July 2014 at the time of the final closing of the Series A redeemable convertible preferred stock. Additionally, the Company had recorded a redeemable convertible preferred stock call option liability in August 2014 related to the Collaboration Agreement, from which the call option expired in April 2015 at the time of the closing of the Company&#8217;s Series B redeemable convertible preferred stock financing.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Revenue Recognition
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company generates revenue from collaboration and license agreements for the development and commercialization of its products. Collaboration and license agreements may include non-refundable upfront license fees, partial or complete reimbursement of research and development costs, contingent consideration payments based on the achievement of defined collaboration objectives and royalties on sales of commercialized products. To date, the Company has not recognized revenue from sales of its product candidates.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company recognizes revenue when all four of the following criteria have been met: (i)&#160;collectability is reasonably assured; (ii)&#160;delivery has occurred or services have been rendered; (iii)&#160;persuasive evidence of an arrangement exists; and (iv)&#160;the fee is fixed or determinable. Revenue under collaboration and license arrangements is recognized based on performance requirements of the contract. Collectability is assessed based on evaluation of payment criteria as stated in the contract as well as the creditworthiness of the collaboration partner. Determination of whether delivery has occurred or services rendered are based on management&#8217;s evaluation of the performance obligations as stated in the contract and progress made against those obligations. Evidence of arrangement is deemed to exist upon execution of the contract. Fees are considered fixed and determinable when the amount payable to the Company is no longer subject to any acceptance, refund rights or other contingencies that would alter the fixed nature of the fees charged for the deliverables.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU86">
</A>
	License and collaboration agreements may contain multiple elements as evaluated under Accounting Standards Codification (ASC) 605-25,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Revenue Recognition- Multiple-Element Arrangements,
</FONT>
	including agreements to provide research and development services, and manufacturing and commercialization services, grants of licenses to intellectual property rights and know-how, as well
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-9
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage87"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	as participation in development and/or commercialization committees. Each deliverable under the agre
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ement is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has standalone value to the customer. The arrangement&#8217;s consideration that is fixed or determinable is then allocated to each separate un
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	it of accounting based on the following hierarchy: (i)&#160;vendor-specific objective evidence of the fair value of the deliverable, if it exists; (ii)&#160;third-party evidence of selling price, if vendor-specific objective evidence is not available; or (iii)&#160;the b
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	est estimate of selling price if neither vendor-specific objective evidence or third-party evidence is available.
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Upfront payments for licenses are evaluated to determine if the licensee can obtain standalone value from the license separate from the value of the research and development services and other deliverables in the arrangement to be provided by the Company. The assessment of multiple-element arrangements also requires judgment in order to determine the allocation of revenue to each deliverable and the appropriate period of time over which the revenue should be recognized. If the Company determines that the license does not have standalone value separate from the research and development services, the license and the services are combined as one unit of accounting and upfront payments are recorded initially as deferred revenue in the consolidated balance sheet. Revenue is then recognized on a straight-line basis over an estimated performance period that is consistent with the term of performance obligations, unless the Company determines there is a discernible pattern of performance other than straight-line, in which case the Company uses a proportionate performance method to recognize the revenue over the estimated performance period. If the license is determined to have standalone value, then the allocated consideration is recorded as revenue when the license is delivered.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	License and collaboration agreements may also contain milestone payments that become due upon the achievement of certain milestones. The Company applies ASC 605-28,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Revenue Recognition&#8212;Milestone Method.
</FONT>
	Under the milestone method, payments that are contingent upon achievement of a substantive milestone are recognized in the period in which the milestone is achieved. Milestones are defined as an event that can only be achieved based on the Company&#8217;s performance and there is substantive uncertainty about whether the event will be achieved at the inception of the arrangement. Events that are contingent only on the passage of time or only on counterparty performance are not considered milestones subject to this guidance. Further, the amounts received must relate solely to prior performance, be reasonable relative to all of the deliverables and payment terms within the agreement and commensurate with the Company&#8217;s performance to achieve the milestone.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and Development Expenses
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development costs are expensed as incurred and consist of salaries and benefits, lab supplies and facility costs, as well as fees paid to others that conduct certain research and development activities on the Company&#8217;s behalf. Amounts incurred in connection with collaboration and license agreements are also included in research and development expense.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Preclinical Study and Clinical Trial Accruals
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company&#8217;s preclinical study and clinical trial accruals are a component of research and development expenses and based on patient enrollment and related costs at clinical investigator sites as well as estimates for the services received and efforts expended pursuant to contracts with multiple research institutions and clinical research organizations (&#8220;CROs&#8221;) that conduct and manage clinical trials on the Company&#8217;s behalf.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company estimates preclinical study and clinical trial expenses based on the services performed, pursuant to contracts with research institutions and CROs that conduct and manage preclinical studies and clinical trials on its behalf. The Company estimates these expenses based on discussions with internal clinical management personnel and external service providers as to the progress or stage of completion of trials or services and the contracted fees to be paid for such services. If the actual timing of the performance of services or the level of effort varies from the original estimates, the Company will adjust the accrual accordingly. Payments made to third parties under these arrangements in advance of the performance of the related services by the third parties are recorded as prepaid expenses until the services are rendered.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stock-Based Compensation
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU87">
</A>
	The Company accounts for stock-based compensation arrangements with employees in accordance with ASC 718,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Stock Compensation.
</FONT>
	Stock-based awards granted include stock options with time-based vesting, performance-based stock options and market-based stock options. ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all stock-based payments. The Company&#8217;s determination of the fair value of stock options with time-based vesting on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as other variables
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-10
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage88"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	including, but not limited to, expected term that options will remain outstanding, expected common stock price volatility over the term of the option awards, risk-free interest rates and expected dividends.
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stock-based compensation expense for performance stock options is based on the probability of achieving certain performance criteria, as defined in the individual option grant agreement. The Company estimates the number of performance options ultimately expected to vest and recognizes stock-based compensation expense for those options expected to vest when it becomes probable that the performance criteria will be met and the options vest. The Company has also granted stock options to purchase common stock that vest upon the achievement of market-based stock price targets.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The fair value of a stock-based award is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period) on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. Non-employee stock-based compensation expense was not material for all periods presented.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Estimating the fair value of equity-settled awards as of the grant date using valuation models, such as the Black-Scholes option pricing model, is affected by assumptions regarding a number of complex variables. Changes in the assumptions can materially affect the fair value and ultimately how much stock-based compensation expense is recognized. These inputs are subjective and generally require significant analysis and judgment to develop.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Income Taxes
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company provides for income taxes under the asset and liability method. Current income tax expense or benefit represents the amount of income taxes expected to be payable or refundable for the current year. Deferred income tax assets and liabilities are determined based on differences between the financial statement reporting and tax bases of assets and liabilities and net operating loss and credit carryforwards, and are measured using the enacted tax rates and laws that will be in effect when such items are expected to reverse. Deferred income tax assets are reduced, as necessary, by a valuation allowance when management determines it is more likely than not that some or all of the tax benefits will not be realized.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company accounts for uncertain tax positions in accordance with ASC 740-10,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Accounting for Uncertainty in Income Taxes.
</FONT>
	The Company assesses all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing authorities. Assessing an uncertain tax position begins with the initial determination of the position&#8217;s sustainability and is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and the Company will determine whether (i)&#160;the factors underlying the sustainability assertion have changed and (ii)&#160;the amount of the recognized tax benefit is still appropriate. The recognition and measurement of tax benefits requires significant judgment. Judgments concerning the recognition and measurement of a tax benefit might change as new information becomes available.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company includes penalties and interest expense related to income taxes as a component of other expense and interest expense, net, as necessary.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Comprehensive Loss
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:7.33%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Comprehensive loss is defined as a change in equity of a business enterprise during a period, resulting from transactions from non-owner sources. There have been no items qualifying as other comprehensive loss and, therefore, for all periods presented, the Company&#8217;s comprehensive loss was the same as its reported net loss.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net Loss per Share of Common Stock
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU88">
</A>
	Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-11
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage89"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	shares and potentially
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, the redeemable convertible preferred stock, common stock subject to repurchase, and stock options are considered to be potentially dilutive securiti
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	es. Basic and diluted net loss attributable to common stockholders per share is presented in conformity with the two-class method required for participating securities as the convertible preferred stock is considered a participating security. The Company&#8217;s
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	participating securities do not have a contractual obligation to share in the Company&#8217;s losses. As such, the net loss was attributed entirely to common stockholders. Because the Company has reported a net loss for all periods presented, diluted net loss p
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	er common share is the same as basic net loss per common share for those periods.
</FONT>
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Recent Accounting Pronouncements
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), the Company meets the definition of an emerging growth company, and has irrevocably elected to opt out of the extended transition period for complying with new or revised accounting standards pursuant to Section&#160;107(b) of the JOBS Act.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In
<FONT STYLE="COLOR:#000000;">
	February
</FONT>
	2016, the FASB issued Accounting Standard Update (&#8220;ASU&#8221;) No. 2016-02
<FONT STYLE="BACKGROUND-COLOR:#F4F6F8;COLOR:#3C3C3D;">
	(Topic 842)
</FONT>
	,
<FONT STYLE="FONT-STYLE:ITALIC;BACKGROUND-COLOR:#F4F6F8;COLOR:#3C3C3D;">
	Leases
</FONT>
<FONT STYLE="BACKGROUND-COLOR:#F4F6F8;COLOR:#3C3C3D;">
	. ASU 2016-02
</FONT>
<FONT STYLE="COLOR:#000000;">
	requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases. The ASU will also require new qualitative and quantitative disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, with early adoption permitted.
</FONT>
	The Company has not determined the potential effects of this ASU on its consolidated financial statements.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In November 2015, the FASB issued ASU
<FONT STYLE="FONT-STYLE:ITALIC;">
	No. 2015-17 (Topic 740), Balance Sheet Classification of Deferred Taxes.
</FONT>
	ASU 2015-17 requires deferred tax liabilities and assets to be classified as noncurrent in the Consolidated Balance Sheet. The standard will be effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for financial statements that have not been previously issued. The ASU may be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The Company adopted this ASU on a prospective basis during the fourth quarter of 2015 and the adoption had no impact on the Company&#8217;s consolidated financial statements.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In August 2014, the FASB issued ASU No.&#160;2014-15,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Disclosure of Uncertainties About an Entity&#8217;s Ability to Continue as a Going Concern.
</FONT>
	The new standard provides guidance around management&#8217;s responsibility to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December&#160;15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated financial statements.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In June 2014, the FASB issued ASU 2014-12,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.
</FONT>
	ASU 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for the Company in its first quarter of 2016 with early adoption permitted. The Company does not expect its pending adoption of ASU 2014-12 to have a material impact on its consolidated financial statements and disclosures.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In May 2014, the FASB issued ASU No.&#160;2014-09,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Revenue from Contracts with Customers
</FONT>
	(Topic&#160;606), which supersedes the revenue recognition requirements in ASC 605,
<FONT STYLE="FONT-STYLE:ITALIC;">
	Revenue Recognition.
</FONT>
	This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The ASU is effective for public entities for annual and interim periods beginning after December&#160;15, 2017, with early adoption for fiscal 2017 permitted. The Company has not determined the potential effects of this ASU on its consolidated financial statements.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-12
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage90"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU89">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Reverse Stock Split
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In October 2015, the Company&#8217;s board of directors and stockholders approved an amendment to the Company&#8217;s certificate of incorporation to effect a reverse split of shares of the Company&#8217;s issued and outstanding common stock at a 1-for-3.675 ratio&#160;and a proportional adjustment to the conversion ratio of its redeemable&#160;convertible preferred stock. The reverse stock split was effected on October 23, 2015. The par value and the authorized shares of the&#160;Company&#8217;s common stock and the par value and the authorized, issued and outstanding shares of the Company&#8217;s redeemable convertible preferred stock were not adjusted as a result of the reverse stock split. All issued and outstanding shares of common stock and common stock per share amounts and an adjustment to the redeemable convertible preferred stock ratio contained in these consolidated financial statements have been retroactively adjusted to reflect this reverse stock split for all periods presented.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3. Fair Value Measurements
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Financial assets and liabilities are recorded at fair value. The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Level 1&#8212;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Level 2&#8212;Inputs (other than quoted market prices included in Level 1 are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#8217;s anticipated life.
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Level 3&#8212;Inputs reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table sets forth the Company&#8217;s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_11"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:90%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.3%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="14" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:47.44%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Fair Value Measurements at
<FONT STYLE="FONT-FAMILY:CALIBRI;">
	&#160;
</FONT>
	December 31, 2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:11PT;FONT-FAMILY:CALIBRI;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.3%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Level 1
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Level 2
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Level 3
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.3%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Money market funds
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	111,533
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	111,533
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.3%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable convertible preferred stock call option
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; liability, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:90%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.3%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="14" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:47.44%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Fair Value Measurements at December 31, 2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.3%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Level 1
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Level 2
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Level 3
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.3%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Money market funds
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	42,804
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	42,804
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.3%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.3%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable convertible preferred stock call option
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; liability, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	314
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	314
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31, 2015, the balance of the redeemable convertible preferred stock call option liability, net was zero.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The fair value measurement of the redeemable convertible preferred stock call option is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect the Company&#8217;s assumptions in measuring fair value. The Company&#8217;s estimated fair value of the redeemable convertible preferred stock call option is calculated using an option pricing model and key assumptions including the estimated fair value of the Company&#8217;s redeemable convertible preferred stock, risk-free interest rates and volatility and the probability of the closing of the future financing tranches. The estimates are based, in part, on subjective assumptions and could differ materially in the future.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-13
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage91"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU90">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Duri
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ng the periods presented, the Company has not changed the manner in which it values assets and liabilities that are measured at fair value using Level 3 inputs. The Company recognizes transfers between levels of the fair value hierarchy as of the end of th
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	e reporting period. There were no transfers within the hierarchy during the year ended December&#160;31, 2015 and 2014.
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table sets forth a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments as follows (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_INCOME_STATEMENT>
<A NAME="FIS_INCOME_STATEMENT_2"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:80.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:16.82%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Convertible
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	preferred stock
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	call option
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	liability, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:80.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Balance at December 31, 2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:15.82%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	303
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:80.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Fair value of call option liability recognized upon issuance in
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; connection with collaboration agreement
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:15.82%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	686
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:80.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exercises
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:15.82%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(288
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:80.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in fair value recorded in statement of operations and
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; comprehensive loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:15.82%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(387
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:80.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Balance at December 31, 2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:15.82%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	314
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:80.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in fair value recorded in statement of operations and
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; comprehensive loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:15.82%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(314
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:80.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Balance at December 31, 2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:15.82%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_INCOME_STATEMENT>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4. Collaboration and License Agreement
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Sanofi (Aventis Inc.)
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In August 2014, the Company entered into the Collaboration Agreement with Aventis Inc., a wholly-owned subsidiary of Sanofi S.A., for the research, development and potential commercialization of pharmaceutical products for the treatment, prevention and diagnosis of hypertrophic and dilated cardiomyopathy, as well as potential additional indications.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Pursuant to the Collaboration Agreement, in addition to potential future royalty payments, Sanofi agreed to provide up to $200.0 million in financial consideration to the Company consisting of the following components:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	a $35.0 million upfront cash payment
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	a $10.0 million initial equity investment
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	a $25.0 million milestone-based contingent payment
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	up to an $85.0 million project continuation payment if Sanofi elects to extend the term of the research collaboration beyond December&#160;31, 2016, as described below
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	up to $45.0 million in funding from Sanofi of approved in-kind research and clinical activities over a four-year period.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company is also entitled to receive tiered royalties beginning in the mid-single digits to the mid-teens on net sales of certain hypertrophic cardiomyopathy (&#8220;HCM&#8221;) and dilated cardiomyopathy (&#8220;DCM&#8221;) finished products outside the United States and on net sales of certain DCM finished products in the United States. Sanofi is eligible to receive tiered royalties beginning in the mid-single digits to the low teens on the Company&#8217;s net sales of certain HCM finished products in the United States.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Collaboration Agreement covers three main research programs, &#8220;HCM1&#8221; (or HCM-1 or MYK-461), &#8220;HCM2&#8221; (or HCM-2) and &#8220;DCM1&#8221; (or DCM-1). The Company is solely responsible for conducting research and development activities through early human efficacy studies, except for specified research activities to be conducted by Sanofi. The estimated completion of proof-of-concept phases are staggered, depending on the program. Thereafter, the Company will lead worldwide development and United States commercial activities for the MYK-461 and HCM-2 programs, Sanofi will lead global development and commercial activities for DCM-1 and Sanofi will lead ex-United States development and commercial activities for the MYK-461 and HCM-2 programs where it has ex-United States commercialization rights. Sanofi also has the option to co-promote in the U.S. for potential expanded cardiovascular diseases outside of the genetically targeted indications for the MYK-461 and HCM-2 programs, with the Company having the option to co-promote the DCM-1 program in the United States.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-14
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage92"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU91">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company accounted for the Collaboration Agreement by evaluating each of the financial components discussed above:
</FONT>
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	$35.0 million upfront payment.
<FONT STYLE="FONT-WEIGHT:NORMAL;">
	The Company received a non-refundable upfront payment and identified the following performance obligations at the inception of the Collaboration Agreement: (i)&#160;the transfer of intellectual property rights and know-how (license), (ii)&#160;the obligation to provide certain limited research and development services during the term of the license agreement and (iii)&#160;the obligation to participate on the development and commercialization committees. The Company applied the guidance under ASC 605-25,
</FONT>
<FONT STYLE="FONT-STYLE:ITALIC;FONT-WEIGHT:NORMAL;">
	Multiple Element Arrangements,
</FONT>
<FONT STYLE="FONT-WEIGHT:NORMAL;">
	to account for this upfront payment. The Company evaluated the underlying goods and services delivered under the Collaboration Agreement and concluded that the performance obligations do not have standalone value, and accordingly accounted for the deliverables as one unit of accounting. The $35.0 million payment was recorded by the Company as deferred revenue on its consolidated balance sheet upon receipt, which the Company is recognizing as revenue on a straight-line basis over the expected term of research and development services through December 31, 2016 because there is not a more discernible pattern of performance in which the research and development services occur. During the year ended December&#160;31, 2015 and 2014, the Company recognized $14.2 million and $5.9&#160;million of revenue, under the Collaboration Agreement, respectively. As of December&#160;31, 2015 and 2014, the Company had recorded deferred revenue on its consolidated balance sheet of $14.2 million and $28.4&#160;million, respectively.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	$10.0 million upfront investment in Series A-1 redeemable convertible preferred stock.
<FONT STYLE="FONT-WEIGHT:NORMAL;">
	In August, 2014 the Company entered into a Series A-1 redeemable convertible preferred stock purchase agreement with Sanofi. The Agreement was signed as a separate transaction from the Collaboration Agreement. Pursuant to the stock purchase agreement, the Company sold 6,666,667&#160;shares of Series&#160;A-1 redeemable convertible preferred stock to Sanofi at $1.50&#160;per share. The Company concluded that the $1.50&#160;per share price represented the fair value of the redeemable convertible preferred stock issued.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	$25.0 million milestone-based payment.
<FONT STYLE="FONT-WEIGHT:NORMAL;">
	The Company is eligible to receive a one-time, non-refundable, non-creditable payment of $25.0&#160;million upon the submission of an investigational new drug application for any DCM-1 development candidate to the FDA or a comparable regulatory authority in Europe or another major market country for any DCM-1 product. The Company will account for this milestone payment separately from the rest of the agreement and recognize revenue upon achievement of the milestone. The Company had not achieved this milestone as of December 31, 2015.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Up to $85.0 million continuation payments.
<FONT STYLE="FONT-WEIGHT:NORMAL;">
	Under the Collaboration Agreement, Sanofi must determine by December&#160;31, 2016 whether or not to continue the Collaboration Agreement. Sanofi agreed that if it so elected to continue the Collaboration Agreement, it would pay:
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	a one-time, non-refundable, non-creditable cash payment of $45.0&#160;million
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9.06%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:'SYMBOL';FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#183;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-SIZE:10PT;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;">
	an additional $40.0&#160;million in connection with the purchase of the Company&#8217;s preferred stock, assuming the Company has not previously closed (i)&#160;either a Qualified IPO (at which time this obligation will terminate) or a private financing prior to a Qualified IPO and (ii)&#160;Sanofi has not previously purchased shares of the Company&#8217;s stock pursuant to such rights to purchase the Company&#8217;s capital stock in accordance with the terms of the Collaboration Agreement. The $40.0 million payment was reduced by $5.0&#160;million to $35.0&#160;million in connection with Sanofi&#8217;s subsequent purchase of shares of the Company&#8217;s Series&#160;B redeemable convertible preferred stock in April 2015, and the remaining obligation terminated in connection with the Company&#8217;s IPO in October 2015.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:9.07%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Sanofi also had a time-restricted right to purchase $40.0&#160;million in shares of the Company&#8217;s redeemable convertible preferred stock at the discounted price, which would have satisfied the $40.0&#160;million obligation to purchase shares of the Company&#8217;s capital stock in connection with the continuation decision. Sanofi&#8217;s option to purchase $40.0&#160;million of additional shares of the Company&#8217;s redeemable convertible preferred stock at the discounted price expired upon the closing of the Series&#160;B redeemable convertible preferred stock financing in April&#160;2015.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:9.07%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company believes that the continuation payments have significant uncertainty and are outside the control of the Company because Sanofi has sole discretion to determine whether or not to continue, and will therefore account for these potential payments separate from the other deliverables in this agreement.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:9.07%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company has determined that Sanofi&#8217;s right to purchase the redeemable convertible preferred stock at the discounted price, and the Company&#8217;s corresponding obligation to issue this additional redeemable convertible preferred stock, represents a freestanding financial instrument. The freestanding convertible preferred stock call option liability was initially recorded at its fair value of $0.7 million in 2014. The Company recorded a decrease in the fair value of this liability of $0.3 million and $0.4 million in the consolidated statements of operations and comprehensive loss during the year ended December&#160;31, 2015 and 2014, respectively.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-15
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage93"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:9.07%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU92">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31, 2015, Sanofi had not provided the confirmation of continuation under the Collaboration Agreement.
</FONT>
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:BOLD;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Up to $45.0 million in-kind research and collaboration activities.
<FONT STYLE="FONT-WEIGHT:NORMAL;">
	Sanofi can fund up to $45.0 million of pre-approved funding of research and collaboration activities. Since Sanofi will pay its vendors and personnel directly as per the Collaboration Agreement, the Company will not receive cash from Sanofi and therefore will not account for the funding of the in-kind services.
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5. Balance Sheet Components
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_12"></A>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Property and Equipment
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Property and equipment consists of the following (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:68.04%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:30.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:68.04%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.12%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.66%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.12%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Scientific equipment
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,995
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,105
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Furniture and equipment
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	301
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	217
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Capitalized software
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	225
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	164
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Leasehold improvements
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	303
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	123
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:68.04%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Construction in progress
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.66%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	70
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:27.35PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,824
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,679
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:68.04%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Less: Accumulated depreciation and amortization
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2,080
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.66%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,256
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:68.04%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Property and equipment, net
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,744
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.66%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,423
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Depreciation and amortization expense was $1.0 million and $0.7 million for the years ended December&#160;31, 2015 and 2014, respectively.
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_13"></A>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accrued Liabilities
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accrued liabilities consist of the following (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:68.04%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:30.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:68.04%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.12%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.66%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:14.12%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Payroll and related
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,515
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,119
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Clinical research and development
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,145
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	742
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:68.04%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Legal and accounting fees
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	33
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.66%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	299
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:68.04%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Other
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	940
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.66%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	171
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:68.04%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total accrued liabilities
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,633
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.66%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.12%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,331
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-SIZE:9PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6. Commitments and Contingencies
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Purchase Commitments
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company conducts product research and development programs through a combination of internal and collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. The Company has contractual arrangements with these organizations; however, these contracts are generally cancelable on 30 days&#8217; notice and the obligations under these contracts are largely based on services performed.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Facility Leases
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU93">
</A>
	On June&#160;29, 2012, the Company entered into a 66-month lease for approximately 12,000 square feet of office and laboratory space in South San Francisco with annual payments of approximately $0.5 million. In connection with this lease agreement, the Company also entered into a shared facilities and services agreement with Global Blood Therapeutics, Inc. (&#8220;GBT&#8221;), a co-tenant in the office building (See Note 10). In October 2014, the Company entered into a lease assignment agreement with the owner of the
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-16
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage94"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	building and GBT to allow GBT to sublease the Company&#8217;s portion of the building beginning in March 2015. For the year ended December 31, 2015, the Company recorded approximately $0.3 million of sublease income and $0.3 million of sublease
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	expense, which is recorded in interest and other income, net in the consolidated statements of operations and comprehensive loss.
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	On September&#160;15, 2014, the Company entered into a five-year lease for approximately 34,400 square feet of office and laboratory space in South San Francisco. The Company may extend the lease for an additional three year term. The initial annual lease payments are $1.3 million, increasing to $1.6 million in the final year of the agreement. The lease period commenced in January 2015. The Company received a lease abatement for the first three months of the lease term, which is recorded as deferred rent and recognized over the lease term.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company has provided deposits for letters of credit totaling $0.3 million to secure its obligations under its leases, which have been classified as long-term assets on the Company&#8217;s consolidated balance sheet as of December 31, 2015.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	At December&#160;31, 2015, future minimum commitments under non-cancelable operating leases were as follows (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_14"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year ending December 31:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Operating
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Leases
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Less Sublease
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Income
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Commitment
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2016
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,757
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(397
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,360
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2017
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,869
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(409
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,460
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2018
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,648
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(140
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,508
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.44%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2019
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,554
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.4%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,554
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2020
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	80
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	80
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.44%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,908
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(946
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.4%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,962
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Rent expense, net was $1.4 million and $0.5 million for the years ended December&#160;31, 2015, and 2014, respectively.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Contingencies
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	From time to time, the Company may have contingent liabilities that arise in the ordinary course of business activities. The Company accrues for such a liability when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There were no contingent liabilities requiring accrual or disclosure as of December&#160;31, 2015 and 2014.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Guarantees and Indemnifications
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to certain of these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#8217;s technology. The term of these indemnification arrangements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company&#8217;s request in such capacity, as permitted under Delaware law and in accordance with its certificate of incorporation and bylaws, and agreements providing for indemnification entered into with its officers and directors. The term of the indemnification period lasts as long as an officer or director may be subject to any proceeding arising out of acts or omissions of such officer or director in such capacity.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The maximum amount of potential future indemnification of directors and officers is unlimited; however, the Company currently holds director and officer liability insurance. This insurance allows the transfer of risk associated with its exposure and may enable it to recover a portion of any future amounts paid.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company believes that the fair value of these indemnification obligations is minimal. Accordingly, the Company has not recognized any liabilities relating to these obligations for any period presented.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-17
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage95"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU94">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	7. Stockholders&#8217; Deficit
</FONT>
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_15"></A>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Common Stock Reserved for Issuance
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company has reserved shares of common stock, on an as-if-converted basis, for issuance as follows:
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:30.4%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Conversion of Series A redeemable convertible preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,408,162
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Conversion of Series A-1 redeemable convertible preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,814,059
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options issued and outstanding
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,318,647
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	554,669
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options available for grant under stock option plan
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,497,071
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	312,911
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,815,718
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	13,089,801
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Preferred stock
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As amended in November 2015, the Company's Certificate of Incorporation authorizes&#160;5,000,000&#160;shares of preferred stock at a par value&#160;of $0.0001&#160;per share.&#160;As of December 31, 2015, no preferred stock was issued or outstanding.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable Convertible Preferred Stock
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Up until the IPO in October 2015, the Company&#8217;s amended and restated certificate of incorporation authorized the Company to issue 62,235,313 shares of redeemable convertible preferred stock with a par value of $0.0001 per share, of which 38,500,000 are designated Series A redeemable convertible preferred stock, 6,666,667 are designated Series&#160;A-1 redeemable convertible preferred stock, and 17,068,646 are designated Series&#160;B redeemable convertible preferred stock. From September 2012 through December&#160;31, 2013, the Company issued an aggregate of 19,250,000 shares of Series&#160;A redeemable convertible preferred stock for net cash proceeds of $19.2&#160;million. In February, June and July 2014, the Company issued an aggregate of 19,000,000 shares of Series&#160;A redeemable convertible preferred stock for net cash proceeds of $19.0 million. In August 2014, the Company issued 6,666,667 shares of Series&#160;A-1 redeemable convertible preferred stock to Sanofi for net cash proceeds of $9.9 million. In April 2015, the Company issued 17,068,646 shares of Series&#160;B redeemable convertible preferred stock to new and existing stockholders in exchange for net proceeds of $45.8 million. During the IPO in October 2015, all of the 38,500,000 designated Series A redeemable convertible preferred stock, 6,666,667 designated Series&#160;A-1 redeemable convertible preferred stock, and 17,068,646 designated Series&#160;B redeemable convertible preferred stock were converted to common stock.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31, 2015, there was no outstanding redeemable convertible preferred stock.
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December&#160;31, 2014, the outstanding redeemable convertible preferred stock was as follows (in thousands, except share data):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_16"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:90%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.34%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Shares
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Authorized
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Shares
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Issued and
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Outstanding
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Liquidation
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Value
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Carrying
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Value
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Series A
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	38,500,000
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	38,250,000
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	42,006
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	41,359
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.34%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Series A-1
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,666,667
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,666,667
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,327
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10,229
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.34%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	45,166,667
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	44,916,667
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	52,333
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	51,588
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;
</P>
<P STYLE="MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Redeemable Convertible Preferred Stock Call Option Liability
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The preferred stock purchase agreements for Series&#160;A redeemable convertible preferred stock provided the investors the right to participate in future tranches of the respective series funding at a fixed price equal to the original issue price. These rights were provided concurrently with the issuance of the original preferred stock purchase agreement. These liability classified redeemable convertible preferred stock call options were determined to be freestanding financial instruments because they are freely transferable and separately exercisable.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU95">
</A>
	In connection with the Collaboration Agreement, the Company granted Sanofi the right to purchase $40.0 million of shares of redeemable convertible preferred stock at a discounted price in the future, which was determined to be a freestanding financial
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-18
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage96"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	instrument. The Company determined the fair value of the
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	redeemable convertible preferred stock call option liabilities using an option pricing model.
</FONT>
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Series A Redeemable Convertible Preferred Stock Call Option Liability
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	On September&#160;11, 2012, the Company sold a redeemable convertible preferred stock call option right to investors to participate in future tranches of Series A redeemable convertible preferred stock financing. As of December&#160;31, 2012, the Company recorded an initial call option liability of $0.5 million and remeasured the call option liability immediately prior to each exercise as well as at each balance sheet date. The call option right was exercised in subsequent closings of financing from November 2012 through July 2014. During 2013, the Company remeasured the call option liability immediately before exercise and recorded $0.9 million in other income (expense) in the consolidated statements of operations and comprehensive loss and reclassified the fair value of $0.2 million into preferred stock upon issuance of the Series&#160;A redeemable convertible preferred stock. In 2014, the Company remeasured the redeemable convertible preferred stock call option liability at the end of each quarter and immediately before exercise. For the year ended December 31, 2014, the Company recorded $15,000 in other income (expense) in the consolidated statement of operations and comprehensive loss, respectively, and reclassified the fair value of $0.3 million into preferred stock upon issuance of the Series&#160;A redeemable convertible preferred stock. As of December&#160;31, 2014, all closings of the Series A redeemable convertible preferred stock had been completed, and the Series A redeemable convertible preferred stock call option liability balance was zero.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="TEXT-DECORATION:UNDERLINE;">
	Series A-1 Redeemable Convertible Preferred Stock Call Option Liability
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company recorded an initial redeemable convertible preferred stock call option liability of $0.7 million in August 2014 upon entering into the Collaboration Agreement. The Company remeasured the redeemable convertible preferred stock call option liability to $0.3 million at December&#160;31, 2014 and recorded the change in fair value of $0.4 million in other income (expense) in the consolidated statements of operations and comprehensive loss. The Company remeasured the redeemable convertible preferred stock call option liability at December&#160;31, 2015 and recorded the change in fair value of $0.3 million in other income (expense) in the consolidated statements of operations and comprehensive loss reducing the balance to zero as of December&#160;31, 2015. The Company&#8217;s obligation to issue $40.0 million additional shares of the Company&#8217;s redeemable convertible preferred stock to Sanofi at a discounted price expired upon the closing of the Series B redeemable convertible preferred stock financing in April 2015.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Dividends and Distributions
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The holders of the outstanding shares of redeemable convertible preferred stock were entitled to receive, whether or not declared by the Board of Directors, a cumulative cash dividend at the rate of 8% of the original issue price per annum on each outstanding share of redeemable convertible preferred stock. The original issue price was $1.00 for Series A redeemable convertible preferred stock, $1.50 for Series A-1 redeemable convertible preferred stock and $2.695 for Series B redeemable convertible preferred stock. Such dividends were to be payable only when, as and if declared by the Board of Directors or upon a redemption or a Liquidation Event, as described below. After payment of dividends at the rate set forth above, any additional dividends declared were to be distributed among all holders of the redeemable convertible preferred stock and common stock in proportion to the number of shares of common stock that would then be held by each such holder if all shares of the redeemable convertible preferred stock were converted into common stock. No dividends were declared by the Company to date. During the year ended December 31, 2015, the Company reclassified cumulative dividends relating to its Series A, A-1 and B redeemable convertible preferred stock of $6.3 million, $1.0 million, and $1.9 million, respectively to additional paid-in-capital upon the conversion of the Series A, A-1 and B redeemable convertible preferred stock into shares of common stock.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redemption
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Series B redeemable convertible preferred stock was to be redeemed by the Company at a price equal to the applicable original issue price, plus any dividends accrued but unpaid thereon, whether or not declared, in three annual installments commencing not more than 60 days after receipt by the Company of notice from the holders of a majority of the then outstanding shares of Series B redeemable convertible preferred stock at any time on or after five years from the date of issuance. The Series A and A-1 redeemable convertible preferred stock was to be redeemed by the Company at a price equal to the applicable original issue price, plus any dividends accrued but unpaid whether or not declared, in three annual installments commencing not more than 60 days after receipt by the Company of notice from the holders of a majority of the then outstanding shares of Series A and A-1 redeemable convertible preferred stock at any time on or after the later to occur of the redemption in full of the Series B redeemable convertible preferred stock and the date five years after the Series B redeemable convertible preferred stock original issuance date of April 2015.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-19
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage97"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU96">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	If the Company did not have sufficient funds legally available on the redemption date to redeem all of the shares of a class of re
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	deemable convertible preferred stock, the Company was to redeem a pro rata portion of each holder&#8217;s redeemable convertible preferred stock of that class based on the respective amounts which would otherwise be payable in respect of the shares to be redeeme
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	d if the available funds were sufficient to redeem all such shares, and was to redeem such remaining shares as soon as practicable after the Company has funds legally available there for. The redemption of the Series A and A-1 redeemable convertible prefer
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	red stock would only happen following the redemption in full of the Series B redeemable convertible preferred stock, and the redemption of the Series A and A-1 redeemable convertible preferred stock occur on a pari passu basis.
</FONT>
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accretion of Redeemable Convertible Preferred Stock
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company recorded the Series A, A-1 and B redeemable convertible preferred stock at fair value on the dates of issuance, net of offering costs and the allocation of the fair value of the convertible preferred stock tranche liability. The Series B redeemable convertible preferred stock shares were originally issued with a contingent redemption which allowed the holders to redeem their shares in three annual installments upon the vote of a majority of the then outstanding shares of Series B redeemable convertible preferred stock at any time after five years of the Series B redeemable convertible preferred stock original issuance date in April 2015. The Series A and A-1 redeemable convertible preferred stock was redeemable in three annual installments on or after the later to occur of the redemption in full of the Series B redeemable convertible preferred stock and the date five years after the Series B redeemable convertible preferred stock original issuance date. Accordingly, the Company was accreting the Series A, A-1 and B redeemable convertible preferred stock for the change in the redemption value with the change recorded to accumulated deficit at the end of each reporting period. The Company used the straight line method over the accretion periods, which resulted in approximately the same amounts as the effective interest rate method. The Company accreted $0.1 million and $0.2 million during the years ended December&#160;31, 2015 and 2014. During the year ended December 31, 2015, the Company reclassified cumulative accretion costs relating to its Series A, A-1 and B redeemable convertible preferred stock of $0.5 million to additional paid-in capital upon the conversion of the Series A, A-1 and B redeemable convertible preferred stock into shares of common stock.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Liquidation Rights
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Upon any voluntary or involuntary liquidation, dissolution, or winding up of the Company, any merger or consolidation following which the stockholders of the Company do not hold a majority, by voting power, of the capital stock of the surviving or successor entity (or its parent), or any sale or other disposition of all or substantially all of the Company&#8217;s assets (a &#8220;Liquidation Event&#8221;), before any distribution or payment was to be made to the holders of common stock, the holders of Series A, A-1 and B redeemable convertible preferred stock were entitled to be paid out of assets legally available for distribution, an amount equal to the original purchase price of the applicable series of redeemable convertible preferred stock plus all accrued but unpaid dividends. After payments of the full liquidation preferences of the Series B redeemable convertible preferred stock, the remaining assets of the Company available for distribution to stockholders were to be distributed among and paid ratably to the holders of Series A and A-1 redeemable convertible preferred stock. After payments of the full liquidation preferences of the Series A and A-1 redeemable convertible preferred stock, the remaining assets of the Company available for distribution to stockholders were to be distributed among and paid ratably to the holders of common stock in proportion to the number of shares held by them. In October, 2015, the liquidation rights related to the Series A, A-1 and B redeemable convertible preferred stock expired as these classes of preferred stock were converted to common stock.
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Conversion
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU97">
</A>
	Each series of redeemable convertible preferred stock was convertible at the option of the holder at any time into fully paid, nonassessable shares of common stock. The number of shares of common stock to which a holder was entitled upon conversion shall be the product obtained by multiplying the preferred conversion rate (determined by dividing the original issue price by the applicable preferred stock conversion price) by the number of shares being converted. The per share conversion price of the Series A, A-1 and B redeemable convertible preferred stock was initially $1.00, $1.50 and $2.695, respectively, and was subject to adjustment in connection with certain dilutive issuances, stock splits, combinations, dividends, distributions, recapitalizations and the like. Each share of redeemable convertible preferred stock was to automatically convert into common stock upon the closing of the sale of shares of Company common stock to the public in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, provided that such offering results in at least $30.0 million of gross proceeds, after deducting the underwriting&#8217; discount and commissions, to the Company and following such offering such shares are listed on a NASDAQ exchange, the New York Stock Exchange or another internationally recognized stock exchange (a &#8220;Qualified IPO&#8221;). In addition, each share of Series B redeemable convertible preferred stock was to automatically convert into common stock at any time upon the affirmative election of the holders of at least a majority of the outstanding shares of Series B redeemable convertible
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-20
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage98"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	preferred stock, and each share of Series A and A-1 convertible preferred stock was to automatically convert into common stock at any time upon the affirmative election of the holders of at least a majority of the outstanding shares of
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Series A and A-1 redeemable convertible preferred stock voting together. In October 2015, each series of the Company&#8217;s redeemable convertible preferred stock was convertible into common stock on a 3.675:1 basis. During the IPO in October 2015, all of the 3
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8,500,000 designated Series A redeemable convertible preferred stock, 6,666,667 designated Series&#160;A-1 redeemable convertible preferred stock, and 17,068,646 are designated Series&#160;B redeemable convertible preferred stock were converted to common stock.
</FONT>
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Voting Rights
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The holders of each share of convertible preferred stock have one vote for each share of common stock into which such convertible preferred stock may be converted.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8. Stock-Based Compensation
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In June 2012, the Company adopted the 2012 Equity Incentive Plan (as amended, the &#8220;2012 Plan&#8221;). The 2012 Plan provides for the granting of incentive stock options, nonstatutory stock options, stock bonuses and rights to acquire restricted stock to employees, officers, directors and consultants. Incentive stock options may be granted with exercise prices of not less than 100% of the estimated fair value of the common stock and nonstatutory stock options may be granted with an exercise price of not less than 85% of the estimated fair value of the common stock on the date of grant. Stock options granted to a stockholder owning more than 10% of the voting stock must have an exercise price of not less than 110% of the estimated fair value of the common stock on the date of grant. The Board of Directors determines the estimated fair value of common stock. Stock options are generally granted with terms of up to ten years and vest over a period of four years. Upon the exercise of options, the Company issues new common stock from its authorized shares.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In October 2015, the Company&#8217;s Board of Directors and stockholders adopted the 2015 Stock Option and Incentive Plan (the &#8220;2015 Plan&#8221;) and the 2015 Employee Stock Purchase Plan. Under the 2015 Plan, 1,650,000 shares of common stock are initially reserved for issuance, as of the pricing of the Company&#8217;s initial public offering. The number of shares initially reserved for issuance under the 2015 Plan will be increased by (i)&#160;the number of shares represented by awards outstanding under the Company&#8217;s 2012 Equity Incentive Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2012 Plan, and (ii)&#160;an annual increase on January&#160;1 of each year beginning on January 1, 2017. A total of 255,000 shares of common stock are initially reserved for future issuance under the 2015 Employee Stock Purchase Plan, subject to an annual increase on January 1 of each year beginning on January 1, 2017.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In October 2015, the Company adopted the 2015 Employee Stock Purchase Plan, or ESPP, which provides eligible employees with the opportunity to acquire an ownership interest in the Company through periodic payroll deductions, based on a six -month look-back period, at a price equal to the lesser of 85% of the fair market value of the common stock at either the first business day or last business day of the relevant offering period, provided that no more than 2,500 shares of common stock may be purchased by any one employee during each offering period. The ESPP is intended to constitute an &#8220;employee stock purchase plan&#8221; under Section 423(b) of the Internal Revenue Code of 1986, as amended. The ESPP may be terminated by the Company&#8217;s board of directors at any time. The first offering period commenced on October 29, 2015 and ends on April 29, 2016.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December&#160;31, 2014, 2,503,401 shares of common stock were reserved under the 2012 Plan for the issuance of options and restricted stock. In April 2015, the Board of Directors reserved an additional 945,138 shares of common stock under the 2012 Equity Incentive Plan. Upon the adoption of the 2015 Plan, the Company reserved 1,650,000 shares of common stock for issuance under the 2015 Plan and also discontinued the 2012 Plan and retired 348,150 shares of common stock remaining for issuance under the 2012 Plan. As of December 31, 2015, there were 1,497,071 shares reserved for issuance under the 2015 Equity Incentive Plan.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-21
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage99"></A>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_17"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU98">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following summarizes option activity under the 2012 and 2015 Equity Option and Incentive Plans:
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Shares
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Available
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	for Grant
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Shares
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Subject to
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Outstanding
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Weighted
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Average
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exercise
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Price Per
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Share
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Weighted
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Average
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Remaining
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Contractual
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Term
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(in years)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:8.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Aggregate
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Intrinsic
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Value
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(in
<FONT STYLE="FONT-FAMILY:CALIBRI;">
	&#160;
</FONT>
	thousands)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:11PT;FONT-FAMILY:CALIBRI;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Balance at December 31, 2012
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,091,571
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	268,974
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.18
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options authorized
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	680,262
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options granted
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,219,031
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,219,031
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.28
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options exercised
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,179,446
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.27
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options canceled
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	15,645
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(15,645
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.18
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Balance at December 31, 2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	568,447
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	292,914
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.22
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9.2
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	32
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options authorized
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	462,573
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options granted
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(802,707
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	802,707
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.44
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options exercised
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(480,723
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.34
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options repurchased
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	24,369
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.32
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options canceled
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	60,229
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(60,229
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.30
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Balance at December 31, 2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	312,911
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	554,669
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.43
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9.2
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	109
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options authorized
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,595,138
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options retired
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(348,150
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options granted
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,124,406
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,124,406
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.80
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options exercised
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(352,978
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.00
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:44.74%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options repurchased
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	54,128
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.36
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.08%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options canceled
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	7,450
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(7,450
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.72
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Balance at December 31, 2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,497,071
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,318,647
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.29
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9.0
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	16,305
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options outstanding and exercisable as of
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; December 31, 2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	605,638
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.01
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8.7
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8,266
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:44.74%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options vested and expected to vest as of
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; December 31, 2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.94%; BORDER-TOP:DOUBLE 2.5PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,005,275
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.49
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8.7
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.08%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:7.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	12,236
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The aggregate intrinsic values were calculated as the difference between the exercise price of the options and the estimated fair value of common stock. The aggregate intrinsic value of options exercised was $417,000 and $46,000 for the years ended December&#160;31, 2015 and 2014, respectively. The total estimated grant date fair value of options vested during the years ended December&#160;31, 2015 and 2014 was $186,000 and $82,000, respectively.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table summarizes information with respect to stock options outstanding and currently exercisable as of December&#160;31, 2015:
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_18"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:40.34%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:27.84%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options Outstanding
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:27.84%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Options Outstanding and Exercisable
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:40.34%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exercise Price
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Number
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Outstanding
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Weighted
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Average
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Remaining
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Contractual
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Life
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(in Years)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Aggregate
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Intrinsic
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Value
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(in&#160;thousands)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Number
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exercisable
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Weighted
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Average
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exercise
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Price Per
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Share
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:7.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Aggregate
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Intrinsic
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Value
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(in&#160;thousands)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:40.34%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$0.18
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	183,260
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	7.0
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,653
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	152,730
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.18
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,211
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:40.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$0.33
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	89,270
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8.4
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,279
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	45,915
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.33
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	658
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:40.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$0.62
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	135,099
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8.9
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,896
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	65,824
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.62
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	924
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:40.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$1.51
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	699,442
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9.4
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9,200
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	337,541
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.51
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,440
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:40.34%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$4.04-$12.50
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	211,576
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:6.96%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9.8
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,277
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,628
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:6.96%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5.53
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	33
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:40.34%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$0.18&#8212;$12.50
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:11PT;FONT-FAMILY:CALIBRI;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,318,647
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:6.96%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	16,305
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	605,638
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:6.96%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:6.96%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8,266
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-22
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage100"></A>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_19"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU99">
</A>
<FONT STYLE="FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stock-Based Compensation
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stock-based compensation expense, net of estimated forfeitures, is reflected in the statements of operations and comprehensive loss as follows (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:30.4%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	206
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	38
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	General and administrative
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	310
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	54
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total stock-based compensation
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	516
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	92
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31, 2015, total unamortized stock-based compensation was $3.3 million relating to stock options, which is expected to be recognized over the remaining vesting period of 3.3 years. As of December&#160;31, 2014, total unamortized stock-based compensation was $0.4 million, which is expected to be recognized over the remaining vesting period of 3.0 years.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In relation to stock options to purchase common stock that vest upon the achievement of performance criteria, no stock-based compensation expense had been recorded as of December 31, 2015, because the Company concluded that the achievement of the applicable performance criteria had not been considered probable.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The weighted&#8209;average grant date fair value of options granted under the Company&#8217;s stock plans in the years ended December&#160;31, 2015 and 2014 was&#160;$4.00&#160;and&#160;$0.33&#160;per share, respectively.
<FONT STYLE="COLOR:#000000;">
	The following table illustrates the assumptions for the Black-Scholes option-pricing model used in determining the fair value of time-based and performance-based options granted to employees:
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_20"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:30.4%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risk-free interest rate
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.53%-1.94%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.7%&#8211;2.0%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Expected life (in years)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5.5-6.5
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6.0&#8211;6.1
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Volatility
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	79%-109%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	84%&#8211;94%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Dividend yield
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In relation to stock options that vest upon the achievement of market-based stock price target, the Company estimated the fair value on the original grant date using a Monte-Carlo simulation model. Since its IPO, the Company has recognized the stock-based compensation expense on a straight-line basis over the implicit service period as derived under that simulation model.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Prior to the Company&#8217;s IPO in October 2015, the fair value of the shares of common stock underlying the stock options was determined by the Board of Directors. The Board of Directors determined the fair value of the common stock at the time of grant by considering a number of objective and subjective factors including valuation of comparable companies, sales of redeemable convertible preferred stock, operating and financial performance and general and industry-specific economic outlook, amongst other factors. The fair value of the underlying common stock shall be determined by the Board of Directors until such time as the Company&#8217;s common stock is listed on an established stock exchange or national market system. The fair value was determined in accordance with applicable elements of the practice aid issued by the American Institute of Certified Public Accountants entitled
<FONT STYLE="FONT-STYLE:ITALIC;">
	Valuation of Privately Held Company Equity Securities Issued as Compensation.
</FONT>
	Subsequent to the Company&#8217;s IPO, the fair value of common stock has been determined on the grant date using the Company&#8217;s closing stock price on The NASDAQ Global Select Market.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-23
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage101"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU100">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Estimating the fair value of equity-settled awards as of the grant date using valuation models, such as the Black-Scholes option pricing model, is affected by assumptions
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	regarding a number of complex variables. Changes in the assumptions can materially affect the fair value and ultimately how much stock-based compensation expense is recognized. These inputs are subjective and generally require significant analysis and judg
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ment to develop.
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Expected Term
<FONT STYLE="FONT-STYLE:NORMAL;">
	&#8212;The expected term assumption represents the weighted-average period that the Company&#8217;s stock-based awards are expected to be outstanding. The Company has opted to use the &#8220;simplified method&#8221; for estimating the expected term of the options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Expected Volatility
<FONT STYLE="FONT-STYLE:NORMAL;">
	&#8212;For all stock options granted to date, the volatility data was estimated based on a study of publicly traded industry peer companies. For purposes of identifying these peer companies, the Company considered the industry, stage of development, size and financial leverage of potential comparable companies.
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Expected Dividend
<FONT STYLE="FONT-STYLE:NORMAL;">
	&#8212;The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company currently has no history or expectation of paying cash dividends on its common stock.
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:4.54%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Risk-Free Interest Rate
<FONT STYLE="FONT-STYLE:NORMAL;">
	&#8212;The risk-free interest rate is based on the yield available on U.S. Treasury zero-coupon issues similar in duration to the expected term of the equity-settled award.
</FONT>
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Liability for Early Exercise of Stock Options
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December&#160;31, 2015 and 2014, there were 948,092 and 1,143,660, respectively, of unvested common shares outstanding that were issued upon the early exercise of stock options prior to the vesting of the underlying shares and subject to repurchase by the Company at the original issuance price upon termination of the stockholders&#8217; services. The right to repurchase these shares generally lapses with respect to 25% of the shares underlying the option after one year of service to the Company and 1/48 of the shares underlying the original grant per month for 36 months thereafter. The shares purchased by the employees pursuant to the early exercise of stock options are not deemed, for accounting purposes, to be issued until those shares vest. The cash received in exchange for exercised and unvested shares related to stock options granted is recorded as a liability for the early exercise of stock options on the consolidated balance sheets and will be reclassified to common stock and additional paid-in capital as the shares vest. As of December&#160;31, 2015 and 2014, the Company recorded $526,000 and $354,000, respectively, within accrued liabilities and other long-term liabilities associated with shares issued subject to repurchase rights.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	9. Net Loss per Share Attributable to Common Stockholders
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_21"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:30.4%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Numerator
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(22,946
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(16,829
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Cumulative dividends on redeemable convertible
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(5,151
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2,864
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Accretion of redeemable convertible preferred stock to
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; redemption value
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(158
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss attributable to common stockholders, basic
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; and diluted
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(28,195
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(19,851
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Denominator
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Weighted average shares outstanding
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	7,594,115
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,394,727
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Less: weighted average shares subject to repurchase
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,301,315
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1,637,827
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Weighted average shares used to compute basic and diluted
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;&nbsp; net loss per share
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,292,800
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,756,900
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss per share attributable to common stockholders:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Basic and diluted
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(4.48
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(11.30
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-24
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage102"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU101">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Basic net loss attributable to common stockholders per share is computed by
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	stockholders by the weighted average number of common shares and potentially dilutive securities for the period, determined using the treasury-stock method and the as-if converted method, for convertible securities, if inclusion of these is dilutive. Basi
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	c and diluted net loss per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities as the holders of the Company&#8217;s redeemable convertible preferred stock are entitled to receive c
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	umulative dividends, payable prior and in preference to any dividends on shares of common stock. Any additional dividends will be distributed among the holders of preferred stock and common stock pro rata, assuming the conversion of all preferred stock int
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	o common stock. Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income less current period earnings allocated to participating securities based on their respec
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	tive rights to receive dividends. In computing diluted net income attributed to common stockholders, undistributed earnings are re-allocated to reflect the potential impact of dilutive securities. Basic net income per common share is computed by dividing t
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	he net income attributable to common stockholders by the weighted average number of common shares outstanding during the period. The Company&#8217;s preferred stockholders do not have a contractual obligation to share in the Company&#8217;s losses. As such, the net lo
</FONT>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	ss is attributed entirely to common stockholders. Because the Company has reported a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_22"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:30.4%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.94%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.64%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Redeemable convertible preferred stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	12,222,221
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Common stock subject to repurchase
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	990,609
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,486,602
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.94%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Stock options to purchase common stock
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,318,647
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.64%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	554,669
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10. Related Party Transactions
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In September 2012, the Company began receiving consulting and management services pursuant to an unwritten agreement with Third Rock Ventures, which owned 85% of the Company&#8217;s redeemable convertible preferred stock outstanding at December&#160;31, 2014. Charles Homcy and Kevin Starr, both directors of the Company, are general partner and partner, respectively, of Third Rock Ventures. The consulting fees paid to Third Rock Ventures were incurred by the Company in the ordinary course of business, and were $89,000 and $270,000 for the years ended December&#160;31, 2015 and 2014, respectively. As of December&#160;31, 2015 and 2014, the Company had an outstanding liability to Third Rock Ventures of $13,000 and $33,000, respectively.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Effective July&#160;29, 2013, the Company entered into a shared facilities and services agreement with GBT, a company that was majority-owned by Third Rock Ventures as of such date. In connection with that agreement, the Company reimbursed GBT for shared facilities and equipment of the Company&#8217;s former corporate headquarters location. During the years ended December&#160;31, 2015 and 2014, the Company reimbursed expenses and equipment of $41,000 and $234,000, respectively, to GBT. As of December&#160;31, 2015 and 2014, the Company had an outstanding liability to GBT of zero and $24,000, respectively. In October 2014, the Company entered into a lease assignment agreement with the owner of the former headquarters building and GBT to allow GBT to sublease the Company&#8217;s portion of the office after the Company relocated to its new corporate headquarters.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	11. Employee Benefit Plan
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company sponsors a 401(k) Plan, which stipulates that eligible employees can elect to contribute to the 401(k) Plan, subject to certain limitations of eligible compensation.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	12. Income Taxes
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	For the years ended December&#160;31, 2015 and 2014, the effective income tax rate and tax provision was zero, primarily attributable to losses generated which are not more likely than not to be realized.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-25
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage103"></A>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_23"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU102">
</A>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The provision for income taxes differs from the amount expected by applying the federal statutory rate to the loss before taxes as follows:
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:30.38%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Federal statutory income tax rate
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	34.00
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	34.00
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	State taxes (tax effected)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	7.19
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8.41
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Non-deductible expenses and other
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	0.67
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development credits
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.98
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3.55
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in valuation allowance
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(44.17
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(46.63
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)%
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	%
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December&#160;31, 2015 and 2014, the components of the Company&#8217;s deferred tax assets are as follows (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_24"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:30.38%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:13.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Deferred tax assets:
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net operating loss carryforwards
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14,830
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	11,298
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Deferred Revenue
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,656
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Start-up costs
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,260
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,423
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Research and development credits carryforwards
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,157
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1,151
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Depreciation
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(565
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(402
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Other
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	437
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	213
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:66.98%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:13.7PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total deferred tax assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	24,775
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.62%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14,683
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Less valuation allowance
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(24,775
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(14,683
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:66.98%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net deferred tax assets
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.62%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:12.88%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company&#8217;s primary deferred tax asset of $14.8 million at December&#160;31, 2015 and $11.3&#160;million at December&#160;31, 2014 relates to its net operating loss carryforwards. Based on a history of cumulative losses in recent periods and consideration of other available positive and negative evidence, the Company has recorded a valuation allowance to offset the net deferred tax assets at December&#160;31, 2015 and December&#160;31, 2014, respectively.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December 31, 2015, the Company had approximately $37.4 million and $36 million of federal and state net operating losses, respectively, that will begin to expire in 2032. As of December 31, 2015, the Company had approximately $1.8 million and $1.6 million of federal and state research and development tax credit carryovers, respectively. If not utilized, the federal credit carryforward will expire in 2032, and the state credit carryforward does not expire. The valuation allowance increased by approximately $10.1 million and $7.9 million during the years ended December 31, 2015 and 2014, respectively. In general, if the Company experiences a greater than 50 percentage point aggregate change in ownership over a three-year period (a Section 382 ownership change), utilization of its pre-change net operating loss carryforwards, or NOLs, are subject to an annual limitation under Section 382 of the Internal Revenue Code, as well as a similar law under the laws of the state of California. The annual limitation generally is determined by multiplying the value of the Company&#8217;s stock at the time of such ownership change (subject to certain adjustments) by the applicable &#8220;long-term tax-exempt rate.&#8221; Such limitations may result in expiration of a portion of the NOLs before utilization. The Company has determined that an ownership change occurred on April 20, 2015 that resulted in an annual limitation, but that all NOLs generated prior to April 20, 2015 can be utilized prior to expiration.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	As of December&#160;31, 2015 and 2014, the Company did not have a liability related to unrecognized tax benefits. All unrecognized tax benefits have been netted against the research and development deferred tax asset.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company records interest and penalties related to unrecognized tax benefits within income tax expense. As of December 31, 2015 and 2014, the Company had not accrued any interest or penalties related to unrecognized tax benefits. The Company is subject to U.S. federal and California income tax assessment for years beginning in 2011. However, since the Company has incurred net operating losses every year since inception, all of its income tax returns are subject to examination and adjustments by the Internal Revenue Service for at least three years and by California Franchise Tax Board for four years following the year in which the tax attributes are utilized. The Company does not believe that there will be a material change in it unrecognized tax positions over the next twelve months. There is no amount of unrecognized tax benefit that, if recognized, would affect the effective tax rate.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-26
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage104"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA, INC.
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Notes to Consolidated Financial Statements&#8212;(Continued)
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:18PT;MARGIN-BOTTOM:0PT;MARGIN-LEFT:2.27%;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU103">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Uncertain Tax Positions
</FONT>
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company has not been audited by the Internal Revenue Service or any state tax authority. It is subject to taxation in the United States. Because of the net operating loss and research credit carryforwards, substantially all of its tax years, from 2012 through 2015, remain open to U.S. federal and California state tax examinations.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	There were no interest or penalties accrued at December&#160;31, 2014 and 2015.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	At December 31, 2015 and 2014, the Company&#8217;s reserve for unrecognized tax benefits is approximately $719,000 and $465,000, respectively. Due to the full valuation allowance at December 31, 2015, current adjustments to the unrecognized tax benefit will have no impact on the Company&#8217;s effective income tax rate.
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_25"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:80%;">
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:40.1%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	For the
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Year Ended December 31,
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:CALIBRI;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:11.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2013
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:57.48%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Beginning balance
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	465
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	56
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.38%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:11PT;FONT-FAMILY:CALIBRI;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	7
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.48%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Increases of unrecognized tax benefits related to current year
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	254
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	409
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:11PT;FONT-FAMILY:CALIBRI;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-BOTTOM:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	49
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:57.48%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Ending balance
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	719
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	465
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.38%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:11PT;FONT-FAMILY:CALIBRI;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.76%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:DOUBLE 2.5PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	56
</P>
</TD>
<TD VALIGN="BOTTOM" BGCOLOR="#CFF0FC" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:DOUBLE 2.5PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-SIZE:1PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The Company does not anticipate material changes to its uncertain tax positions through the next 12 months.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	13. Subsequent Events
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:6PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Since December 31, 2015, the Company granted 605,134 stock options with a weighted-average exercise price of $8.79 to directors, officers and employees.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	14. Quarterly Financial Data (unaudited)
</P>
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	The following table summarizes the unaudited quarterly financial data for the last two fiscal years (in thousands, except per share data):
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_26"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:90%;">
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(in thousands, except per share amounts)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	First
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Second
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Third
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Fourth
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:50.34%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Quarter
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Quarter
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Quarter
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1.22%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="2" VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:10.18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Quarter
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%; BORDER-TOP:SOLID 0.75PT #000000;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Revenues
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,550
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,549
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,550
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,550
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total operating expenses
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8,381
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8,625
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8,972
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	11,434
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss attributable to common stockholders
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(5,485
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(6,782
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(7,388
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(8,540
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Basic and diluted net loss per common share
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2.47
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2.78
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2.78
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(0.48
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2014
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Revenues
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2,366
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3,550
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Total operating expense
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4,827
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,749
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5,755
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	6,803
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Net loss attributable to common stockholders
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(5,442
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(6,284
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(4,729
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(3,396
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#CCEEFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:50.34%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:6.85PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Basic and diluted net loss per common share
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(3.56
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(3.79
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(2.77
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1.22%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	$
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:9.18%;WHITE-SPACE:NOWRAP;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(1.62
</P>
</TD>
<TD VALIGN="MIDDLE" BGCOLOR="#FFFFFF" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0.75PT;PADDING-TOP:0.75PT;PADDING-BOTTOM:0PT;WIDTH:1%;WHITE-SPACE:NOWRAP;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	)
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	F-27
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
<A NAME="eolPage105"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<EFX_SIGNATURES>
<A NAME="FIS_SIGNATURES"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU104">
</A>
<A NAME="MYOK-10K_20151231_HTM_SIGNATURES">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM_SIGNATURES">
</A>
	SIGNAT
</FONT>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	URES
</FONT>
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:59.76%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD COLSPAN="3" VALIGN="TOP" STYLE="WIDTH:40.24%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MYOKARDIA,&#160;INC.
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:59.76%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD COLSPAN="3" VALIGN="TOP" STYLE="WIDTH:40.24%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:12PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:59.76%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:2.68%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	By:
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:0.78%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:36.78%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Tassos Gianakakos
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:59.76%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:2.68%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:0.78%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:36.78%; BORDER-TOP:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Tassos Gianakakos
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Chief Executive Officer
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Principal Executive Officer and Authorized Signatory)
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:8PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	POWER OF ATTORNEY
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Tassos Gianakakos and Steven Chan, as his true and lawful attorney-in-fact and agent, with full power of substitution for him, and in his name in any and all capacities, to sign any and all amendments to this Annual Report on Form&#160;10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents and their respective substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report on Form&#160;10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Signature
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Title
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.98%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Date
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Tassos Gianakakos
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	President and Chief Executive Officer and Director (Principal Executive Officer)
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March&#160;18, 2016
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-TOP:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Tassos Gianakakos
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Steven Chan
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Vice President, Corporate Controller (Principal Financial and Accounting Officer)
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March&#160;18, 2016
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-TOP:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Steven Chan
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Charles Homcy, M.D.
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Director
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March&#160;18, 2016
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-TOP:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Charles Homcy, M.D.
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Mark Perry
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Director
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March&#160;18, 2016
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-TOP:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Mark Perry
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Kevin Starr
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Director
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March&#160;18, 2016
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-TOP:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Kevin Starr
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Eric Topol, M.D.
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Director
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March&#160;18, 2016
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-TOP:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Eric Topol, M.D.
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-BOTTOM:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Sunil Agarwal, M.D.
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:32.9%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Director
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.98%; BORDER-BOTTOM:SOLID 1PT TRANSPARENT;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March&#160;18, 2016
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:31.46%; BORDER-TOP:SOLID 1PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Sunil Agarwal, M.D.
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:32.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:31.98%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
</EFX_SIGNATURES>
<A NAME="eolPage106"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<EFX_EXHIBIT_INDEX>
<A NAME="FIS_EXHIBIT_INDEX"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<A NAME="MYOK-10K_20151231_HTM__AEIOULASTRENDEREDPAGEBREAKAEIOU105">
</A>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	EXHIBIT INDEX
</FONT>
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_27"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="WIDTH:25.56%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Incorporated by Reference
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Number
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit Title
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Form
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	File No.
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filing Date
</P>
</TD>
</TR>
<TR>
<TD VALIGN="MIDDLE" STYLE="WIDTH:9%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" STYLE="WIDTH:33.9%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" STYLE="WIDTH:9%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" STYLE="WIDTH:14.86%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" STYLE="WIDTH:9.86%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="MIDDLE" STYLE="WIDTH:18%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;&#160;&#160;3.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Restated Certificate of Incorporation of the Registrant
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10-Q
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	001-37609
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	November&#160;18,&#160;2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;&#160;&#160;3.2
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Amended and Restated Bylaws of the Registrant
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1/A
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3.4
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	October 13, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;&#160;&#160;4.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Specimen Common Stock Certificate
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1/A
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	October 19, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;&#160;&#160;4.2
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Second Amended and Restated Investors&#8217; Rights Agreement, by and among the Registrant and certain of its stockholders dated April 20, 2015
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4.2
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;&#160;&#160;4.3
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Amendment No. 1 to Second Amended and Restated Investors&#8217; Rights Agreement, by and among the Registrant and certain of its stockholders dated April 20, 2015
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4.3
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.1#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2012 Equity Incentive Plan and forms of award agreements thereunder
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.2#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015 Stock Option and Incentive Plan and forms of award agreements thereunder
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1/A
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.2
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	October 19, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.3#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Employment Offer Letter Agreement, by and between the Registrant and Robert S. McDowell, Ph.D., dated June 8, 2012
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.3
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.4#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;LETTER-SPACING:-0.25PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Employment Offer Letter Agreement, by and between the Registrant and T. Anastasios Gianakakos, dated September 19, 2013
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.4
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.5#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Employment Offer Letter Agreement, by and between the Registrant and Jacob Bauer, dated July&#160;2, 2014
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.5
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.6#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Employment Offer Letter Agreement, by and between the Registrant and Steven Chan, dated September&#160;20, 2014
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.6
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.7#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Employment Offer Letter Agreement, by and between the Registrant and Joseph Lambing, Ph.D., dated February 27, 2014
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.7
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.8
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Lease Agreement, by and between the Registrant and HCP LS Redwood City, LLC, dated September&#160;15, 2014
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.9
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.9&#8224;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	License and Collaboration Agreement, by and between the Registrant and Aventis Inc., dated August&#160;1, 2014
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1/A
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.10
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	October 27, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.10#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Form of Indemnification Agreement, by and between the Registrant and each of its directors and officers
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1/A
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.11
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	October 13, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.11#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2015 Employee Stock Purchase Plan
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1/A
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.14
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	October 19, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;
<FONT STYLE="COLOR:#000000;">
	&#160;10.12#
</FONT>
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Change in Control Policy
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1/A
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.15
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	October 19, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.13#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Non-Employee Director Compensation Policy
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1/A
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.16
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	October 19, 2015
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<HR STYLE="PAGE-BREAK-AFTER:ALWAYS;WIDTH:100%;">
</EFX_UNIDENTIFIED_TABLE>
<A NAME="eolPage107"></A>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_28"></A>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="WIDTH:25.56%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Incorporated by Reference
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Number
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit Title
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Form
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	File No.
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%; BORDER-TOP:SOLID 0.75PT #000000; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;;FONT-SIZE:8PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-WEIGHT:BOLD;COLOR:#000000;FONT-SIZE:8PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filing Date
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;10.14#
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Senior Executive Cash Incentive Policy
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	8-K
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	001-37609
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	10.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	February 5, 2016
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;21.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	List of Subsidiaries
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	S-1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	333-207151
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	21.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	September 28, 2015
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;23.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Consent of independent registered public&nbsp;&nbsp;accounting firm
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;24.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Power of attorney (included on signature page to this Annual Report)
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;31.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Certification of Principal Executive Officer of the Registrant, as required by Rule&#160;13a-14(a) or Rule&#160;15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section&#160;302 of the Sarbanes-Oxley Act of&#160;2002.
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;31.2
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Certification of Principal Financial Officer of the Registrant, as required by Rule&#160;13a-14(a) or Rule&#160;15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section&#160;302 of the Sarbanes-Oxley Act
<FONT STYLE="COLOR:#000000;">
	of&#160;2002
</FONT>
	.
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;32.1
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Certification by the Principal Executive Officer, as required by Rule&#160;13a-14(b) or Rule&#160;15d-14(b) and Section&#160;1350 of Chapter&#160;36 of Title 18 of the United States Code (18&#160;U.S.C. &#167;1350).
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;&#160;&#160;32.2
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Certification by the Principal Financial Officer, as required by Rule&#160;13a-14(b) or Rule&#160;15d-14(b) and Section&#160;1350 of Chapter&#160;36 of Title 18 of the United States Code (18&#160;U.S.C. &#167;1350).
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;101.INS
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	XBRL Instance Document
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;101.SCH
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	XBRL Taxonomy Extension Schema Document
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;101.CAL
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	XBRL Taxonomy Extension Calculation Linkbase Document
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;101.DEF
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	XBRL Taxonomy Extension Definition Linkbase Document
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;101.LAB
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	XBRL Taxonomy Extension Label Linkbase Document
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-SIZE:6PT;">
	&nbsp;
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#160;101.PRE
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:33.9%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	XBRL Taxonomy Extension Presentation Linkbase Document
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:14.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:9.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#252525;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8212;
</P>
</TD>
<TD VALIGN="TOP" STYLE="PADDING-LEFT:0PT;PADDING-RIGHT:0PT;WIDTH:0.86%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="BOTTOM" STYLE="WIDTH:18%;">
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Filed herewith
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<P STYLE="BORDER-BOTTOM:SOLID 0.75PT;PADDING-BOTTOM:1PT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-RIGHT:86.67%;TEXT-INDENT:0%;FONT-SIZE:6PT;">
	&nbsp;
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	&#8224;
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	An order for confidential treatment of certain provisions has been granted by the Securities and Exchange Commission. Omitted material for which confidential treatment has been requested has been filed separately with the Securities and Exchange Commission.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	#
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Represents management compensation plan, contract or arrangement.
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_EXHIBIT_INDEX>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:9PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</EFX_FORM>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage108"></A>
<A NAME="MYOK-EX231_10_HTM"></A>
<EFX_EXHIBIT_23>
<A NAME="FIS_EXHIBIT_23"></A>
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	EXHIBIT 23.1
</P>
<EFX_EXPERTS_CONSENT>
<A NAME="FIS_EXPERTS_CONSENT"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	To the Board of Directors and Stockholders
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	MyoKardia, Inc.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:12PT;TEXT-INDENT:4.54%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	We hereby consent to the incorporation by reference in the Registration Statement on Form S&#8209;8 (No. 333- 207674) of MyoKardia, Inc. of our report dated March 18, 2016 relating to the financial statements, which appears in this Form 10&#8209;K.
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:18PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ PricewaterhouseCoopers LLP
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:10PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	San Jose, California
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March 18, 2016
</P>
</EFX_EXPERTS_CONSENT>
</EFX_EXHIBIT_23>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage109"></A>
<A NAME="MYOK-EX311_9_HTM"></A>
<EFX_EXHIBIT_31>
<A NAME="FIS_EXHIBIT_31"></A>
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit&#160;31.1
</P>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	CERTIFICATIONS
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;MARGIN-RIGHT:10%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	I, Tassos Gianakakos, certify that:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:12PT;">
<FONT STYLE="FONT-SIZE:10PT;">
	I have reviewed this Annual Report on Form&#160;10
</FONT>
<FONT STYLE="FONT-FAMILY:MS MINCHO;FONT-SIZE:10PT;">
	&#8209;
</FONT>
<FONT STYLE="FONT-SIZE:10PT;">
	K of MyoKardia,&#160;Inc.;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:12PT;">
<FONT STYLE="FONT-SIZE:10PT;">
	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:12PT;">
<FONT STYLE="FONT-SIZE:10PT;">
	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:12PT;">
<FONT STYLE="FONT-SIZE:10PT;">
	The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a
</FONT>
<FONT STYLE="FONT-FAMILY:MS MINCHO;FONT-SIZE:10PT;">
	&#8209;
</FONT>
<FONT STYLE="FONT-SIZE:10PT;">
	15(e) and 15d
</FONT>
<FONT STYLE="FONT-FAMILY:MS MINCHO;FONT-SIZE:10PT;">
	&#8209;
</FONT>
<FONT STYLE="FONT-SIZE:10PT;">
	15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a
</FONT>
<FONT STYLE="FONT-FAMILY:MS MINCHO;FONT-SIZE:10PT;">
	&#8209;
</FONT>
<FONT STYLE="FONT-SIZE:10PT;">
	15(f) and 15d
</FONT>
<FONT STYLE="FONT-FAMILY:MS MINCHO;FONT-SIZE:10PT;">
	&#8209;
</FONT>
<FONT STYLE="FONT-SIZE:10PT;">
	15(f)) for the registrant and have:
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:12PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(a)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:12PT;">
<FONT STYLE="FONT-SIZE:10PT;">
	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(b)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(c)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(a)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(b)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-RIGHT:10%;TEXT-INDENT:0%;FONT-SIZE:12PT;">
	&nbsp;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:54%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March 18, 2016
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:45%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Tassos Gianakakos
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:54%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:45%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Tassos Gianakakos
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Chief Executive Officer
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Principal Executive Officer)
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_CERTIFICATION>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-RIGHT:10%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</EFX_EXHIBIT_31>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage110"></A>
<A NAME="MYOK-EX312_8_HTM"></A>
<EFX_EXHIBIT_31>
<A NAME="FIS_EXHIBIT_31_2"></A>
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit&#160;31.2
</P>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION_2"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	CERTIFICATIONS
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;MARGIN-RIGHT:10%;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	I, Steven Chan, certify that:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	I have reviewed this Annual Report on Form&#160;10
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	K of MyoKardia,&#160;Inc.;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	3.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	4.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	15(e) and 15d
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	15(f) and 15d
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	15(f)) for the registrant and have:
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(a)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(b)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(c)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	5.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(a)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(b)
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:6PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-SIZE:12PT;">
	&nbsp;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:54%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March 18, 2016
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:45%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Steven Chan
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:54%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:45%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Steven Chan
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Vice President, Corporate Controller
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Principal Financial and Accounting Officer)
</P>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_CERTIFICATION>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</EFX_EXHIBIT_31>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage111"></A>
<A NAME="MYOK-EX321_7_HTM"></A>
<EFX_EXHIBIT_32>
<A NAME="FIS_EXHIBIT_32"></A>
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit&#160;32.1
</P>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION_3"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION&#160;1350,
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	AS ADOPTED PURSUANT TO SECTION&#160;906
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	OF THE SARBANES-OXLEY ACT OF&#160;2002
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	I, Tassos Gianakakos, the Chief Executive Officer of MyoKardia, Inc. (the &#8220;Company&#8221;), do hereby certify in accordance with 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	Oxley Act of 2002 that, based upon my knowledge:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:12PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:12PT;">
<FONT STYLE="FONT-SIZE:10PT;">
	This Annual Report on Form 10-K of the Company, to which this certification is attached as an exhibit (the &#8220;Report&#8221;), fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934; and
</FONT>
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:54%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March 18, 2016
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:45%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Tassos Gianakakos
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:54%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:45%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Tassos Gianakakos
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Chief Executive Officer
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Principal Executive Officer)
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	A signed original of this written statement required by Rule&#160;13a-14(b) of the Securities Exchange Act of 1934, as amended, and Section&#160;1350 of Chapter&#160;63 of Title 18 of the United States Code (18 U.S.C. Section&#160;1350), has been provided to MyoKardia,&#160;Inc. and will be retained by MyoKardia,&#160;Inc. and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies the Form&#160;10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of MyoKardia Pharmaceuticals,&#160;Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form&#160;10-K), irrespective of any general incorporation language contained in such filing.
</P>
</EFX_CERTIFICATION>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</EFX_EXHIBIT_32>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage112"></A>
<A NAME="MYOK-EX322_6_HTM"></A>
<EFX_EXHIBIT_32>
<A NAME="FIS_EXHIBIT_32_2"></A>
<P STYLE="TEXT-ALIGN:RIGHT;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Exhibit&#160;32.2
</P>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION_4"></A>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION&#160;1350,
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	AS ADOPTED PURSUANT TO SECTION&#160;906
</P>
<P STYLE="TEXT-ALIGN:CENTER;MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	OF THE SARBANES-OXLEY ACT OF&#160;2002
</P>
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	In connection with the Annual Report of MyoKardia,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	K for the period ended December&#160;31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Steven Chan, the Vice President, Corporate Controller (Principal Financial and Accounting Officer) of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes
<FONT STYLE="FONT-FAMILY:MS MINCHO;">
	&#8209;
</FONT>
	Oxley Act of 2002, that:
</P>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	1.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-TOP:12PT;MARGIN-BOTTOM:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934; and
</P>
</TD>
</TR>
</TABLE>
</DIV>
<DIV ALIGN="LEFT">
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:4.54%;WHITE-SPACE:NOWRAP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	2.
</FONT>
</P>
</TD>
<TD VALIGN="TOP">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<DIV>
<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="BORDER-COLLAPSE:COLLAPSE; WIDTH:100%;">
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:54%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	March 18, 2016
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%; BORDER-BOTTOM:SOLID 0.75PT TRANSPARENT;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:45%; BORDER-BOTTOM:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	/s/ Steven Chan
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" STYLE="WIDTH:54%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:1%;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</TD>
<TD VALIGN="TOP" STYLE="WIDTH:45%; BORDER-TOP:SOLID 0.75PT #000000;">
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Steven Chan
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	Vice President, Corporate Controller
</P>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;MARGIN-LEFT:0PT;;TEXT-INDENT:0PT;;FONT-STYLE:ITALIC;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	(Principal Financial and Accounting Officer)
</P>
</TD>
</TR>
</TABLE>
</DIV>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
<P STYLE="MARGIN-TOP:2PT;MARGIN-BOTTOM:0PT;TEXT-INDENT:4.54%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;FONT-WEIGHT:NORMAL;FONT-STYLE:NORMAL;TEXT-TRANSFORM:NONE;FONT-VARIANT: NORMAL;">
	A signed original of this written statement required by Rule&#160;13a-14(b) of the Securities Exchange Act of 1934, as amended, and Section&#160;1350 of Chapter&#160;63 of Title 18 of the United States Code (18 U.S.C. Section&#160;1350), has been provided to MyoKardia,&#160;Inc. and will be retained by MyoKardia,&#160;Inc. and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies the Form&#160;10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of MyoKardia,&#160;Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form&#160;10-K), irrespective of any general incorporation language contained in such filing.
</P>
</EFX_CERTIFICATION>
<P STYLE="MARGIN-BOTTOM:0PT;MARGIN-TOP:0PT;TEXT-INDENT:0%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:10PT;">
	&nbsp;
</P>
</EFX_EXHIBIT_32>

<!-- FOOTER LOGO -->
</BODY>
</HTML>
